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ABSTRACT
IDENTIFYING THE CARDIOVASCULAR EFFECTS OF MULTIPLE POLLUTANTS
Katlyn E. McGraw
7 April 2021
Cardiovascular disease (CVD) is the leading cause of death from environmental
exposures. Although exposure to PM2.5 is an established risk factor for CVD, the contribution of
other hazardous pollutant exposure to CVD is less clear. Overall, this work aimed to examine the
effect of pollutants with lesser documented effects on cardiovascular disease using a multipronged approach to exposure assessment. The three aims were to examine the relationship
between county-level toxic chemical releases and CVD mortality in the contiguous United States
between 2002 and 2012, to assess the relationship between individual-level VOC metabolites
and vascular function, and to build multipollutant models from the previous two aims to assess
the role of mixtures and mixture components in CVD mortality and vascular function. In our
national, county-level study, we found that for every 25% increase in annual county-level toxic
release, we found a 2.8% (1.2, 4.4; p-value=0.0006) increase in CVD mortality rate. We also
found that for every 25% increase in annual county-level risk score, there was a 3.0% (95%CI
1.3, 4.6; p-value=0.0003) increase in CVD mortality. Using the multipollutant method, elastic net,
we identified five out of 467 potentially toxic chemicals at the county-level: bromoform,
dichlorobromomethane, dichlorotrifluoroethane, nitrophenol, and thallium. In our study of
individual-level VOC metabolites, we found that the acrolein metabolite, 3HPMA, was positively
associated with systolic BP (+0.98 per SD of 3HPMA; CI: 0.04, 1.91; P=0.04). For each IQR of
3HPMA or DHBMA (a 1,3-butadiene metabolite), there was a 3.3% (CI: -6.18, -0.37; p-value:
0.03) or a 4.0% (CI: -7.72, -0.12; P=0.04) decrease in endothelial function. Urinary levels of the
1,3-butadiene metabolite, MHBMA3, were positively associated with a 2.9% increase in urinary
epinephrine (CI: 0.48, 5.37; P=0.02). Using the multipollutant method, Bayesian Kernel Machine

v

Regression, we found that the whole mixture of VOC metabolites (CEMA, 3HPMA, DHBMA,
MHBMA3, and HPMMA) was significantly associated with blood pressure, which was primarily
driven by 3HPMA. Taken together, these findings suggest that exposure to under regulated
pollutants like TRI chemicals and VOCs contribute to CVD mortality and vascular dysfunction.
Further research is required to corroborate these findings.
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POLLUTION AND CARDIOVASCULAR DISEASE

INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of death from environmental
exposures, surpassing cancer mortality.1 In 2017, the Lancet Commission on Pollution and
Health estimated the global burden of disease caused by pollution is responsible for 9 million
premature deaths annually.2 Approximately seven million premature deaths are attributed to
either household or ambient air pollution.3 The World Health Organization estimates that
exposure to air pollution is associated with 1.4 million deaths from stroke and 2.4 million deaths
from heart disease, annually.3
Air pollution is a mixture of particulates and gaseous components, including particulate
matter, nitrogen oxides, sulfur dioxides, ozone, carbon monoxide, organic and black carbon, and
volatile organic compounds (VOCs).The majority of air pollution studies use population weighted,
annual mean concentrations of particulate matter of diameter 2.5 µm (PM2.5) and tropospheric
ozone (O3) to estimate air pollution exposure-related mortality.4 However, even though the links
between exposure to these two pollutants and CVD are well-documented,5-7 PM2.5 and O3 only
represent a portion of multifactorial pollution. Therefore, there is a need to understand the role of
other pollutants in the development of CVD in exposed individuals.
Volatile organic compounds (VOCs) are gaseous compounds that comprise a major part
of indoor and outdoor air pollution. Primary sources of VOCs are combustion from tobacco smoke
and vehicle exhaust, industrial releases, hazardous waste sites, consumer goods production, and
products that contain organic solvents.8 VOCs also interact with other pollutants to create
intermediates and secondary pollutants such as tropospheric O3 and secondary organic aerosols
(SOAs), a major component of particulate matter.9, 10 However, compared with PM2.5, VOC
exposure approximation is complicated by a lack of routine air monitoring of VOCs,11, 12 large
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variations of VOCs in space and time,13, 14 and a high volume of chemicals in production each
year.15 Despite decreasing national trends in pollutants,11, 12, 16 VOCs remain under-regulated and
uncharacterized in relation to cardiovascular health.
Although there are difficulties inherent in the quantification of VOCs and VOC exposure,
some evidence suggests exposure to VOCs causes adverse health effects such as CVD. Previous
epidemiological studies have shown significant associations between exposure to ambient VOCs
such as alkenes, alkynes, and BTEX compounds (benzene, toluene, ethyl benzene and xylene)
and cardiovascular events such as heart failure,17 stroke,
cardiovascular mortality rates.20

18

ischemic heart disease,

18, 19

and

Indoor exposure to total VOCs has been associated with

increased blood pressure and heart rate,21 and VOC metabolites measured in blood are associated
with an increased prevalence of doctor-diagnosed CVD in the National Health and Nutrition
Examination Survey (NHANES) cohort.22 Hazardous air pollutants (HAPs) released from industrial
facilities are associated with cardiovascular mortality in an ecological study, many of which are
classified as VOC.19 Likewise, VOC-containing mixtures of pollutants such as automobile and
diesel engine emissions, and tobacco smoke have been linked to the development of CVD.23-29
However, the role of individual VOCs and mixtures of VOCs in CVD pathophysiology remains to
be identified in human studies.
To better understand the role of VOC exposure in the development of CVD, I proposed
three distinct methods to assess human exposure to VOCs: source proximity, human
biomonitoring, and mixture modelling. These three methods were then used to assess the
relationship between VOC exposure and CVD, the overall research goal. This study fills a gap in
existing literature around VOCs, specifically in exposure assessment methods, as well as
presenting further evidence of a relationship between VOC exposure and CVD. Although these
exposure assessment methods have been used before, this study extends prior research by
using both aggregate and individual level data, longitudinal data, mixed models, and mixture
analyses to improve previously published work. This study improves and provides new models to
elucidate the link between exposure to VOCs and CVD in humans.
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To provide context for this study, I briefly describe national VOC trends, classification,
and sources of VOCs. Next, I describe the regulation, surveillance, and measurement of VOCs to
give context to the exposure assessment problem. I then evaluate the literature on exposure to
VOCs and CVD in ecological and epidemiological studies. The problem is then stated with an
outline of the hypotheses and aims. I further introduce the rationale, relevance, and significance
of the study, and describe assumptions, limitations, and delimitations of the study. Terms are
defined and a description of the following chapters ends the introductory chapter.
BACKGROUND
General Overview of VOCs
The National Emissions Inventory Report estimated VOC emissions represent 13.7% of
total emissions in 2014. Despite reductions in VOC emissions from approximately 20.2 million
tons in 2002 to 16.9 million tons in 2014,30 VOCs continue to be prevalent as they arise from
other major, area, and mobile sources. The regulation of VOCs occurs largely via maximum
control technologies, emission reduction programs, and mobile source regulation. However, the
extent to which VOCs are present in our environment is underestimated by the lack of routine
monitoring. Thus, it is important to acknowledge the impact of VOCs in our environment and to
better understand their role in contributing to adverse health effects.
VOCs represent a large class of chemicals defined by high vapor pressure, low boiling
point, and low molecular weight. Therefore, these compounds volatilize quickly into the
atmosphere, signifying their importance as an environmental pollutant in indoor and outdoor air.
They contain carbon and are emitted from liquids and solids, or are released during combustion.31
High vapor pressure is the property which first led to regulation and nomenclature of VOCs due to
their ability to vaporize into the atmosphere and contribute to photochemical smog or ozone, a
federally regulated secondary pollutant. The U.S. Environmental Protection Agency (EPA) defines
a VOC as ‘…any compound of carbon, excluding carbon monoxide, carbon dioxide, carbonic
acid, metallic carbides or carbonates, and ammonium carbonate, which participates in
atmospheric photochemical reactions.’32 Although VOCs are prevalent in air as primary and
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secondary pollutants, they also contaminate soil and drinking water, especially in close proximity
to hazardous waste sites.33, 34
VOCs are ubiquitous in the environment, varying spatially and temporally because of
weight and reactivity.20 They arise from both anthropogenic and natural sources. Natural sources
include volcanoes, vegetation, and animals. Anthropogenic sources include combustion
processes such as vehicle exhaust or fuel combustion, industry emissions, chemical feedstocks
to produce consumer products, oil and gas, and waste sites. Source types include point, area,
and mobile sources. Point sources, or major sources, are stationary sources such as industrial
facilities, chemical plants, steel mills, oil refineries and hazardous waste incinerators. Area
sources are multiple, smaller sources which release pollutants into the air like dry cleaners, gas
stations, and woodstoves. Mobile sources are cars, trucks, trains, airplanes, marine vessels, and
other non-road equipment. Major sources are divided into sectors: agriculture, dust, fire, fuel
combustion, industrial processes, miscellaneous, mobile, and solvent. Point source pollution is a
localized source of toxics while area source emissions are well-distributed. Federal regulation of
VOCs occurs only at area and point sources.
VOCs are a major source of indoor pollution as well. The average person spends at least
80% of time indoors.35 According to the EPA, indoor VOC levels are much higher than outdoor,
mostly due to inadequate ventilation after diffusion of ambient pollution indoor. Indoor VOCs
come from many household and common consumer products such as cosmetics, personal care
products, furniture, cleaning products, and building materials. Thus, these organics are ubiquitous
in the indoor and outdoor environment, threatening all routes of human exposure.
Exposure to VOCs can cause varied human health effects, such as neurological
disorders, organ toxicity, and cancer, dependent on the chemical compound. Many VOCs are
thereby classified hazardous air pollutants (HAPs) or air toxics.36 The Clean Air Act (CAA) lists
188 chemicals as HAPs known to be harmful to human health (Table 1-1), several of which are
VOCs. Federal public health and regulatory agencies, such as the Environmental Protection
Agency (EPA), the Agency for Toxic Substances and Disease Registry (ATSDR), and the
Occupational Health and Safety Administration (OSHA) publish permissible rates of human
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exposure, based on established toxicological studies of humans and animals. However, many
permissible rates originate from occupational cohorts with large doses, values not indicative of
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Table 1-1.
Hazardous Air
Pollutants under the
Clean Air Act.
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Acetaldehyde
Acetamide
Acetonitrile
Acetophenone
2-Acetylaminofluorene
Acrolein
Acrylamide
Acrylic acid
Acrylonitrile
Allyl chloride
4-Aminobiphenyl
Aniline
o-Anisidine
Asbestos
Benzene-including
gasoline
Benzidine
Benzotrichloride
Benzyl chloride
Biphenyl
Bis(2-ethylhexyl)phthalate
Bis(chloromethyl)ether
Bromoform
1,3-Butadiene
Calcium cyanamide
Caprolactam
Captan
Carbaryl
Carbon disulfide
Carbon tetrachloride
Carbonyl sulfide
Catechol

Chloramben
Chlordane
Chlorine
Chloroacetic acid
2-Chloroacetophenone
Chlorobenzene
Chlorobenzilate
Chloroform
Chloromethyl methyl ether
Chloroprene
Cresols/Cresylic acid
o-Cresol
m-Cresol
p-Creso
Cumene
2,4-D, salts and esters
DDE
Diazomethane
Dibenzofurans
1,2-Dibromo-3chloropropane
Dibutylphthalate
1,4-Dichlorobenzene(p)
3,3-Dichlorobenzidene
Dichloroethyl ether
1,3-Dichloropropene
Dichlorvos
Diethanolamine
N,N-Dimethylaniline
Diethyl sulfate
3,3-Dimethoxybenzidine
Dimethyl
aminoazobenzene
3,3'-Dimethyl benzidine
Dimethyl carbamoyl
chloride
Dimethyl formamide
1,1-Dimethyl hydrazine
Dimethyl phthalate
Dimethyl sulfate
4,6-Dinitro-o-cresol
2,4-Dinitrophenol
2,4-Dinitrotoluene

1,4-Dioxane
1,2-Diphenylhydrazine
Epichlorohydrin
1,2-Epoxybutane
Ethyl acrylate
Ethyl benzene
Ethyl carbamate
Ethyl chloride
Ethylene dibromide
Ethylene dichloride
Ethylene glycol
Ethylene imine
Ethylene oxide
Ethylene thiourea
Ethylidene dichloride
Formaldehyde
Heptachlor
Hexachlorobenzene
Hexachlorobutadiene
Hexachlorocyclopentadie
Hexachloroethane
Hexamethylene-1,6diisocyanate
Hexamethylphosphoramid
Hexane
Hydrazine
Hydrochloric acid
Hydrogen fluoride
Hydrogen sulfide
Hydroquinone
Isophorone
Lindane
Maleic anhydride
Methanol
Methoxychlor
Methyl bromide
Methyl chloride
Methyl chloroform
Methyl ethyl ketone
Methyl hydrazine
Methyl iodide
Methyl isobutyl ketone
Methyl isocyanate

Methyl methacrylate
Methyl tert butyl ether
4,4-Methylene bis(2chloroaniline)
Methylene chloride
Methylene diphenyl
diisocyanate (MDI)
4,4'-Methylenedianiline
Naphthalene
Nitrobenzene
4-Nitrobiphenyl
4-Nitrophenol
2-Nitropropane
N-Nitroso-N-methylurea
N-Nitrosodimethylamine
N-Nitrosomorpholine
Parathion
Pentachloronitrobenzene
Pentachlorophenol
Phenol
p-Phenylenediamine
Phosgene
Phosphine
Phosphorus
Phthalic anhydride
Polychlorinated biphenyls
1,3-Propane sultone
beta-Propiolactone
Propionaldehyde
Propoxur
Propylene dichloride
Propylene oxide
1,2-Propylenimine
Quinoline
Quinone
Styrene
Styrene oxide
2,3,7,8Tetrachlorodibenzo-pdioxin
1,1,2,2Tetrachloroethane
Tetrachloroethylene

Titanium tetrachloride
Toluene
2,4-Toluene diamine
2,4-Toluene diisocyanate
o-Toluidine
Toxaphene
1,2,4-Trichlorobenzene
1,1,2-Trichloroethane
Trichloroethylene
2,4,5-Trichlorophenol
2,4,6-Trichlorophenol
Triethylamine
Trifluralin
2,2,4-Trimethylpentane
Vinyl acetate
Vinyl bromide
Vinyl chloride
Vinylidene chloride
Xylenes all isomers
o-Xylenes
m-Xylenes
p-Xylenes
Antimony Compounds
Arsenic Compounds
Beryllium Compounds
Cadmium Compounds
Chromium Compounds
Cobalt Compounds
Coke Oven Emissions
Cyanide Compounds
Glycol ethers
Lead Compounds
Manganese Compounds
Mercury Compounds
Fine mineral fibers
Nickel Compounds
Polycyclic Organic Matter
Radionuclides
Selenium Compounds

Abundance of data: > 20 monitoring sites with sufficient data to create a valid annual average between 2003-2005, up to 434 sites
Little data: < 20 monitoring sites with sufficient data to create a valid annual average between 2003-2005, between 1-17 sites
No data: No valid annual averages between 2003-2005 from http://www.epa.gov/ttn/atw/188polls.html

the public health impact. Furthermore, toxicological studies focus on organ toxicity and
more easily measurable effects such as cancer, in lieu of more prevalent chronic diseases, such
as CVDs. Therefore, the effect of VOC exposure on cardiovascular and metabolic toxicity
remains under characterized.
Regulation of VOCs
Due to the ubiquity and harmful effects of VOCs, the federal government promulgates
regulations for emission reduction and efforts to reduce adverse health effects. There are two
major federal laws governing VOCs, the Clean Air Act (CAA), and the Emergency and
Community Right to Know Act (EPCRA). Both laws are part of Title 42 of the United States Code
on Public Health and Welfare. Title 40 is the Protection of the Environment which largely outlines
how these promulgations will be followed. The CAA was first promulgated in 1970 and continues
to be amended to meet public health and welfare needs. In Title 42, Chapter 85, Subchapter 1
Part A of the U.S. code, congress recognizes that rapid urbanization, growth in amount and
complexity of air pollution, and ability of pollution to cross boundaries as important evidence for
the regulation of air pollution for the protection of public health and welfare. The U.S. code
specifically declares ‘to protect and enhance the quality of air resources to promote public welfare
and productive capacity of the working public.’37
The key regulations of the CAA are the primary and secondary national ambient air
quality standards (NAAQS). Six criteria pollutants were named NAAQS: particulate matter (PM),
ozone (O₃), carbon monoxide (CO), sulfur dioxide (SO₂), nitrogen dioxide (NO₂), and lead (Pb).
Established NAAQS are to be thoroughly reviewed by the administrator and an independent
scientific review committee every five years to uphold applicability and relevance. States are
required to adopt and submit a plan for implementation, maintenance, and enforcement of
standards in each air quality region within the state.38 Conversely, VOCs do not have regulatory
ambient air concentrations to meet in the CAA. Instead, Section 7412 of the CAA classifies a list
of 188 hazardous air pollutants (HAPS) or air toxics, of which several are volatile organic
pollutants. According to the section, emission regulations will be promulgated by source type:
major, stationary, or area source; excluding mobile or off-road sources. Major sources are
7

stationary or multiple stationary sources with potential to emit 10 tons per year of any HAP, or
potential to emit 25 tons per year of any combination of HAPs. Hazardous air pollutants are any
pollutant listed in section 7412 (and Table 1) and represent pollutants which present or may
present adverse health effects including but not limited to carcinogenicity, teratogenicity,
mutagenicity, neurotoxicity, reproductive dysfunction, or are acutely or chronically toxic through
route of inhalation. HAPs also represent pollutants which present or may present adverse
environmental effects whether through ambient concentrations, bioaccumulation, deposition, or
releases.
Under the CAA, EPA must regulate HAPS using maximum allowable control technologies
(MACTs) or national standards for fuels, cars, and trucks. Major sources releasing HAPS (10 tons
per year) are regulated by standards requiring the application of air pollution controls known as
MACTs. Air toxics or HAPS are monitored through an air toxics program which focuses primarily
on reducing HAPS by applying available control technologies for industrial sources and area
sources. Air toxics monitoring programs measure success in reduction in emissions, not air
quality. The three primary objectives of the air toxics monitoring program are 1) determine trends
and account for program progress, 2) support exposure assessments by providing comparison
data for personal measurements, and 3) provide a basic structure for models for exposure
assessments, emission control standards, and program effectiveness assessments.39 The
National Air Toxics Monitoring Program uses three distinct monitoring methods: National Air
Toxics Trends Stations, Community Scale projects, and existing state and local program
monitoring. The EPA uses air dispersion modeling to estimate the impact of HAP emissions on
ambient air and human health through the National Air Toxics Assessment.
The second major federal law governing VOCs in the environment is the Emergency
Planning and Community Right to Know Act (EPCRA) which was first promulgated in 1986 as
Title III of the Superfund Amendments and Reauthorization Act. Title 42, Chapter 116,
Subchapters I, II, and III cover EPCRA. The chapter promulgates emergency planning and
notification, reporting requirements, and general provisions regarding hazardous chemicals and
extremely hazardous chemicals. Extremely hazardous substances require creation and
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submission of a comprehensive emergency response plan by the local emergency planning
committee (LEPC). Alternatively, the owner or operator of a facility with ten or more employees
that manufactures, processes, or otherwise uses more than 25,000 pounds of a hazardous
chemical must complete a toxic chemical release form. The administrator of the EPA establishes
and maintains a national toxic chemical release inventory based on data submitted under section
Title 42 Chapter 116 Subchapter II Section 11023. The inventory is known as the annual toxic
release inventory (TRI).
Surveillance of VOCs
To monitor and regulate VOCs and air pollution, the National Emissions Inventory (NEI)
program measures criteria pollutants, criteria precursors, and HAPs or air toxics from air
emissions sources. National, regional, state, and local air monitoring is key to regulation and
human health and ecology assessment. Ambient air monitoring is the systematic, long-term
assessment of pollution in surrounding, outdoor air and is integral to managing and maintaining
air quality and protecting public health. Some reasons to collect air pollution data are to assess
the extent of pollution, provide air pollution data to the public, support implementation of air
quality standards or goals, evaluate the effectiveness of emission control strategies, provide
information on air quality trends, provide data for the evaluation of air quality models, and to
support research. Monitoring plans are developed based on the type of pollutant and what the
data is trying to achieve.40
Public health surveillance systematically collects data on specific health events affecting
a population, analyzes and interprets those data, and effectively communicates those data to
public health professionals and lawmakers.41 Air monitoring surveillance acquires data via
stationary monitoring stations to meet four objectives: 1) to define air quality in heavily polluted
areas, 2) to define air quality in less populated areas, 3) to provide area wide representation of
ambient air quality, and 4) to define air quality with respect to the source category, or source, or
both, to provide feedback relative to the effectiveness of adopted control strategies.42 National
level surveillance helps to provide a clear distribution of the data while states collecting data
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provide more specific characteristics on a site by site basis. Monitoring is required at all levels to
understand and reduce risk, the primary objective of air toxics monitoring.43
There are two major national monitoring efforts specific to monitoring air toxics: the
National Air Toxics Trends Stations and the Urban Air Toxics Monitoring Program. Other ambient
air monitoring programs developed for other purposes but which still provide air toxics data are
Photochemical Assessment Monitoring Station program, the Chemical Speciation Network and
the Speciation Trends Network, and the Interagency Monitoring of Protected Visual Environments
(Figure 1-1 and 1-2). State and local government operate air toxics monitoring programs and
design special studies to understand air toxics in their communities.
The National Air Toxics Trends Stations (NATTS) were first created in 2003 to meet the
requirements of the Clean Air Act regarding the 187 HAPs causing adverse health effects. The
primary objective of NATTS are to provide long-term monitoring of air toxics to assess trends,
emission reduction program efficiency, and to assess and verify air quality models across the
nation. The goal of the monitoring network is to be able to detect a 15% difference between
successive 3-year annual mean concentrations.44 The NATTS currently include 27 national air
toxics trends sites with 20 in urban areas and 7 in rural areas. The National Air Toxics
Assessment (NATA) is a screening tool based on air quality monitoring and includes data from
NATTS. NATA is a screening tool for state, local, and tribal agencies that assesses outdoor air
quality with respect to emissions. NATA helps to identify areas of concern, characterize risk, and
track progress.43 Air toxic concentrations are reported at the census level. Six assessments have
been conducted and published for years 1996, 1999, 2002, 2005, 2011, and 2014.
The Urban Air Toxics Monitoring Program (UATMP) is a voluntary monitoring program
which encourages state, local, and tribal agencies to understand the nature and extent of
potentially toxic pollution in urban areas. The UATMP includes some NATTS, local scale
monitoring stations, and approximately 105 funded air toxics monitoring sites.45 The Integrated
Urban Air Toxics Strategy is part of the National Air Toxics Program and was developed by the
EPA in 1999 to further regulate air toxics in urban areas by collectively looking at large and small
industrial and commercial operations and mobile sources. The strategy addresses air toxics in
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Figure 1-1. Federal air monitoring programs monitoring hazardous air pollutants in the contiguous
United States.

Figure 1-2. Select air monitoring stations measuring volatile organic compounds classified as
hazardous air pollutants in the contiguous United States.
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urban areas and outlines actions to reduce emissions and improve understanding of the health
risks of air toxics. The goals of the strategy are 1) reduce by 75% the risk of cancer associated
with air toxics from industrial and commercial sources; 2) substantially reduce noncancer health
risks associated with air toxics from industrial and commercial sources; and 3) address
disproportionate impacts of air toxics hazards across urban areas, such as those known as hot
spots and minority and low-income communities. Air toxics pose special threats in urban areas
because they are densely populated areas with a variety of toxic sources. These pollution
sources combined could potentially pose significant health threats. Furthermore, minority and low
income communities are often closely located to industrial and commercial urbanized areas
indicating environmental injustice.46
Other programs under which VOCs are monitored are the Photochemical Assessment
Monitoring Station Program, Chemical Speciation Network, and the Interagency Monitoring of
Protected Visual Environments. The primary objective of the Photochemical Assessment
Monitoring Station Program (PAMS) is to assess ozone control programs by identifying key
constituents, tracking trends, characterizing transport, assisting in forecasting episodes, and
assisting in improving emission inventories. The VOCs measured in the PAMS network include
acetaldehyde, benzene, ethylbenzene, formaldehyde, styrene, toluene, and xylenes. State
implementation plans are required to implement measures for monitoring ozone precursors. Title
40 of the Code of Regulations, Part 58 requires states to establish PAMS as part of their state
implementation plan monitoring networks in ozone nonattainment areas classified as serious,
severe, or extreme.47 The Chemical Speciation Network (CSN) supports the PM2.5 NAAQS. The
purpose of the CSN is to provide nationally consistent speciated PM2.5 data for the assessment
of trends. The CSN quantifies mass concentrations and PM2.5 constituents which include trace
elements, elemental carbon, and organic carbon.43 The Interagency Monitoring of Protected
Visual Environments (IMPROVE) program also provides PM2.5 speciation and mass
measurements in national parks and wilderness areas. However speciated PM2.5 metals are the
only toxics measured in this network. 43
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Finally, state and local air monitoring programs inform local air quality. The EPA began
programs to fund local scale monitoring programs in the 2004 fiscal year. The goal of local air
monitoring is to provide more flexibility to address middle and neighborhood scale issues that are
not handled well by national networks. Specific objectives include identifying and profiling air
toxics sources, developing and assessing emerging measurement methods, characterizing the
degree and extent of local air toxics problems, and tracking progress of air toxics reduction
activities. Projects are selected through an open competition process. Local scale monitoring is
typically conducted for one and a half to three years. Expected outcomes of these projects are
increased state, local, and tribal agency ability to 1) characterize the sources and local
distribution of HAPS, and 2) assess human exposure and risk at a local scale. The program is
referred to as the Community Scale Air Toxics Ambient Monitoring (CSATAM) projects.43, 48
Measurement of VOCs in Air
Air toxics or HAPS are present in the atmosphere in gaseous, particulate, and semivolatile form and are therefore difficult to quantify with one single measurement method.
Differences in chemical and physical properties of compounds further complicate quantification of
HAPS. The choice of measurement technique depends on the objectives of data collection
including chemical species of interest, funds available, and desired detection limit.
Measurement in air requires three main components: sample method, extraction method,
and detection method.49 Sampling methods include active, passive, and grab sampling. Active
sampling uses a pump to draw in a specified volume of air through an absorbent tube, at a
constant, low flow rate. Active sampling is advantageous in long-term or regulatory settings due
to the ability to constantly monitor. Passive sampling contains an absorbent material covered by
cross-section tube and functions by diffusion. The distance between the cross-section and
absorbent material determines the sampling rate. Grab sampling uses a stainless steel cannister
with a flow restrictive inlet. Grab sampling is useful for short sampling times of 10-30 seconds in
microenvironments.
Sample extraction is important to remove the sample for further analysis. Some common
extraction methods are chemical and thermal desorption, solvent extraction, and solid phase
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microextraction. Chemical desorption uses organic solvent to desorb target VOCs from solid
sorbent. Thermal desorption subjects the sorbent to high temperatures of 200°C to 380°C to
remove the analyte. Passive sampler membrane extraction transfers analyte from a donor to an
acceptor phase using a multi-membrane device.
Gas chromatography is the commonly employed method for VOC detection.
Chromatography separates the analyte in a column containing liquid stationary phase. A carrier
gas transports the analyte through the column to be eluted by polarity. The detector produces
quantified measurements of peaks and retention times for speciated VOCs as they come off the
column. Gas chromatography varies by detection method and includes mass spectrometer (MS),
flame Ionization (FID), thermal conductivity (TCD), electron-capture (ECD), atomic emission
(AED), chemiluminescence (CS), and photoionization (PID). Depending on mixture sample, a
specific detector may be more applicable. Mass spectrometers are the most beneficial due to
their ability to identify unknown components and applicability to any sample. Flame ionization is
commonly used for analysis of hydrocarbons of low molecular weight. Specifically, FID is
unaffected by flow rate, noncombustible gases, and water, allowing high sensitivity and low noise.
Electron capture detectors are highly selective and sensitive of electronegative groups.
Photoionization detectors are selective of aromatic compounds, and inorganic and organic
species and commonly used for air, water, and soil samples.50
Measurement of VOCs in air is difficult due to the large variation in chemicals, multiple
available techniques, and a lack of standardized and documented methods. The EPA has
established a compendium of methods which can be found in Table 1-2. The methods are
federally regulated monitoring methods and are considered a standard for measuring toxic
organics in air. Monitoring occurs at multiple stations across the nation to assess trends, assess
exposure, and to evaluate air quality models. The goal of air toxics monitoring is to support the
reduction of exposure to HAPs. However, the data is not quite granular enough to estimate health
effects as these ambient air concentrations are sparse, indirect measures of human exposure.
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Table 1-2. Toxic organic (TO) method for quantifying toxic organic compounds in air as defined
by the Environmental Protection Agency.
Method No.

Compound

Sample Collection Device

Analytical Methodology

TO-1

VOCs

Tenax Solid Sorbent

GC/MS

TO-2

VOCs

Molecular Sieve Sorbent

GC/MS

TO-3

VOCs

Cryotrap

GC/FID

TO-4

Pesticides/PCBs

Polyurethane Foam

GC/MD

TO-5

Aldehydes/Ketones

Impinger

HPLC

TO-6

Phosgene

Impinger

HPLC

TO-7

Anilines

Adsorbent

GC/MS

TO-8

Phenols

Impinger

HPLC

TO-9

Dioxins

Polyurethane Foam

HRGC/HRMS

TO-10

Pesticides /PCBs

Polyurethane Foam

GC/MD

TO-11

Formaldehyde

Adsorbent

HPLC

TO-12

NMOC

Canister or on-line

FID

TO-13

PAHs

Polyurethane Foam

GC/MS

TO-14

VOCs (nonpolar)

Specially-Treated Cannister

GC/MS and GC/MD

TO-15

VOCs (polar/nonpolar)

Specially-Treated Cannister

GC/MS

TO-16

VOCs

Open Path Monitoring

FTIR

TO-17

VOCs

Single/Multi-Bed Adsorbent

GC/MS, FID, etc

Risk Assessment Framework
A major pillar of environmental health science is the risk assessment framework which is
focused around the methods to evaluate exposure, predict health risks and outcomes, and inform
decision making to control or otherwise respond to unacceptable exposures to environmental
hazards.51 Human health risk assessment consists of four major parts: hazard identification, dose
response assessment, exposure assessment, and risk characterization. Hazard identification
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determines whether the environmental chemical has the potential to cause harm to humans.
Dose response assessment identifies the relationship between the dose of exposure and effect
response. Exposure assessment investigates the source, frequency, and timing of exposure to
the environmental chemical. Risk characterization quantifies and communicates the risk of the
environmental chemical to human health.52
Exposure assessment aims to answer the questions of how much of the pollutant are
people exposed to during a specific period and how many people are exposed. Exposure is the
contact between a hazard in the environment and an individual, group, or population by
inhalation, ingestion, dermal contact, or via placental transfer.53 The exposure assessment step
identifies the affected population; calculates the amount, frequency, length of time, and route of
exposure; identifies sources of containment; identifies exposure pathways and environmental
fate; and finally, measures or estimates the dose or intake based on calculations.54 Exposure is
the most important and least informed step in the hazard, exposure, and outcome pathway.
Despite being the most informative pathway, exposure is often the weakest link with little
information describing the hazard, exposure, or disease pathway.53
To measure exposure, researchers utilize direct or indirect measures of exposure. Direct
measures of exposure are biological samples or personal monitoring and represent the gold
standard of exposure assessment. Indirect measures of exposure are approximations of human
exposure. Indirect measures of exposure include environmental samples and models. Direct and
indirect methods of exposure assessment exist on a continuum of cost and precision (Figure 1-2).
Indirect methods of exposure are often lower cost and approximate ambient exposure. Direct
methods of exposure are more expensive and better approximate personal exposures. A
comprehensive exposure assessment uses multiple methods to measure exposure, both direct
and indirect.
As human beings, we interact with multiple microenvironments. We all interact with a
global environment, and then we each interact with multiple microenvironments.
Microenvironments are highly variable across individuals. Typical microenvironments are
workplaces, school, indoor, and outdoor. Humans interact with each microenvironment at
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different rates and frequencies. The two major microenvironments are indoor and outdoor. While
outdoor might be considered uniform, many pollutants vary spatially and temporally, as well as by
nearby sources. Indoor environments are typically divided into work or school, or home
environment. Thus, depending on the individual and their geographical region, an individual’s
exposure metric will be unique. Exposure assessment methods function to quantify the most
appropriate exposure based on the primary microenvironment, or multiple microenvironments.
To assess the risk of a hazard to human health, it is important to assess exposure as
accurately as possible using both direct and indirect monitoring, sampling of microenvironments,
and consider tradeoffs. Exposure misclassification is a common source of bias in epidemiological
studies. Additionally, exposure assessment in environmental epidemiology is a methodological
problem due to long induction times between presumed causal action and incidence of disease.55
Therefore, exposure assessment methods must function to reduce as much bias as possible.
Figure 1-3. Cost and exposure approximation tradeoffs in exposure assessment
methods.
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Conceptual Framework
Cardiovascular disease (CVD) is the leading cause of mortality worldwide, accounting for
31% of all deaths in 2015.56 In the United States, one in three adults have some type of CVD. By
the year 2030, approximately 44% of the US population is projected to have at least one form of
CVD, of which the direct medical costs are projected to reach $818 billion.57 Cardiovascular
disease encompasses a group of diseases of the heart and blood vessels, which result from
gene-environment interactions.58 Behavioral risk factors of CVD include unhealthy diet, physical
inactivity, tobacco use, and excessive alcohol use.56 Although much effort has been invested in
the prevention of CVD by reducing or ceasing behavioral risk factors, rates of heart disease
continue to climb. Traditional risk factors neglect to account for 10-25% of CVD prevalence.59
Furthermore, risk factors and gene-environment interactions can act as modifiers which influence
CVD penetrance.60 Cardiovascular disease is largely regarded as a behavioral disease
dependent on lifestyle changes, yet recent evidence shows that environmental exposure plays a
key role in disease incidence as well as clinical events.61 Thus, it is important to identify
attributable risk factors, such as environmental chemicals, in CVD etiology; because genetic
changes alone cannot account for the immense changes in disease incidence over short
durations of time.62
In the 2010 update to the American Heart Association’s scientific statement, authors gave
evidence of a causal link between exposure to PM2.5 and CVD, establishing PM2.5 as a risk factor
for the development of heart disease.6 In addition, the contributors to this statement released a
call to action to better understand the role of other pollutants in the development of CVD,
specifically of VOCs as constituents of particulate matter. The authors proposed three biological
mechanisms by which exposure to environmental pollutants is linked to CVD. The three
generalized intermediary pathways include 1) systemic oxidative stress and inflammation, 2)
autonomic nervous system imbalance, and 3) transmission of PM or constituents into the blood.
These generalized pathways were formulated on previous studies evidencing acute vascular
dysfunction, chronic biological effects like atherosclerosis progression, and molecular level
reactive oxygen species dependent pathways.
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This research aims to evaluate the relationship between exposure to pollutants like VOCs
and CVD. We use the large review of PM and CVD and the proposed mechanisms as the basis
for our research of pollutant exposure. Although there is a clear link between exposure to air
pollution and cardiovascular disease, adverse effects of many gaseous pollutants such as VOCs,
are less understood. Therefore, we hypothesize that VOC exposure occurs via similar biological
pathways as PM. Already there is epidemiological research supporting a relationship between
VOC exposure and CVD events such as heart failure,17 stroke, 18 ischemic heart disease, 18, 19
and cardiovascular mortality rates.20 Indoor exposure to VOCs has been associated with
increased blood pressure and heart rate,21 and VOC metabolites measured in blood have been
linked to an increased prevalence of doctor-diagnosed CVD.22 Similarly, HAPS released from
industrial facilities are associated with cardiovascular mortality,19 and VOC-containing mixtures of
pollutants such as automobile and diesel engine emissions, and tobacco smoke have been linked
to the development of CVD.23-29
However, measuring exposure to VOCs is specifically challenging due to minimal routine
air monitoring,11 spatial and temporal variability,14, 20 and quick transformation to secondary
pollutants in the atmosphere.9, 10 While exposure is the most important and least informed step in
the hazard, exposure, and outcome pathway of the risk assessment process, exposure is often
the weakest link with potential for bias in environmental epidemiological investigations.53
Therefore, our research utilizes multiple exposure assessment methods to assess the
relationship between VOC exposure and CVD. To conduct impactful environmental
epidemiological investigations of the relationship between exposure to VOCs and CVD, we will
use source proximity, human biomonitoring, and mixture modelling. Given that exposure metrics
vary in strength, new epidemiological studies must investigate relationships using multiple
measures of exposure.
Literature Review of Relationship between VOC Exposure and CVD
Until now, we have identified 187 chemicals of concern classified as HAPs, of which
several are VOCs. For the remainder of the work, we will focus on seventeen VOCs which are
also classified as HAPs and are measured in the National Health and Nutrition Health Survey
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(Table 1-3). The seventeen included VOCs are acrolein, acrylamide, acrylonitrile, benzene, 1bromopropane, 1,3-butadiene, crotonaldehyde, N,N-dimethylformamide, ethylbenzene, ethylene
oxide, propylene oxide, styrene, tetrachloroethylene, toluene, trichloroethylene, vinyl chloride, and
xylene. Since CVD is our outcome of interest, we will focus on both direct, personal measures of
exposure in observational and experimental human studies as well as indirect measures such as
environmental monitoring or modeling and their link with CVD outcomes.
To review the literature, we entered the following search in NCBI PubMed database
((((volatile organic compounds) OR hazardous air pollutants) OR air toxics) OR industrial
chemicals) AND cardiovascular disease. Eighty-three articles were chosen based on abstract and
title content. These articles were then imported into the Health Assessment Workplace
Collaborative platform (www.hawcproject.org). The HAWC project integrates and documents the
overall workflow of a systematic literature review.63 The HAWC project has been adopted for use
by the National Toxicology Program (NTP), the U.S. Environmental Protection Agency (US EPA),
and the Texas Commission for Environmental Quality (TCEQ). From the 83 articles, 20
epidemiological studies were chosen after thorough review of abstracts. Articles were published
between 1998 and 2019. Two were published in 1998 while the rest were published in the last ten
years.
Volatile organic compounds are ubiquitous in the environment. Primary sources of
anthropogenic VOCs include combustion, dry cleaners, hazardous waste sites, contaminated
environmental media, and consumer goods. VOCs are classified by low molecular weight and
high vapor pressure which subsequently allows quick vaporization into the air. Thus, the primary
route of exposure to VOCs is inhalation. Due to spatial and temporal variation of VOCs, the
literature includes several methods of approximating or measuring exposure in humans. Direct
exposure measurement includes personal monitoring and biomonitoring. Indirect exposure
measurement includes environmental or indoor monitoring, existing surveillance programs,
occupational exposures, and proximity to sources. Of the 20 reviewed articles, 4 use direct
exposure measurements and 16 use indirect exposure measurements.
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Table 1-3. Volatile organic compound parent names, urinary metabolite long names, short
names, and estimated half-lives.
Parent Compound

Metabolite

Short Name

Half-Life

Acrolein

N-Acetyl-S- (2-carboxyethyl)-L-cysteine
N-Acetyl-S- (3-Hydroxypropyl)-L-cysteine
N-Acetyl-S-(2-carbamoylethyl)-L-cysteine
N-Acetyl-S-(2-carbamoyl-2-hydroxyethyl)L-cysteine
N-Acetyl-S-(2-cyanoethyl)-L-cysteine
N-Acetyl-S- (2-hydroxyethyl)-L-cysteine

CEMA
3HPMA
AAMA
GAMA

Unknown
10h
3.5h
3.5h

CYMA
HEMA

8h
Unknown

Benzene
1-Bromopropane

trans, trans -Muconic acid
N-Acetyl-S-(n-propyl)-L-cysteine

MU
BPMA

5h
Unknown

1,3-Butadiene

N-Acetyl-S- (3,4-dihydroxybutyl)-Lcysteine
N-Acetyl-S-(1-hydroxymethyl-2-propenyl)L-cysteine
N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-Lcysteine
N-Acetyl-S-(3-hydroxypropyl-1-methyl)-Lcysteine
N-Acetyl-S-(N-methylcarbamoyl)-Lcysteine

DHBMA

Unknown

MHBMA1

>9h

MHBMA3

>9h

HPMMA

Unknown

AMCC

23h

Ethylbenzene,
styrene

Phenylglyoxylic acid

PGA

6h

Propylene oxide
Styrene

N-Acetyl-S-(2-hydroxypropyl)-L-cysteine
N-Acetyl-S-(1-phenyl-2-hydroxyethyl-Lcysteine + N-Acetyl-S-(2-phenyl-2hydroxyethyl)-L-cysteine
Mandelic acid
N-Acetyl-S-(trichlorovinyl)-L-cysteine
N-Acetyl-S-(benzyl)-L-cysteine
N-Acetyl-S-(1,2-dichlorovinyl)-L-cysteine
N-Acetyl-S-(2,2-dichlorovinyl)-L-cysteine
Urinary N-Acetyl-S-(dimethylphenyl)-Lcysteine
2-Methylhippuric acid
3-Methylhippuric acid + 4-Methylhippuric
acid

2HPMA
PHEMA

Unknown
Unknown

MA
TCVMA
BMA
1,2DCVMA
2,2DCVMA
DPMA

2h
14h
Unknown
5.6h
5.6h
Unknown

2MHA
3MHA &
4MHA

Unknown
Unknown

Acrylamide

Acrylonitrile
Acrylonitrile, vinyl
chloride, ethylene
oxide

Crotonaldehyde
N, NDimethylformamide

Tetrachloroethylene
Toluene
Trichloroethylene
Xylene
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Cardiovascular disease is a chronic condition encompassing a group of diseases of the
heart and blood vessels, which result from gene-environment interactions.58 Modifiable and nonmodifiable risk factors contribute to the development of heart disease. Modifiable risk factors
include physical activity, diet, obesity, high blood pressure, and blood lipids. Non-modifiable risk
factors include age, sex, race or ethnicity, socioeconomic status, family history of CVD, diabetes,
and environmental factors. Risk factors contribute to the development of hypertension,
atherosclerosis, thrombosis, and ischemia resulting in cardiovascular events such as stroke,
myocardial infarctions, heart failure, and eventually, mortality. Outcomes from the literature
review included high blood pressure and heart rate, electrocardiograph changes, oxidative stress
and inflammatory markers, measures of endothelial function, doctor diagnosed CVD, CVD events
and hospital admissions, and mortality.
The major differences found in review were the methods of assessing relationships
between exposure to VOCs and CVD outcomes. Classification of VOCs includes a wide range of
chemicals difficult to assess individually or together. Many papers utilize dimension reduction
techniques by further grouping VOCs into subclasses based on structural similarities, reactivity,
benzene or substituted benzenes, BTEX compounds, or by using cluster or principal component
analyses. Therefore, the exposure measurement varies widely throughout this review. The major
themes of methods are 1) individual VOC 2) structural similarities 3) total VOCs or 4) principal
component analysis. Principal component analysis is a technique often used to understand
exposures to multiple components and the sources from which they are derived.
Six articles assessed the relationship between VOC exposure and blood pressure or
hypertension. In a subset of the Detroit Exposure and Aerosol Research Study (DEARS), 63
participants wore personal exposure vests for six seasons to assess personal exposures to 12
VOCs. These exposures were further reduced to three principal components based on a primary
petroleum source, a butadiene source indicating industrial exposure, and a freon source. Systolic
blood pressure (SBP) was not significantly associated with any of the three principal components.
Diastolic blood pressure (DBP) was consistently negatively associated with the butadiene
principal component. Two large pregnancy cohorts, the Consortium on Safe Labor and the
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Consecutive Pregnancy Study, were used to assess the relationship between VOC exposure and
gestational hypertension. Exposure to ambient VOCs was estimated with the Community
Multiscale Air Quality Models (CMAQ). Nobles et al. found no significant associations with
ambient VOCs and gestational hypertension, though there were increased risks for preeclampsia
when estimating ambient VOCs.64 Contrary to Nobles, Zhu et al found significant associations for
gestational hypertension and exposure to ambient ethylbenzene, toluene, and m- and o-xylene.65
Two studies in Taiwan measured indoor and personal exposure to total VOCs (TVOCs). In
Taipei, 200 healthy homemakers were visited 12 times in two years. There were significant
changes in blood pressure, a 4.32% (2.41, 6.23) change in SBP per IQR (0.65ppm) of TVOCs
and a 2.47% (1.13, 3.81) change in DBP.66 From the cross-sectional study in Taiwan, TVOCs
measured in the workplace were significantly associated with SBP, DBP and heart rate,
independent of BMI.67 Finally, in a case-control occupational study, 345 workers were split among
three exposure groups 1) benzene exposure, 2) xylene and benzene exposure, and 3) phenol
exposure. Both SBP and DBP were significantly higher than controls. Arterial hypertension was
prevalent in group 1, 30.51% [OR = 2.44; 95% CI 1.24-4.85; P = 0.0054] and in group 2, 27.92%
(OR = 2.00; 95% CI 1.11-3.61; P = 0.0136).68
Five papers assessed the relationship between VOC exposure and CVD biomarkers or
ECG changes. Biomarkers of CVD are noninvasive measures of endothelial function, oxidative
stress, clotting, or inflammation. These biomarkers can be useful sensitive, subclinical outcomes
for CVD. In an occupational study, solvent and paint workers had significantly greater relative
risks for cardiovascular effects of arrythmia, P wave changes, and QRS complex changes.69
Chuang et al found a 2.41% (1.63, 3.19) change in inflammatory marker hs-CRP, and a 2.18%
(1.83, 4.01) change in oxidative stress marker 8-OHdG per IQR (0.665ppm) of TVOCs.66 In the
DEARS sub cohort, heart rate, flow mediated dilation (FMD) and basal arterial tone were
positively associated with the petroleum source. Non endothelial mediated dysfunction was
negatively associated with the petroleum source.70 Metabolites of BTEX compounds were
assessed in an occupational cohort of Korean shipbuilding workers. Only toluene metabolites
were significantly associated with the oxidative stress biomarker MDA.71 In a cross-sectional
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study of 300 healthy participants in Taiwan, indoor TVOCs were significantly associated with hsCRP (19.7% 10.2,29.1), 8-OHdG (3.8% 1.5,6.1), fibrinogen (8.9% 4.2,13.6), the standard
deviation of normal-to-normal intervals of heart rate variability (-6.2% -9.1,-3.2), and the square
root of the mean of the sum of the square of differences between adjacent normal-to-normal
intervals of heart rate variability (-2.6% -4.7, -0.5) in mixed linear models.72
In a subset of NHANES participants enrolled during 1999-2002, 2001-2002, and 20032004, n=3,408 participants were assessed for alkylbenzene metabolites in blood and their
relationship to doctor diagnosed cardiovascular disease. Greater exposure to toluene was
associated with greater prevalence of CVD (50-85th percentile OR 2.3, >85th percentile 3.49).
Greater exposure to styrene was also associated with prevalence of CVD (50-85th percentile OR
2.03, >85th percentile 4.64). Additionally, greater exposure to Ethyl benzene (50-85th percentile
OR .81, >85th percentile 3.1), M/p-xylene (50-85th percentile OR 1.12, >85th percentile 2.31),
and O-xylene (50-85th percentile OR 1.49, >85th percentile 2.68) were associated with
prevalence of CVD.22
Two papers assessed the relationship between VOC contaminated drinking water or
domestic water and stroke. Benzene and trichloroethylene (TCE) contaminated drinking water
occurred from contaminated hazardous waste sites on the Superfund National Priorities Lists.
Participants were enrolled in the National Exposure Registry. On the basis of 60 cases of
reported stroke, the prevalence odds ratios were 4.14 (1.54, 11.09; 2-12ppb TCE); 3.88 (1.4,
10.74; >12-60ppb TCE); and 3.2 (1.14, 8.99; >60-12,800ppb TCE).34 In Lybarger et al., the
authors estimated the economic health burden associated with VOC contamination at Superfund
sites. They found the excess prevalence rate for stroke was 5 per 1000 people and the excess
prevalence rate for diabetes was 5 per 1000.33
Four papers assessed the relationship between ambient VOC exposures and
cardiovascular events such as emergency department visits for CVD, emergency hospital
admissions for heart failure, cardiovascular events at labor and delivery, and cardiovascular
events at delivery admission. Two studies used the Consortium on Safe Labor to determine
cardiovascular events at labor and delivery or at delivery admission. Both studies estimated
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ambient VOCs from the CMAQ. In Ha et al., there were increased odds of a cardiovascular event
at labor and delivery for all VOCs at different lag times. However, models were not adjusted for
other criteria pollutants such as PM. Specifically, 1,3-butadiene and cyclohexane had increased
odds for the weekly average.73 Mannisto et al. found that recent exposure (5-day lag) to high
ambient concentrations of some VOCs, specifically, exposure to ethylbenzene (OR 1.50, 99% CI
1.08 to 2.09), m-xylene (OR 1.54, 99% CI 1.11 to 2.13), o-xylene (OR 1.51, 99% CI 1.09 to 2.09),
p-xylene (OR 1.43, 99% CI 1.03 to 1.99) and toluene (OR 1.42, 99% CI 1.02 to 1.97), were
associated with increased odds of cardiovascular events.74 In Hong Kong, exposure to benzene
and alkynes was significantly associated with emergency hospital admissions for heart failure.75
Daily 24-hour average concentrations of VOCs were measured in the five county area of Atlanta,
GA and split into groups of hydrocarbons (alkane, isoalkane, other alkane, cycloalkane, alkene,
alkyne, aromatic) and oxygenates (aldehydes, acids, ketones). Almost all hydrocarbon groups
were associated with cardiovascular ED visits. Oxygenates were not.76
Four studies assessed the relationship between ambient VOCs and cardiovascular
mortality. Three studies estimated ambient VOC concentrations from fixed monitoring stations.
The fourth study approximated exposure from industrial releases using the Toxic Release
Inventory. In Hong Kong, benzene was significantly associated with a 4.1 (1.0, 7.4) and 5.8 (1.0,
10.8) percent excess risk in circulatory deaths per IQR of benzene for lag days 5-9 and 0-9. TEX
compounds were also significantly associated with circulatory deaths 2.9 (1.1, 4.6) and 3.5 (1.0,
6.1) for lag days 5-9 and 0-9.77 In Taichung City, Taiwan, benzene, m,p-xylene, and o-xylene
were all associated with all-cause mortality. Only benzene was significantly associated with
cardiovascular mortality.78 In Ontario, Canada, adjusted relative risks showed weak positive
associations for benzene, hexane, and total hydrocarbons with cardiovascular mortality.20 In the
U.S., HAPS and CERCLA chemicals released from industry were significantly associated with
cardiovascular mortality (1.87, p:0.0001 and 1.73 p:0.0001) and ischemic heart disease (1.57,
p:0.0001 and 1.32, p:0.0001).19
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PROBLEM STATEMENT
In our literature review, we found significant associations between several individual
VOCs including acrolein, benzene, 1,3-butadiene, ethylbenzene, toluene, and xylene and
cardiovascular outcomes like blood pressure, endothelial function, doctor-diagnosed CVD, and
CVD mortality. Additionally, we found several significant associations between groups of
chemicals like total VOCs, hydrocarbons, and component sources such as butadiene and
petroleum, and cardiovascular outcomes. The reviewed works include both direct and indirect
exposure assessment methods such as ambient air concentrations, indoor air concentrations, the
CMAQ, drinking water concentrations, source proximity, and metabolite concentrations from
human biomonitoring. While there is some evidence of an association between VOC exposure
and CVD, results are limited by cohort and exposure assessment method. Several studies
assessed VOC exposure in exposed workers which may not represent real-world exposures
outside the studied industry.79, 80 The one study which examined direct measures of VOC
exposure and doctor-diagnosed CVD in a nationally representative cohort used VOC metabolites
in blood, those which are not as robust in capturing an individual’s daily exposure. 16, 81, 82 Studies
using fixed monitoring stations and community modelling to assess VOCs in ambient air are
limited by the sparsity of national coverage.83-85 Finally, several of these studies grouped VOCs
by structure, source, or federal regulatory classification to improve interpretability. Given that
there are more sophisticated and robust methods to assess exposure to individual pollutants and
pollutant mixtures, we must employ more recently developed methods to better elucidate the role
of environmental exposure in the development of CVD.
PURPOSE OF THE STUDY
The purpose of this study is to identify environmental stressors in the development of
CVD using a multi-pronged approach to exposure assessment. Three methods of exposure
assessment are used to evaluate the relationship between exposure to VOCs and CVD: 1)
source proximity, 2) human biomonitoring, and 3) mixture modelling. Two populations are used in
this study to evaluate VOC exposure. The first is a national population of the contiguous United
States in which there is county-level data of industrial releases and age-adjusted, all cause and
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CVD mortality. The independent variable, industrial releases, and the dependent variable,
mortality, are assessed longitudinally in an ecological study during the years 2002-2012. The
second is a local population in Louisville, Kentucky in which there is individual-level urinary VOC
metabolites and multiple CVD risk markers. The independent variables, the VOC metabolites,
and the dependent variables, CVD risk markers, are assessed cross-sectionally. Finally, mixture
modelling is used to assess multi-pollutant exposure in these two populations with two distinct
methods: 1) the Bayesian Kernel Machine Regression, and 2) the variable selection procedure,
elastic net.
The proposed study will contribute to the field by presenting more granular and
mechanistic evidence of human exposure to environmental pollutants like VOCs and their role in
the development of CVD. This study highlights the use of both aggregate-level and individuallevel human data to understand population and individual effects. The methods used to evaluate
this relationship are more sophisticated than previous methods used, specifically the longitudinal
evaluation and the newer mixture modelling methods. Finally, this study assesses multiple CVD
outcomes that are mechanistic steps in the development of CVD as well as CVD endpoints like
mortality. The study further illuminates the need for better environmental health and pollution
regulations for improved public health.
RESEARCH QUESTIONS AND HYPOTHESES
For this dissertation, we hypothesize that exposure to environmental pollutants like VOCs
contribute to the development of CVD. This study takes a three-pronged approach to exposure
measurement to assess the link between VOC exposure and CVD. To measure and model
exposure to VOCs, we use publicly available inventories of toxic chemicals collected and
maintained by the federal government, human biomonitoring to quantify VOCs in urine, and
machine learning and variable selection to model exposure to mixtures of VOCs. Our three
specific aims include:

1. Examine the relationship between county level toxic chemical releases and CVD
mortality. We will acquire publicly available data at the county level to create a dataset
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for an ecological analysis of the association between toxic releases and circulatory
disease mortality. Variables will be obtained from CDC Wonder, EPA, IHEH, and the U.S.
Census to accurately assess county level associations. Data will be acquired for
consecutive years 2002-2012 in the contiguous United States. We will use mixed models
to longitudinally assess fixed and random effects using the restricted maximum likelihood.
We will create a county level risk score to account for chemical potency within the
releases.

2. Assess the relationship between individual level VOC metabolites and vascular
function. We will conduct a secondary data analysis of a cross-sectional cohort, the
Louisville Healthy Heart Study. We will restrict the analysis to nonsmokers since tobacco
smoke is a major source of VOCs. We will examine the associations between exposure
to 17 individual VOCs and the classical cardiovascular risk factors. In addition, we will
analyze the associations between exposure to individual VOC metabolites and
biomarkers of vascular injury and dysfunction such as endothelial function and urinary
metabolites of catecholamines, to assess the function and significance of these changes.

3. Apply multipollutant models to existing aims using new statistical methods. We will
use statistical methods like the Bayesian Kernel Machine Regression (BKMR) to
determine the effects of exposure to multiple VOCs on the development of CVD. BKMR
flexibly models the exposure response function of multiple components on one health
outcome, incorporating non-linearity and interaction among the mixture components. We
will use the elastic net procedure to identify potential toxic chemicals associated with
CVD mortality at the county level. Elastic net is a variable selection method which uses
penalized regression to select more contributive variables.
RATIONALE, RELEVANCE, AND SIGNIFICANCE OF THE STUDY
An exposure assessment is the study of the distribution and determinants of substances
and factors affecting human health. Exposure assessments address variable microenvironments
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using direct and indirect measures of exposure. Direct methods include biological monitoring and
personal air monitoring. Indirect methods include exposure estimates and proxies such as
environmental monitoring, modeling, and questionnaires. A combination of both direct and
indirect methods provides a more complete view of exposure. Exposure assessments are a major
factor of environmental epidemiology, the study of factors in the environment that are out of the
individual’s control, which often affect many people simultaneously.55
Exposure assessment in environmental epidemiology is a methodological problem due to
long induction times between presumed causal action and incidence of disease.55 Exposure is the
most important and least informed step in the hazard, exposure, and outcome pathway. The
exposure metric is the estimate of exposure for each individual or group of the study quantified by
using direct and indirect methods. Researchers must consider tradeoffs of cost and data
availability in exposure quantification. To assess the risk of a hazard to human health, we assess
exposure as accurately as possible with the data available and the most appropriate models. We
use three methods to assess exposure: 1) source proximity, 2) human biomonitoring, and 3)
mixture modelling.
In the first aim, we use source proximity to ecologically assess the relationship between
industrial releases and CVD mortality in the contiguous United States. The Toxic Release
Inventory (TRI) is a publicly available dataset which quantifies industrial releases by location and
chemical each year, a beneficial proxy for exposure to VOCs. Due to the time series nature of the
data, we were able to assess the relationship longitudinally in small area units known as counties
across the United States. The spatial and temporal methodology improve the strength of the
study. Data acquisition required no cost.
In the second aim, we use human biomonitoring to individually assess the relationship
between urinary VOC metabolites and risk markers of CVD in a cross-section of time. Human
biomonitoring of blood and urine plays a major role in assessing human health risk. Assessing
exposures in biofluids offers a whole measurement of exposure, including absorption, adsorption,
injection, ingestion, and inhalation. Urine analysis for VOC metabolites is advantageous due to
longer half-lives of metabolites compared with parent compounds and the specificity of
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mercapturic acid metabolites. Urinary analysis is sensitive enough to detect background exposure
from tobacco smoke or solvent exposure. 86, 87 Although exposures are acute, they offer a realtime perspective of prevalent chemicals in everyday environments.
In the third aim, we use statistical methods to model exposure to mixtures in our previous
two aims. Although people are exposed to a myriad of environmental chemicals every day,
epidemiological studies have historically assessed the relationship between one exposure and
multiple adverse health effects. As a result, the impact of multiple exposures has not been well
characterized. To combat this gap in the literature, we use two supervised methods to assess
mixtures, a variable selection technique called elastic net, and a machine learning technique
called the Bayesian Kernel Machine Regression in the previous two aims.
The proposed research uses a multi-pronged approach to assess exposure to VOCs and
the relationship to CVD. There is a lack of critical information on the health effects of chemicals in
our environment. Furthermore, new evidence suggests that there are no safe exposures and the
effect of low level exposure on chronic diseases such as CVD. This project aims to gain
information on cardiovascular effects of exposure to VOCs. Although much research has
explored organ toxicity and carcinogenicity of VOCs, cardiovascular toxicity remains under
researched. Additionally, there is deficient environmental monitoring of VOCs. Therefore, the
project will assess how exposure to VOCs contributes to cardiovascular risk and disease rates
using multiple exposure assessment methods.
The potential implications of results of this research are many. First, new methods of
exposure assessment create new models of exposure to VOCs which better estimate the
relationship to CVD. Traditional ordinary least squares regression is no longer the best estimate
in assessing health effects. Here, we use mixed models for repeated measures, generalized
linear models, penalized regression, and machine learning regressions, methods superior to
traditional ordinary least squares estimation. Second, there is a deficiency in monitoring and
quantification of VOCs in the environment. New information about environmental exposures to
VOCs calls to action better surveillance and regulation of environmental pollutants. Third, we
uncover more information about how the environment contributes to CVD, the leading cause of
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death in the world. These results implicate new CVD prevention methodology and require the
need for more research.
SUMMARY AND ORGANIZATION OF THE REMAINDER OF THE STUDY
In summation, we know that CVD is the leading cause of death from environmental
exposures.1 Environmental exposures are complex and infinite, targeting multiple routes of
human exposure. Volatile organic compounds are pervasive environmental pollutants known to
cause adverse health effects such as neurological effects, organ toxicity, and cancer.7, 8 However,
the role of VOC exposure in the development of CVD is less understood. The approximation of
human exposure to VOCs is complicated by a lack of routine air monitoring of VOCs,11 large
variations of VOCs in space and time,13, 14 and high chemical production each year.15 The goal of
this study is to identify environmental stressors in the development of CVD using a multi-pronged
approach to exposure assessment. Three methods of exposure assessment are used to evaluate
the relationship between exposure to VOCs and CVD: 1) source proximity, 2) human
biomonitoring, and 3) mixture modelling.
The following three chapters are individual studies using each exposure assessment
method. Each of the three individual study chapters will commence with an introduction to the
topic, the methods of the analysis, description of the results, and a discussion of the results.
Chapter 2 describes the assessment of the longitudinal relationship between county-level toxic
releases and all cause and CVD mortality. Chapter 3 describes the assessment of the crosssectional relationship between individual urinary VOC metabolites and CVD risk markers. Chapter
4 evaluates the role of mixtures of these exposures in the previous outcomes in Chapters 2 and
3, CVD mortality and blood pressure. Finally, Chapter 5 concludes the dissertation by
summarizing results and generalizability of the three individual studies.
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DEFINITION OF TERMS
The following terms were used operationally in this study.
Cardiovascular Disease (CVD), the name for the group of disorders of heart and blood
vessels, and include: hypertension (high blood pressure), coronary heart disease (heart attack),
cerebrovascular disease (stroke), peripheral vascular disease, heart failure, rheumatic heart
disease, congenital heart disease, and cardiomyopathies (World Health Organization 2021)
Air Pollution, a heterogeneous, complex mixture of gases, liquids, and particulate matter
(Brook et al 2004)
Particulate Matter (PM), particulate matter ("thoracic particles" [PM10] <10 [mu]m in
aerodynamic diameter, "fine particles" [PM2.5] <2.5 [mu]m, and "coarse particles" [PM10 to 2.5])
(Brook et al 2004)
Ozone (O3), a highlight reactive, colorless-to-bluish gas with a characteristic odor
associated with electrical discharges. O3 has been recognized since the 1950s as the principal
component of photochemical smog. In the troposphere, it is formed by the action of solar UV
radiation on nitrogen oxides and reactive hydrocarbons, both of which are emitted by motor
vehicles and many industrial sources. (Brook et al 2004)
Volatile Organic Compounds (VOCs), any compound of carbon, excluding carbon
monoxide, carbon dioxide, carbonic acid, metallic carbides or carbonates, and ammonium
carbonate, which participates in atmospheric photochemical reactions (40 CFR § 51.100)
Hazardous Air Pollutants (HAPs), Hazardous air pollutants, also known as toxic air
pollutants or air toxics, are those pollutants that are known or suspected to cause cancer or other
serious health effects, such as reproductive effects or birth defects, or adverse environmental
effects (EPA 2017)
Exposure Assessment, a cornerstone of environmental epidemiology, the development
of the exposure metric, the estimate of exposure for each individual of the study population (Weis
et al 2005)
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Direct Methods, direct measurements obtained in external (to the individual’s body)
environmental media or through the determination of contaminants or their metabolites in biologic
medium (Weaver et al 1998)
Indirect Methods, an indirect approach to exposure assessment which relies on
validated models that evolve from well-characterized relationships between causative variables
and exposure from studies using direct measurements (Weaver et al 1998)
Source Proximity, an indirect exposure assessment based on spatial analysis theory
where location denotes the disposition of objects with respect to one another, in this case,
distance. Distance is defined in terms of relationships and in qualitative terms. Proximity acts a
proxy for frequency. Used for proximity to contaminant source. (Haining 2003)
Human Biomonitoring (HBM), a noninvasive process which provides an integrative
perspective to one's whole, acute exposure, across all routes, and from all environmental media,
and effective and useful method in quantifying risk (National Research Council 2006)
Mixture, three or more independent chemicals which cause multiple stressors. Stressors
can include chemical and non-chemical stressors (NIEHS 2021)
Bayesian Kernel Machine Regression (BKMR), statistical approach that assumes
linear and additive associations between each mixture component and health. The health
outcome is modeled as a smooth function (h), represented using a kernel function, of the
exposure variables, adjusted for possible confounding factors. Variable selection is used to
identify which of these components are responsible for the health effects of the mixture (Bobb et
al 2015)
Elastic Net, penalized least squares regression method which shrinks coefficients toward
zero but also has the ability of selecting grouped variables (Zou and Hastie 2005)
Cross-Sectional Study, observational study design which examines the relationship
between a disease and an exposure among individuals in a defined population at a point in time
(Aschengrau 2020)
Longitudinal Study, an observational or experimental study design which evaluates an
association over time (Aschengrau 2020)
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Ecological Study, an observational study design which evaluates an association using
the population rather than the individual as the unit of analysis (Aschengrau 2020)
Microenvironment, a component of the personal exposure assessment, the
microenvironment is where a person’s action takes place, at work, at home, commuting (Steinle
et al 2013)
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COUNTY LEVEL TOXIC RELEASES ARE ASSOCIATED WITH
CARDIOVASCULAR MORTALITY BETWEEN 2002 AND 2012

INTRODUCTION
Pollution is the largest environmental cause of disease and premature death in the world
today.2 Air, soil, and water pollution and toxic chemical pollution are among the leading
noncommunicable disease (NCD) risk factors globally; and are responsible for an estimated 71%
of all NCD mortality.2 Cardiovascular diseases (CVDs) account for the majority of NCD
deaths,88 as well as the majority of deaths from environmental exposures.1 In 2015, pollution was
responsible for 21% of deaths from all CVDs, 26% of deaths from ischemic heart disease, and
23% of deaths due to stroke.89 Although there are several well quantified pollutants such as
particulate matter, ozone, and lead, other known toxic chemical pollutants are poorly defined in
their contribution to CVD mortality.
Toxic chemical pollution is a growing global problem. Between 1970 and 1995,
production volume of synthetic organic chemicals tripled from 50 million tons to 150 million tons.90
Specifically, the United States Environmental Protection Agency (EPA) estimates 84,000
chemicals are in commerce from the Toxic Substances Control Act.91 Yet, thousands of these
pollutants are not well monitored or quantified in the environment.90 Furthermore, many of these
chemicals have not been well-assessed for adverse health effects. The lack of surveillance
presents a challenge to scientists in the assessment of adverse health effects from exposures to
environmental chemicals.
The Toxic Release Inventory (TRI) may provide a remedy to understanding the effects of
chemical pollution on mortality, although with limitations. The United States EPA launched the
first pollutant release and transfer register known as the TRI under the Emergency Planning and
Community Right to Know Act (EPCRA) of 1986.92 The TRI is a reporting system for facilities with
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a primary sector industry code included in the required reporting list, facilities employing ten or
more people, or facilities manufacturing, processing or using EPCRA Section 313 chemicals.
Qualifying facilities must report estimates of annual releases if they exceed thresholds of 25,000
pounds per year for manufacturing; 25,000 pounds per year for processing; or 10,000 pounds per
year for otherwise use. There are currently 767 listed chemicals and 33 chemical categories
covered under EPCRA Section 313. Chemicals reported in the TRI are classified as metals,
Clean Air Act chemicals, or carcinogens and thus may have overlap in multiple categories.
Although this list is not comprehensive, the TRI provides a starting point for assessing the burden
of disease from toxic chemical pollution.
Previous studies have used the TRI to assess racial and sociodemographic disparities,9396

to describe toxic release trends and the need for risk communication,97-99 to assess cancer

incidence,100-103 and to assess the association with mortality.19, 104, 105 However, few studies have
examined the role of toxic releases in cardiovascular disease, and none have examined the effect
longitudinally. We hypothesize that changes in annual toxic releases are associated with changes
in annual age-adjusted all cause and CVD mortality rates. Here, we conduct a longitudinal,
ecological study by using the TRI to approximate county-level exposure and assess the
relationship to all cause and CVD mortality in the contiguous United States from 2002 to 2012.
METHODS
Study Design and Population
Our overall objective was to assess the longitudinal relationship between county-level
toxic releases from the TRI and age-adjusted, all cause, and circulatory disease (CVD) mortality
in the contiguous United States. Our secondary aim was to create a risk score based on toxicity
of the chemicals released and the relationship to mortality. This National County Level TRI Study
(NCLTS) is a longitudinal ecological study measured at the small area or county level to assess
the change in mortality over time in relation to hazardous chemicals. All data was publicly
available at the county level and thus inexpensive and easily accessible.

36

We initially intended to analyze the period between 2000 and 2018 for two reasons: First,
the USA switched from the ninth revision to the tenth revision of the International Classification of
Disease (ICD) system in 1999, so data from 2000 on would contain a consistent assignment of
the medical cause of death. Second, data from this period would be the most recent and relevant
information. However, due to the unavailability of other determinants of mortality, we trimmed the
data to the period of 2002 to 2012.
Data Sources
We used data on deaths by underlying cause of death and county of residence from vital
registration through the National Center for Health Statistics106 and on population from the U.S.
Census Bureau107 for intercensal estimates of county-level percentages of age, sex, and race.
From 2002 to 2012, there were a total of 31.8 million deaths in the contiguous U.S.; 11 million of
these deaths were from circulatory disease (ICD-10 codes beginning with I) for which there is
evidence of an association with toxic chemical pollution.2 Annual toxic chemical releases were
acquired from the TRI database.92 We downloaded national annual basic data files from the U.S.
Environmental Protection Agency website for the consecutive years of 2002 to 2012.

We also gathered publicly available data on other county descriptors that may affect mortality:
➢

Population and Housing Unit Estimates

Population and housing unit estimates were downloaded from the United States Census
Bureau108, 109 for the census years 2000 and 2010.
➢

Unemployment, Median Household Income, Education, and Poverty Estimates

Unemployment, median household income, and education were published by the U.S.
Department of Labor, Bureau of Labor Statistics, Local Area Unemployment Statistics (LAUS)
and acquired from United States Department of Agriculture’s Economic Research Service.
Educational attainment for adults age 25 and older for the U.S. by state and county was
published by the U.S. Census Bureau for the years 2000 and 2010. The data was acquired from
the United States Department of Agriculture’s Economic Research Service.
➢

Alcohol and Smoking
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The Institute for Health Metrics and Evaluation (IHME)110 is an independent global health
research center at the University of Washington. Results were published in ‘Cigarette Smoking
Prevalence in US Counties: 1996-2012’ with prevalence estimates by county, year, and sex.111
Similarly, IHME published alcohol use prevalence estimates by county, year, and sex for 20022012. Estimates include any drinking, heavy drinking, and binge drinking. Estimates were
produced by applying small area models to data from the Behavioral Risk Factor Surveillance
System (BRFSS). Results were published in ‘Drinking Patterns in US Counties from 2002 to
2012’.112
➢

Temperature and Heat Index

Temperature and heat index data were acquired from the CDC Wonder website. The North
America Land Data Assimilation System (NLDAS) published daily air temperatures and heat
index for the years 1979 to 2011.113 Data are available for the 48 contiguous United States plus
the District of Columbia. We downloaded data from 2000 to 2011. The variables we include are
the average daily maximum temperature in degrees Fahrenheit (°F) and the average maximum
daily heat index in °F.
➢

PM2.5 and Ozone

Kim et al published Land Use Regression models of outdoor concentrations for PM2.5 and ozone
(O3) throughout the contiguous U.S for the years 1979-2015.114 Model estimates include annual
average values for PM2.5 and the average during May through September of the daily maximum
8-hour moving averages for O3. The variables included were PM2.5 in micrograms per cubic meter
(µg/m3) and O3 in parts per billion (ppb). Data are available at national, state, county, and census
tract. We acquired data from the Center for Air, Climate, and Energy Solutions (CACES) website.
➢

National Priority List Sites

The U.S. Environmental Protection Agency published a list of all National Priority List sites as of
February 2014. We acquired the data from Columbia University’s Socioeconomic Data and
Applications Center.115 Sites at the national level were accounted for. The frequency of sites per
county ranged from zero to 23. We created a categorical variable where a county with zero sites
was classified as zero and a county with greater than zero sites was classified as one.
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➢

Rural Urban County Codes

The NCHS developed a six-level urban rural classification scheme for U.S. counties and countyequivalent entities.116 The classifications are updated every ten years with the most recent in
2013. Counties are classified by four levels of metropolitan areas and two levels of
nonmetropolitan areas. The classes of metropolitan areas include large central, large fringe,
medium, and small metropolitan. The classes of nonmetropolitan areas include micropolitan and
noncore.
Units of Analysis
There were 3,108 counties in the contiguous U.S. in 2010. A total of 2,603 counties had
TRI chemical observations and recorded mortality rates between 2002-2012. The number of
counties reporting each year ranged from 1,569 to 1,630. There were n=264 unmatched
observations due to no mortality counts. Therefore, we excluded the counties Broomfield CO,
Campbell SD, Esmeralda NV, Eureka NV, Jackson SD, Oliver ND, and Sheridan MD.
We used the log-transformed, age-adjusted mortality rate for all cause and CVD as the
outcome variables. We used two exposure variables to differentially assess toxic releases by
volume and risk. The volume-based exposure variable was created by summing total facility
releases by county and year. The risk-based exposure variable was created by summing the
toxicity of the releases which was calculated by dividing the chemical volume by the reportable
quantity (RQ) or the toxicity equivalent score (TES) as reported by the Agency for Toxic
Substances and Disease Registry (ATSDR). We refer to the volume-based predictor variable as
the county sum (Cij) and the risk-based predictor variable as the risk sum (Rij). Both predictor
variables were log transformed for analysis.

𝐶𝑖𝑗 = ∑ 𝑇𝑅𝑖𝑗

For each county (i), each year (j), we summed the total chemical releases in pounds (TR).
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𝑚

𝑅𝑖𝑗 = ∑ 𝐶𝑅𝑖𝑗𝑘 ∗
𝑘

1
𝑅𝑄𝑘

For each county (i), each year (j), we summed the product of each chemical release (CR) in
pounds (m) multiplied by the inverse of the RQ or the TES as determined by the ATSDR.

k=1:m chemicals released (CR), where m is possible number of chemicals released
CR= chemical released in pounds in each county each year
RQ= EPA reportable quantity or ATSDR toxicity environmental score

There are currently 767 individually listed chemicals and 33 chemical categories covered
by the TRI program. Chemicals covered are those that cause cancer or chronic human health
effects, significant adverse acute human health effects, and significant adverse environmental
effects.
To account for the toxicity level of each chemical reported by amount, in each county, each year,
we created a risk score.
The ATSDR creates a biannual point system ranking hazardous substances based on
three criteria: the frequency of occurrence at a NPL site, of at least three or more sites, the
toxicity as a reportable quantity (RQ) or toxicity equivalent score (TES), and the potential for
human exposure based on the concentration of substances in environmental media at sites, and
the exposure status of population at sites. We decided to use a regulatory agency developed
value for toxicity to create our own risk score. Because TRI releases are not typically at
Superfund or NPL sites, we could not use their definition of frequency or human exposure.
Therefore, we used the toxicity equivalent to build our risk score. The toxicity component was
developed by EPA to set RQs for hazardous substances as required by CERCLA Section 103(a).
The EPA assigns CERCLA substances to one of five tiered RQ categories (1, 10, 100, 1000,
5000) based on acute toxicity, chronic toxicity, carcinogenicity, aquatic toxicity, and ignitability
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and reactivity. For chemicals without RQs, ATSDR applied RQ methodology to candidate
substances to create a TES.
Missing Data
After merging of all variables and reduction to the years 2002 to 2012, there were 17,700
observations from a total of 2,603 counties in the contiguous United States. There were no
missing predictor variables for all observations. However, some counties report zero pounds or
grams of releases. Reasons for zeroes include 1) facilities that report NA for a quantity on form R
because the release or waste management quantity is not possible for that facility, 2) facilities do
not respond to quantity questions and leave them blank which may have occurred more when
paper reporting was still accepted, or 3) facilities may submit a form A certification statement
which allows facilities to certify that they do not exceed annual releases of 500 pounds for a
particular chemical.
A total of 1,015 counties (39%), had at least one observation with a reported release of
zero pounds. A total of 506 counties had zero values that occurred only once per FIPS code in
1,015 counties, approximately 50% of the counties. The second largest frequency was two
zeroes per FIPS code; 27% of missing values. Because it is difficult to replicate analyses with
60% or more missing data, we excluded FIPS with seven or more missing observations for initial
analyses. Therefore, we excluded four counties in total with seven or more missing observations.
The final cohort includes 2,599 counties with repeated observations for the consecutive years
2002 to 2012 (Figure 2-1).
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Figure 2-1. Data acquisition flow chart for the National County Level TRI Study.

Data Distribution
County level toxic substance releases and calculated county level risk scores were
gamma distributed and log transformed prior to analysis. Mortality rates were log normally
distributed. County level demographic percentages were not normally distributed. We use the
logit transformation of the demographic variables: percent male, percent White, percent Black,
and percent Hispanic. Education of percent less than high school was normally distributed.
Unemployment and poverty estimates were gamma distributed and log transformed. Median
household income was gamma distributed and log transformed. County level alcohol use and
tobacco use were normally distributed. Superfund NPL frequency was categorical and further
dichotomized into counties with zero classified NPL sites or more than zero classified NPL sites.
All environmental variables (PM2.5, ozone, maximum heat index, and temperature) were
normally distributed.
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Statistical Analyses
This is a longitudinal ecological study. We use repeated measures mixed models where
all variables are measured at the group level (the county-level), and the time in years. We use
FIPS codes for each county as the subject identification number (ID). Observations are timeseries observations occurring for each consecutive year from the year 2002 to 2012.
Mixed models examine and compare responses over time, estimating individual and
population level regression parameters. Mixed models are preferred methodology over the
traditional ordinary least squares method because they do not assume that observations are
independent. Because time series data are measured on the same aggregate unit, the county,
over a series of time points, observations are not likely independent. Mixed models account for
this shortcoming by using maximum likelihood or restricted maximum likelihood (REML) to
estimate effects. REML instead assumes that the subjects (the counties) are independent and
that the observations within subjects (the annual measures) are correlated. REML reduces both
type I and type II error rates. The model assumes that random effects and error terms are
normally distributed and independent, and that the relationship between response variable and
predictor variable is linear.117 Therefore, we used the general linear mixed model.

𝑦 = 𝑋𝛽 + 𝑍𝛾 + 𝜀
𝑦 is the vector of observed responses
𝑋 is the design matrix of predictor variables
𝛽 is the vector of regression parameters
𝑍 is the design matrix of random variables
𝛾 is the vector of random effect parameters
𝜀 is no longer required to be independent and homogenous

Within subject correlation is addressed by a series of covariance structures. Estimation in
mixed models employs the use of the variance-covariance matrix. The covariance structure of the
random effects is referred to as the G matrix. The covariance structure of the random errors is
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referred to as the R matrix. The G and R matrices are estimated using the maximum likelihood
method. Maximum likelihood estimation finds the parameter estimates that are most likely to
occur given the data, ie, the joint probability of obtaining the data expressed as a function of
parameter estimates.
Covariance structures model the variability in the data which cannot be explained by the
fixed effects. They represent the background variability that the fixed effects are tested against.
Covariance structures must be carefully selected to obtain valid references for the parameters of
the fixed effects. To select the appropriate covariance structure, we must find a reasonable
estimate for matrix R, a block diagonal covariance structure where the block corresponds to the
covariance structure for each subject. Observations outside the blocks are assumed to be
independent. One must select the covariance structure that best fits the true covariance of the
data. We want to know which component of variability is the dominant component. The
components of variability include 1) random effects, 2) serial correlation, and 3) measurement
error. Variograms can describe the association among repeated measures.
Model Fitting
To fit the model, we conducted an exploratory data analysis of the cross-sectional and
longitudinal relationships in the data. We then fit a complex mean model by both backward
elimination and forward addition of covariates. Once final covariates were decided, we output
OLS residuals to create a sample variogram to assess the appropriate covariance structure.118
The sample variogram had a process variance of 0.029. The fitted line was horizontal with a
slope close to zero indicating little serial correlation. Because the curve did not tend to zero as the
time interval tended to zero, there seems to be some measurement error. Random effects were
also observed in the sample variogram because the fitted line did not reach the process variance,
indicating unexplained between subject variance. We chose the compound symmetry covariance
structure because constant correlation is assumed regardless of the lag between pairs of
repeated measurements. Compound symmetry is best for models with little to no serial
correlation. We added the LOCAL statement to PROC MIXED to correct for measurement error
and included a random intercept for between subject variability. Because the model would not
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converge, we removed the random intercept option from the model. Finally, we used the Akaike
Information Criteria (AIC) to determine the best fit for each covariate addition or elimination after
final selection of the covariate structure for each mortality outcome.
Data acquisition, merge, and data cleaning were conducted using tidyverse119 in R
software (version 3.1.3),120 in addition to all figures and maps. Statistical analysis was performed
using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA).
Key assumptions and limitations of the methods
Our study is an ecological study and is thus prone to ecologic bias and nondifferential
classification. Bias may be introduced by interaggregate variation in the disease rate among
those not exposed to the risk factor, by groups acting as effect modifiers in the dose response
relationship, or by confounding. Nondifferential misclassification may come from within group, ie
within county, misclassification. Finally, the risk score that we created is only available for some,
not all chemicals required to be reported under the TRI and therefore may reduce the number of
observations.
RESULTS
The difference in population estimates between the baseline year 2002 and the final year
2012 are reported in Table 2-1. Mean values of county-level exposure variables, county sum, and
outcome variables, all cause and CVD mortality rates, declined between 2002 and 2012,
indicating a time-series association. However, the risk sum did not decline significantly.
Population demographics changed significantly with a decline in percent White population and an
increase in percent Black and Hispanic populations. Educational attainment, income, and poverty
estimates were unchanged between 2002 and 2012, but unemployment levels increased.
Mortality risk factors of smoking status and environmental risk factors of PM2.5 and O3 declined.
Hazardous waste sites and facilities releasing toxic chemicals prevail across the
contiguous United States, especially in the eastern region and are concentrated in more populous
areas (Figure 2-2). Between 2002 and 2012, there were 21,642 unique TRI facilities, with an
average of 5,502 reporting each year. Additionally, there were 1,816 listed Superfund NPL sites.
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However, annual toxic releases declined by 34%, from 70 million to 46 million pounds during this
period (Mann Kendall trend p-value: 0.043). Similarly, age-adjusted, all-cause and CVD mortality
rates decreased during this period, from 909.6 in 2002 to 807.7 in 2012 and from 344.7 in 2002 to
248.1 in 2012 (Mann Kendall trend p-value: 0.0003 and 2.6e-05), respectively (Figure 2-3).

Table 2-1. Descriptive statistics (number and median [minimum, maximum]) for counties in the
contiguous U.S. for the baseline year, 2002 and the final year, 2012.
Variable
n
County Sum (lbs)
Risk Sum
All Age Adjusted Mortality Ratea
CVD Age Adjusted Mortality Rateab
% Male
% White
% Black
% Hispanic
Median Household Incomec
% Smoking
% Alcohol
% Less Than High School
% High School Diploma
% Some College or Associates
% Bachelor or Higher
% Unemployment
Populationc
Average Daily Temperature (F°)
Average Heat Index (F°)
Ozone (ppb)
PM2.5 (µg/m3)
NPL Frequencyd

2002
1616
230665 (1872745)
1434 (32766)
909.58 (127.68)
344.67 (65.74)
0.49 (0.02)
0.86 (0.15)
0.11 (0.15)
0.06 (0.10)
38k (9549)
27.07 (3.58)
49.03 (12.67)
21.61 (7.80)
34.41 (6.83)
26.27 (5.12)
17.72 (8.07)
5.78 (1.67)
153 (396)
64.77 (8.15)
90.56 (2.80)
52.79 (6.08)
11.16 (2.49)
0 [0,19]

a

2012
1613
134585 (567164)
1418 (27087)
807.69 (133.41)
248.06 (56.99)
0.50 (0.02)
0.84 (0.16)
0.11 (0.15)
0.09 (0.12)
39k (9640)
23.27 (3.95)
51.10 (10.95)
21.20 (7.71)
34.21 (6.90)
26.59 (5.08)
18.00 (8.23)
7.93 (2.40)
152 (395)
66.51 (9.48)
92.36 (4.06)
48.97 (5.57)
8.54 (1.39)
0 [0,19]

p
0.031
0.727
<0.001
<0.001
<0.001
0.015
0.406
<0.001
0.998
<0.001
<0.001
0.902
0.996
0.891
0.999
<0.001
1
<0.001
<0.001
<0.001
<0.001
0.997

Age-adjusted mortality rates are estimated at the county-level as per 100,000 people.
Age adjusted CVD mortality rate are circulatory disease mortality rates with ICD10 codes
starting with I
c
Measured in thousands (k)
d
National Priority List hazardous waste sites are measured as median [minimum, maximum]
b
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Figure 2-2.Toxic Release Inventory (TRI) sites in dark blue and hazardous waste sites (NPL) in
light blue in the contiguous United States.

Figure 2-3. Secular trends in county-level TRI releases and All Cause and CVD Cause Mortality
between 2002 and 2012.
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There are currently 767 listed chemicals and 33 chemical categories covered under
EPCRA Section 313. The top chemicals released each year include metal compounds, acids, and
solvents like ammonia, n-hexane, methanol, and toluene. Lead compounds were the most
released compounds between 2002 and 2012 at a total of 762 million pounds and qualify as the
most released Clean Air Act chemical, and metal (Figure 2-4). Styrene was the most released
carcinogen.
Maps of median releases between 2002-2012 show variation is low between quantitybased releases and risk -based releases. Compared to the quantity-based map in panel A, the
risk-based map shows few differences, specifically in the Gulf region in Louisiana and Texas, and
in Utah and Nevada (Figure 2-5). Counties with high volume of toxic releases were not the same
counties with high-risk scores. Calcasieu Parish, LA, Sumter County, AL, and Will County, IL
released chemicals with the most risk in 2002, 2010, and 2011, respectively. Humboldt County,
NV, Pinal County, AZ, and Salt Lake County, UT released the highest chemical volume in 2005,
2002, and 2006, respectively (Figure 2-6).
Both toxic release county sums and risk sums were significantly associated with ageadjusted all cause and CVD mortality rates between 2002 and 2012 (Figure 2-7). However,
estimates from risk scores differed based on cause of mortality. For every 25% increase in county
sum, we found a 1.7% (0.8, 2.6; p-value=0.0002) increase in all-cause mortality rate. For every
25% increase in risk sum, we found a 1.1% (0.2, 2.0; p-value=0.0006) increase in all-cause
mortality rate. For every 25% increase in toxic releases at the county level, we found a 2.8% (1.2,
4.4; p-value=0.0006) increase in CVD mortality rate. Additionally, we found that for every 25%
increase in county level risk score, there was a 3.0% (95%CI 1.3, 4.6; p-value=0.0132) increase
in CVD mortality. Models were adjusted for intercensal demographic estimates of county percent
male, percent White, percent Hispanic, and percent less than a high school diploma earned,
unemployment, median household income, alcohol, smoking, frequency of National Priority List
Superfund sites, and PM2.5.
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Figure 2-4. Top chemicals released at the county-level, annually, between 2002 and 2012 in the
contiguous United States.
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Figure 2-5. Comparison of county-level exposure indices, county sum and risk sum, in the
contiguous United States.

Figure 2-6. Comparison of counties with highest annual county sum and risk sum.
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Figure 2-7. Percent increase in annual, county-level mortality rates (per 100k people) per 25%
increase in county sum or risk sum.

DISCUSSION
In our study, we described the top released chemicals between 2002 and 2012 as
several acids, metals, and solvents, including lead, toluene, and styrene. We found significant
associations between county-level toxic releases and both all cause and CVD cause mortality
between 2002 and 2012 despite decreasing trends. County-level risk scores were also
associated with both all cause and CVD cause mortality with a larger effect estimate in relation to
CVD mortality. Counties releasing the highest risk chemicals were not the same as those
releasing the highest volume of chemicals, indicating a clear need for better risk reporting to the
TRI and more risk assessment for newer chemicals.
The TRI is a quasi-regulatory mechanism that provides publicly available data on toxic
emissions and requires reporting to relevant environmental authorities.121 There are currently
more than 700 chemicals and 33 chemical categories required to be reported under the TRI.
Between 2002 and 2012, we found an overall trend decrease in TRI emissions. Consistent with
these results, the TRI National Analysis reports overall declines except for years 2010 to 2012.122
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Similarly, the TRI National Analysis reported lead and lead compounds accounted for 98% of total
releases in 2012 and substantially increased from 2009 to 2011 by 102%.122 Overall, our
descriptive analysis of the national TRI data between 2002 and 2012 followed the trends reported
by the Environmental Protection Agency.
There is little reported evidence of the longitudinal association between county-level toxic
releases and all-cause and circulatory disease mortality. To the best of our knowledge, Hendryx
et al. was the only study to examine aggregate TRI releases across the U.S., and reported
average annual, county-level TRI releases between 1990 and 1999 were significantly associated
with higher all cause and cardiovascular mortality in 2006-2010.19 However, there are several
reports of the association between CVD mortality and exposure to arsenic,123-125 cadmium,125, 126
dioxins,127 lead,128 pesticides,129 and several other chemicals and metals which are covered
under the TRI. Additionally, previous epidemiological studies have shown significant associations
between exposure to volatile organic compounds and cardiovascular events18, 20, 75 and
cardiovascular mortality rates.20 Thus, our study provides new models of national, ecological data
to understand the longitudinal relationship between pollutants and population mortality rates.
In addition to our aggregate exposure measure, we created a risk score for each county
to examine the effect of chemical toxicity on mortality rates. We found that our county-level risk
scores were more strongly associated with CVD mortality rates than the toxicity independent
exposure score. To create the score, we used a pre-existing toxicity component called the
reportable quantity established by the ATSDR. Although there is an existing TRI risk score called
the Risk Screening Environmental Indicators Model (RSEI), we created our own score for
aggregation and to expand the toxicity included. Compared to the RSEI score, which is only
based on chronic effects, the reportable quantities are based on acute toxicity, chronic toxicity,
carcinogenicity, aquatic toxicity, and ignitability and reactivity. Furthermore, RSEI scores are only
available for approximately 400 covered TRI chemicals. Previous studies have neglected to
account for the TRI chemical risk level when modelling adverse health effects.97-99
Our ecological study has several limitations. First, although our ecological study is
longitudinal, it is an observational study and cannot prove causation. Second, because the study
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uses an aggregate exposure and outcome variable, we cannot extrapolate the results to the
individual level. Furthermore, the ecological design introduces ecological bias: bias due to
interaggregate variation in the disease rate among those not exposed to the risk factor, bias due
to groups acting as effect modifiers in the dose response relationship, and bias due to
confounding variables. Finally, even though our study accounted for chemical toxicity, the values
used were already established by the ATSDR. While advantageous to our development of a risk
score, reportable quantities are often based on limited or dated toxicology studies and do not
represent more sensitive cardiovascular endpoints.
Pollution is the largest environmental cause of disease and premature death in the world
today.2 Yet the effects of pollution on non-communicable diseases like CVD have largely been
underestimated. Particularly, the effects of chemical pollution on human health are poorly defined
due to poor knowledge of many chemicals in common use.90, 91, 130-132 Pollution is a primary
concern due to increases from globalization, technological industrialization, and urbanization.
Furthermore, these increases greatly impact low- and middle-income countries, Black and Brown
populations, and low-income communities in the U.S., and children.
In our study, we found that pollution defined by county-level toxic releases, in quantity
and risk, are associated with county-level, age-adjusted all cause and CVD mortality rates in the
contiguous United States between 2002 and 2012. The most released chemicals during this time
were metal compounds, especially lead, solvents, and acids. Our study implicates the importance
of pollution reduction to reduce deaths. Furthermore, it highlights the need to comprehensively
understand pollution sources. Future studies must determine the most contributive chemicals
both individually, and as mixtures. Even though our study used a composite value, there is value
in parsing out contributions of individual chemicals.
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EXPOSURE TO VOLATILE ORGANIC COMPOUNDS IS ASSOCIATED WITH
VASCULAR DYSFUNCTION

INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of death from environmental
exposures, surpassing the number of attributable deaths to cancer mortality.1 The World Health
Organization estimates that annually, exposure to air pollution is associated with 1.4 million
deaths from stroke and 2.4 million deaths from heart disease, worldwide.3 To estimate the health
effects of air pollution, most studies examine particulate matter of diameter 2.5 µm (PM2.5) and
tropospheric ozone (O3).4 However, even though PM2.5 and O3 show strong associations between
CVD progression and mortality,5-7 these pollutants represent only two components of complex
real-world ambient air pollution, which in most locations around the world is a mixture of different
pollutants, including oxides of nitrogen and volatile organic compounds (VOCs). Therefore, there
is urgent need to assess the health impact of other commonly found pollutants, and to understand
how they affect the risk and progression of cardiovascular and other diseases.
Volatile organic compounds (VOCs) are pervasive environmental pollutants and
exposure to VOCs has been found to be associated with health effects such as CVD,
neurological effects, organ toxicity, and cancer.16, 36 Although these gaseous compounds are
present across all environmental media, they are major components of indoor and outdoor air
pollution due to high vapor pressure and low molecular weight.31, 133, 134 Primary sources of VOCs
include tobacco smoke and vehicle exhaust, industrial releases, consumer goods production,
products that contain organic solvents, and hazardous waste sites.8 VOCs also interact with other
pollutants to create intermediates and secondary pollutants such as tropospheric O3 and
secondary organic aerosols, a major component of fine particulate matter (PM2.5).9, 10 However,
compared with the wealth of epidemiological studies of PM2.5, the approximation of human
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exposure to VOCs is complicated by a lack of routine air monitoring of VOCs,11 large variations of
VOCs in space and time,13, 14 and high chemical production each year.15
The classification of multiple chemicals as VOCs further challenges the understanding of
VOC exposure. Previous epidemiological studies have grouped ambient VOCs by alkenes,
alkynes, and benzene, toluene, ethyl benzene and xylene (BTEX) compounds to show
associations with cardiovascular events such as heart failure,17 stroke,18 ischemic heart
disease,18, 19 and cardiovascular mortality.19, 20 Total VOC exposure is often measured indoors
and has been associated with increased blood pressure (BP) and heart rate,21 heart rate
variability,135 and autonomic nervous system changes.136 Individual VOC metabolites from human
biomonitoring have been associated with doctor-diagnosed CVD22 and metabolic syndrome.137
Likewise, VOC-containing pollutants such as automobile and diesel emissions and tobacco
smoke have been variably linked to the development of CVD and CVD risk.23, 25, 26, 138
Nonetheless the role of exposure to VOCs in CVD pathophysiology in humans remain to be
identified.
In addition to environmental monitoring, VOC exposures can also be monitored by
measuring urinary metabolites of VOCs. The urinary metabolites of VOCs include specific, stable
mercapturic acids with short physiological half-lives quantified by non-invasive sampling.86, 139
Such measurements provide more proximal and individual-level assessments of VOCs.
Therefore, in this study, we measured urinary VOC metabolites to assess the relationship
between short-term exposure to individual VOCs and vascular outcomes. We assessed primary
risk factors for CVD, BP and endothelial function, and sympathetic nervous system
neurotransmitters/ catecholamines, which are reflective of stress leading to the development of
CVD.6 Because personal monitoring and biomonitoring are considered the gold standard of
exposure assessment,140 we measured urinary VOC metabolite levels to test the hypothesis that
VOC exposure contributes to CVD risk in a nonsmoking, diverse, urban cohort.141
METHODS
Both exposure and outcome data were from a cross-sectional study designed to examine
the relationship between exposure to environmental pollutants and CVD risk in an urban cohort.
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The Louisville Healthy Heart Study (LHHS) recruited 615 participants with moderate to high CVD
risk (individuals undergoing primary or secondary prevention for CVD) at University of Louisville
Hospital and associated clinics in Louisville, KY between October 2009 and April 2017. The
primary prevention group refers to those who have known CVD risk factors (e.g. hypertension,
hypercholesteremia, obesity, diabetes) that require management but who have no overt CVD.
The secondary prevention group refers to those who have CVD risk factors that need to be
treated, as well as overt CVD. Participants who met enrollment criteria gave informed consent
and were administered a questionnaire to acquire baseline characteristics and demographic
information. Inclusion criteria were: 1) age 18 years or older; and 2) treatment for CVD at the
University of Louisville Hospital and associated clinics. Persons excluded were: 1) those unwilling
to consent; 2) pregnant or lactating individuals; 3) incarcerated individuals; 4) persons with severe
comorbidities (including lung, liver, kidney disease, cancer, and coagulopathies); 5) substance
abuse; and 6) chronic cachexia. The Institutional Review Board at the University of Louisville
approved the study.
Measures of Vascular Function
Blood pressure and endothelial function were measured at time of enrollment. Systolic
and diastolic BP were measured after ten minutes of rest with an automated cuff and recorded as
continuous variables. Three measurements were taken one minute apart with the last two
measurements averaged. Peripheral endothelial function was measured in a subset of
nonsmoking participants with and without diabetes (n=70) to assess the role of endothelial
function in the manifestation of diabetes. Participants with diabetes were classified by HbA1c >
6.5%, fasting plasma glucose > 126mg/dL, or random plasma glucose > 200mg/dL. Peripheral
endothelial function was measured using fingertip peripheral arterial tonometry, i.e., EndoPAT,
and calculated as a reactive hyperemia index (RHI).142
Urinary Catecholamines and Metabolites
Spot urine samples were collected at day of enrollment. Urinary catecholamines,
monoamines, and their metabolites were quantified by ultra-performance liquid chromatography-
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tandem mass spectrometry (UPLC-MS/MS) as previously described.143 Briefly, frozen urine
samples were thawed on ice, vortexed, and diluted (1:50) with 0.2% formic acid containing
isotopically labeled internal standards. The method quantified epinephrine (EPI); norepinephrine
(NE); dopamine (DA); serotonin (5-hydroxytryptamine, 5HT); metanephrine (MN);
normetanephrine (NMN); 3-methoxytyramine (3MT); homovanillic acid (HVA); vanillylmandelic
acid (VMA); and, 5-hydroxyindole-3-acetic acid (5HIAA) using a Waters Acquity Class-H UPLC
coupled with Xevo TQ-S micro mass spectrometer.143 Analytes were normalized to urinary
creatinine levels and reported as levels (nanograms of metabolite per milligram of creatinine,
ng/mg).
Accuracy was measured by creating four levels of quality control (QC) samples of spiked,
known amounts of analytes. Within and between run accuracy was measured in three
independent runs with five replicates. Accuracy was calculated as the ratio of measured and
expected concentration of analyte. The accuracy of within- and between runs of all analytes was
100 ± 16%. The within- and between run precision values, expressed as coefficient of variation
(CV), were<15% for all analytes, with the exception of 5-HT at LOQ level (17.3%). Recovery was
within the range of 92–113% at all spike levels (SD ± 16%). Collectively, these results
demonstrate excellent precision and accuracy for the determination of all the analytes in urine
samples.143
Urinary VOC Metabolites
Volatile organic compounds are ubiquitous environmental pollutants. Although there are
several sources of VOCs, the major non-occupational source of exposure is tobacco smoke.
However, VOCs can also arise from hazardous waste sites, vehicle exhaust, industrial releases,
and household products.8 Urinary VOC metabolites are the preferred method to assess human
exposure because of high spatial and temporal variability of VOCs in air,13, 14 urine collection is
non-invasive, and mercapturic acids are specific and stable with longer physiological half-lives
than parent compounds.86 Given that half-lives of urinary VOC metabolites range from 2.1 to 34
hours,86 urinary VOC metabolites represent an individual’s short-term or acute exposure.144 We
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measured the most common urinary VOC metabolites, a well-developed panel of 22 metabolites
of 17 parent VOCs86, 139 in spot urine samples collected on the day of enrollment.
To assess VOC exposure, the levels of 22 urinary metabolites of 17 parent VOCs,
(acrolein, acrylamide, acrylonitrile, benzene, 1-bromopropane, 1,3-butadiene, crotonaldehyde,
N,N-dimethylformamide, ethylbenzene, ethylene oxide, propylene oxide, styrene,
tetrachloroethylene, toluene, trichloroethylene, vinyl chloride, and xylene; were quantified using a
modified version of the UPLC-MS method.86, 145 In brief, urine was diluted with 15mM ammonium
acetate and spiked with isotopically labeled internal standards. The analysis was performed on an
Acquity UPLC core system coupled to a Quattro Premier XE triple quadrupole mass spectrometer
with an electrospray source (Waters Inc, MA).145
The VOC metabolites were analyzed using a method adopted from CDC.86, 139 The
method was validated139 and the results showed that the sensitivity, precision, and accuracy of
our method are comparable to the method reported. Specifically, the limit of detection (LOD) of
each analyte is typically within 1 to 10 ng/ml. Precision, assessed by the coefficient of variation of
quality control samples, was within 17%. Accuracy, assessed by analyzing spiked urine, was
determined at three different levels of VOC metabolites, and was within 80 to 120%. The method
is highly reproducible, with relative standard deviations <8%. The sensitivity, accuracy, and
precision were similar to those associated with the method developed by the CDC.
The primary exposure variables were 22 VOC urinary metabolites: N-Acetyl-S-(2carboxyethyl)-L-cysteine (CEMA), N-Acetyl-S-(3-hydroxypropyl)-L-cysteine (3HPMA), N-Acetyl-S(2-cyanoethyl)-L-cysteine (CYMA), N-Acetyl-S- (2-hydroxyethyl)-L-cysteine (HEMA), t,t-Muconic
Acid (MU), N-Acetyl-S-(n-propyl)-L-cysteine (BPMA), N-Acetyl-S-(3,4-dihydroxybutyl)-L-cysteine
(DHBMA), N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine (MHBMA3), N-Acetyl-S-(3hydroxypropyl-1-methyl)-L-cysteine (HPMMA), N-Acetyl-S-(N-methylcarbamoyl)-L-cysteine
(AMCC), Phenylglyoxylic acid (PGA), N-Acetyl-S-(2-hydroxypropyl)-L-cysteine (2HPMA), NAcetyl-S-(1-phenyl-2-hydroxyethyl)-L-cysteine + N-Acetyl-S-(2-phenyl-2-hydroxyethyl)-L-cysteine
(PHEMA), Mandelic Acid (MA), N-Acetyl-S-(trichlorovinyl)-L-cysteine (TCVMA), N-Acetyl-S(benzyl)-L-cysteine (BMA), N-Acetyl-S-(1,2-dichlorovinyl)-L-cysteine (12DCVMA), N-Acetyl-S-
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(2,2-dichlorovinyl)-L-cysteine (22DCVMA), Urinary N-Acetyl-S-(dimethylphenyl)-L-cysteine
(DPMA), 2-Methylhippuric acid (2MHA), and 3-Methylhippuric acid + 4-Methylhippuric acid
(3,4MHA). Analytes were normalized to individual urinary creatinine levels to adjust for dilution
and reported as levels (nanograms of metabolite per milligram of creatinine, ng/mg).
Covariates
Data on age, sex, race, body mass index, and self-reported tobacco exposure were
collected at baseline using questionnaires. Information on medication use, cardiovascular history,
and cardiovascular risk factors was obtained from medical records and questionnaires. We
calculated the Framingham risk score (FRS), the risk for coronary heart disease, using the
National Heart, Lung, and Blood Institute calculator.146 Because PM2.5 is an established CVD risk
factor,5, 6 we estimated PM2.5 exposure on the day of enrollment for adjustment in our models. We
assessed the spearman correlation between PM2.5 and urinary VOC metabolites and found no
significant correlations or correlations of ρ>07. Average daily PM2.5 values for all monitors in the
Louisville Metropolitan Statistical Area were collected from the U.S. Environmental Protection
Agency to estimate daily mean values of PM2.5.
Statistical Analysis
Smoking is a known risk factor for CVD, and a major source and possible confounder of
VOC exposure.138, 145, 147 To assess environmental VOC exposure in individuals, we restricted the
cohort to nonsmokers. We excluded individuals who were smokers, classified as individuals with
urinary cotinine levels greater than 40 ng/mg of creatinine (n=222), despite self-reported positive
smoking status. This range also excludes those exposed to secondhand smoke.148 Participants
without measured VOC metabolite data (n=46) and one participant with catecholamine outliers
(six times the 99th percentile of 21,633 ng/mg) were removed from the analysis. The remaining
cohort (n=346) had ≤10% missing data for other covariates. Observations with unobserved
outcomes were removed from models. Thus, the final cohort for each outcome was n=308 for BP,
n=70 for endothelial function, and n=323 for catecholamines. To summarize these data, variables
were stratified into low and high levels of total VOC metabolites. We created a ‘total VOC score’
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by summing the Z-score of each of the log transformed and creatinine-corrected metabolites.
Values were dichotomized into low and high groups, using the median value of summed Z-scores
(-0.3143426). To determine significant differences between low and high total VOCs, we used Chi
square tests for categorical variables and t-tests for continuous variables. Values of continuous
variables are reported as mean ± SD and categorical variables as n (%).
To examine the link between environmental VOC exposures and CVD risk, we
constructed individual linear regression models by regressing normally distributed BP against
each urinary VOC metabolite after adjusting for potential confounders. The levels of
catecholamines and their metabolites, and RHI values were positive and right skewed; therefore,
we used generalized linear models (GLMs) with a gamma distribution and log link function. Model
adjustments were chosen a priori based on the literature for BP and RHI6, 56, 62 and by creation of
a directed acyclic graph. The relationships between levels of urinary VOC metabolites and BP
were adjusted for age, sex, race, BMI, angiotensin converting enzyme (ACE) inhibitors,
angiotensin II receptor blockers (ARBs), beta blockers, and PM2.5. Models including the
covariates temperature, seasonal adjustment, median household income by census tract,
diabetes, and cotinine did not change the effect estimate by more than 10% and were therefore
not included in final models. The relationship between VOC exposures and RHI was adjusted for
age, sex, race, BMI, diabetes status, and PM2.5. Additionally, we tested BP medications as
moderators of the relationship between VOC exposures and BP, and diabetes and hypertension
as moderators of the relationship between VOC exposures and RHI. To simulate a doseresponse curve, we split the urinary VOC metabolite levels into equal tertiles and constructed
adjusted generalized linear models of predicted means for each tertile as the new exposure
variable to determine the shape of the exposure-response relationship. The lowest tertile
concentration of each VOC metabolite was the reference group. To determine susceptible
groups, we performed sub-analyses based on race and sex strata for blood pressure and
catecholamine outcome variables. The data was not stratified by age due to high median age
among the cohort. RHI was not included in sub-analyses due to small sample size.
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To examine the association between VOC exposures and catecholamines, monoamines,
and their metabolites, we constructed generalized linear models by regressing each of the ten
catecholamines against each urinary VOC metabolite. We built individual models for each VOC
metabolite and adjusted for significant (p<0.1) differences between low and high concentrations
of each VOC metabolite. To determine susceptible groups, we performed sub-analyses based on
race and sex strata.
To understand the relationship between exposure to VOCs and BP, we conducted a
mediation analysis of VOCs and BP mediated by catecholamines. The mediation analysis was
conducted by assessing the direct and indirect effects of each VOC metabolite (X variable) on
SBP and DBP (Y variables) with each urinary catecholamine (M) as mediator. Analysis was
conducted using the PROCESS macro in SAS.149 Additionally, we tested the exposure-mediator
interaction in the relationship to BP.
Although there were multiple exposure variables, we did not correct for multiple testing to
test the null hypothesis that all associations were null.150, 151 Furthermore, this is an exploratory
analysis where the VOC and CVD connection is not very strong. Thus, we wanted to minimize
false negatives. We did not presume that all associations were due to random variation. Values
are reported as mmHg or percent difference in outcome per interquartile range (IQR) of VOC
metabolite concentration. Statistical analysis was performed using SAS version 9.4 (SAS Institute
Inc., Cary, NC, USA) for individual VOC models of CEMA, 3HPMA, DHBMA, MHBMA3, and
HPMMA, and R software (version 3.1.3) was used for graphical displays.
Sensitivity Analysis
We constructed models with and without normalization of VOC metabolites to creatinine.
When the VOC metabolites were not normalized to creatinine, the creatinine variable was
included as a covariate in the model. All models were used with the concentrations of VOC
metabolites normalized to creatinine. Finally, 11 self-reported smokers were included despite
cotinine values of <40ng/mg. The maximum values of cotinine (24.13ng/mg) for the self-reported
smokers was much lower than the maximum values of self-reported nonsmokers (38.10 ng/mg).
We conducted sensitivity analyses to determine changes in associations with and without self61

reported smokers with no difference in result. Thus, we kept nonsmoker status using the above
cotinine cut-off of <40ng/mg.
RESULTS
In Table 3-1, we present descriptive statistics for the restricted non-smoking LHHS
participants (n=346) after excluding smoking participants with urinary cotinine values >40ng/mg
creatinine. Data for individual covariates were missing for ≤10% of participants. More than half
the study population was White, about a third was Black, the mean age was 51.9 years, and the
mean BMI was 32.9 kg/m2. Participants with higher VOC metabolite concentrations were older,
had higher Framingham risk scores, more comorbidities, and were prescribed more CVD
medications.
At least 85% of all VOC metabolite observations in the nonsmoking population were
above the LOD. All VOC metabolites were gamma distributed and highly variable. Boxplots of log
transformed VOC metabolites normalized to creatinine are presented in Figure 3-1A. Women
(n=198) had higher concentrations of DHBMA and HPMMA compared with men (Figure 3-1B);
and White participants (n=214) had higher concentrations of 3HPMA, DHBMA, and HPMMA
compared with Black participants (Figure 3-1C). Parameter estimates were reported for IQR
increase in each VOC metabolite: 88.3ng/mg of creatinine for CEMA, 148.9ng/mg for 3HPMA,
195.0ng/mg for DHBMA, 4.7ng/mg for MHBMA3, and 107.2ng/mg for HPMMA. Systolic and
diastolic BPs and RHI had a log-normal distribution. The levels of catecholamines and
metabolites were gamma distributed.
Figure 3-2A shows fully adjusted estimates for associations with systolic blood pressure
(SBP), which were positive per IQR increase in 3HPMA (0.98 mmHg higher; 95% CI: 0.06, 1.91;
P=0.038). As shown in Figure 3-2B, 3HPMA was associated with SBP in an exposure dependent
manner. Likewise, for each IQR of 3HPMA or DHBMA, there was a -3.3 % (95% CI: -6.18, -0.37;
P=0.024) or a -4.0 % (95% CI: -7.72, -0.12; P=0.012) difference in RHI, respectively, indicating
decreased endothelial function. Notably, RHI was lower in an exposure-dependent manner with
DHBMA concentrations (1.8%; 95% CI: 1.65, 2.06; P=0.011). Although the reduction in absolute
RHI index was similar between 3HPMA and DHBMA, it did not reach statistical significance for
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3HPMA. The other acrolein metabolite, CEMA, approached significance in the association with
SBP (1.53mmHg; 95% CI: -0.27, 3.34; P=0.097) and RHI (4.3%; 95% CI -10.0, 0.9; P=0.123).
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Table 3-1. Descriptive Statistics [number (%) and mean (± standard deviation (SD))] for
nonsmoking participants in the Louisville Heathy Heart Study (n=346), stratified by low and high
VOC metabolite concentrations.

Participant Characteristic

Low VOCa

High VOC

p-valueb

Age
Male
Race
Black (Black v Other)
White (White v Other)
Other (Other v All)
BMI
Daily Mean PM2.5 (µg/m3)
Daily Max O3 (µg/m3)
Temperature (C°)
Humidity (mg/L)
Median Household Incomed
Framingham Risk Score
Hyperlipidemia
Hypertension
Diabetes
Myocardial Infarction
Stroke
Heart Failure
Beta Blockers
Ace Inhibitors
ARBsc
Statins
Aspirin
Diuretics
Vasodilators
Calcium Channel Blockers

49.3 ± 11.9
96 (56.1)

54.5 ± 11.2
102 (59.3)

55 (32.2)
104 (60.5)
13 (7.6)
32.9 ± 8.0
12.9 ± 5.0
0.05 ± 0.02
12.4 ± 13.2
22.3 ± 10.7
49K ± 31K
21.1 ± 11.8
77 (45.6)
99 (58.6)
44 (26.0)
30 (17.9)
10 (5.9)
18 (10.8)
60 (35.9)
64 (37.9)
11 (6.6)
59 (35.3)
60 (35.9)
46 (27.5)
5 (4.0)
34 (20.4)

50 (28.9)
110 (64.0)
12 (6.9)
32.8 ± 8.1
13.7 ± 6.0
0.05 ± 0.02
13.3 ± 12.9
22.2 ± 10.8
45K ± 26K
25.3 ± 9.1
102 (59.6)
129 (75.4)
62 (36.0)
46 (26.7)
13 (7.6)
28 (16.4)
88 (52.4)
76 (44.7)
20 (11.9)
82 (48.8)
83 (48.8)
73 (43.5)
11 (8.0)
40 (23.8)

<0.001
0.63
0.8
0.56
0.24
0.84
0.85
0.26
0.14
0.55
0.91
0.22
0.002
0.013
0.001
0.06
0.07
0.70
0.18
0.003
0.24
0.14
0.017
0.022
0.003
0.28
0.53

a

Low and high VOC strata are dichotomized Z-score sums of the log transformed VOC
metabolite concentrations normalized to creatinine (ng/mg).
b
Continuous variables compared between strata by t-tests and categorical variables compared
between strata by χ² tests
c
Angiotensin II Receptor Blockers
d
Reported in thousands (K)
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Systolic and diastolic blood pressure in the entire cohort centered around 129.1±19.7 and
79.6±11.1 mmHg, respectively. In comparison, Black participants had higher mean SBP
(135.6±23.0 mmHg) and DBP (83.5±11.7.0 mmHg) than White participants’ mean SBP
(126.4±17.4 mmHg) and DBP (77.9±10.4 mmHg). Compared with the relationship between
3HPMA and SBP found in the total cohort, Black participants showed a larger association with
SBP (5.1 mmHg higher; 95% CI: 1.5, 8.8; P=0.006), despite lower levels of urinary 3HPMA in this
population (Figures 3-1C and 3-2C). Additionally, women had a larger association with SBP per
IQR of 3HPMA (1.2 mmHg higher; 95% CI: 0.08, 2.4; P=0.038). In White participants, estimates
were higher for SBP (0.8 mmHg higher; 95% CI: 0.05, 1.5; P=0.037) and diastolic blood pressure
(DBP) (0.6 mmHg higher; 95% CI: 0.2, 1.0; P=0.007) per IQR increase in MHBMA3 (Figure 32C).
Several catecholamines were significantly associated with VOC metabolites. Urinary EPI
levels were positively associated with IQR increases in MHBMA3 (3.1% higher; 95% CI: 0.5,
5.7%; P=0.018) and HPMMA (0.04% higher; 95% CI: 0.0, 6.6%; P=0.036) (Figure 3-3). Urinary
DA levels were positively associated with IQR increases in HPMMA (3.3% higher; 95% CI: 1.1,
4.4%; P=0.001). In Black participants, urinary NE and NMN levels were positively associated with
IQR increases in DHBMA (15.7% higher; 95% CI: 5.6, 27.0%; P=0.001; and 11.6% higher; 95%
CI: 3.7, 20.0%; P=0.002) compared with the entire cohort. DA and serotonin end products, HVA
and 5HIAA, were positively associated with 3HPMA, DHBMA, MHBMA3, and HPMMA.
To understand whether catecholamines modify or mediate relationships between VOC
metabolites and markers of vascular dysfunction, we tested for both interaction and mediation.
Mediation analyses showed null results. Although we observed significant direct effects between
the acrolein metabolites and catecholamines, there were no significant indirect effects of
catecholamines mediating the effects of VOC exposure on blood pressure. However, EPI levels
were shown to modify the associations of MHBMA3 with DBP. Similarly, DA levels modified the
association between HPMMA and SBP (data not shown). There was a positive association
between MHBMA3 and DBP (0.5% higher; 95% CI: 0.0, 1.0%) in participants with higher urinary
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Figure 3-1. Exposure distributions of each VOC metabolite, CEMA, 3HPMA, DHBMA, MHBMA3,
and HPMMA, reported as totals (A), and stratified by sex (B) and race (C).

Values are reported as the log of the concentration of creatinine corrected urinary VOC
metabolites (ng/mg creatinine). Wilcoxon unpaired two sample tests used to compare means.
Single asterisk indicates p-values<0.05, 3 asterisks indicate p-values<0.001, and ns indicates not
significant, p-values>0.05.
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Figure 3-2. Differences (mmHg) and percent differences, and 95% confidence intervals in blood
pressure and RHI per IQR of VOC metabolite (A). Predicted means and 95% confidence
intervals(mmHg) in blood pressure and % difference in RHI with increasing tertile of 3HPMA and
DHBMA (B). Differences and 95% confidence intervals (mmHg) in blood pressure, stratified by
sex and race (C).

Model adjustments for blood pressure (n=308) include age, sex, race, BMI, daily PM2.5, ace
inhibitors, ARBs, and beta blockers. Model adjustments for RHI (n=70) include age, sex, race,
BMI, diabetes, and daily PM2.5. Asterisks indicate p-values<0.05. Model estimates can be found
in supplemental information.
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Figure 3-3. Percent differences and 95% confidence intervals in catecholamines per IQR of VOC
metabolite in the total cohort (+). Models were stratified by male participants (filled circle), female
participants (open circle), Black participants (fliled triangle), and White participants (open
triangle).

Catecholamines include epinephrine (EPI), norepinephrine (NE), dopamine (DA), 5hydroxythreonine (5HT), metanephrine (MN), normetanephrine (NMN), 3-methoxytyramine
(3MT), homovanillic acid (HVA), vanillymandelic acid (VMA), and 5-hydroxyindole acetic acid
(5HIAA). Asterisks indicate p-values<0.05. Model estimates can be found in supplemental
information.
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levels of EPI tertiles (between 6.6 and 31.5ng/mg). There was a positive association between
HPMMA and SBP (3.3% higher; 95% CI: 0.7, 5.9%) in participants with lower levels of EPI
(between 0.0 and 3.1 ng/mg). Similarly, there was a positive association between HPMMA and
SBP (2.7% higher; 95% CI: 0.0, 5.4%) in participants with lower levels of DA tertiles (between 5.2
and 133.7 ng/mg).
DISCUSSION
In this study of participants with moderate to high CVD risk, we found that metabolites of
acrolein and 1,3-butadiene, (3HPMA and DHBMA, respectively), were significantly associated
with SBP and endothelial dysfunction. We also found that Black participants may be more
susceptible to the effects of acrolein (with respect to SBP) and they had higher levels of NE and
NMN associated with 1,3-butadiene exposure. DHBMA was consistently associated with the
dopamine metabolite homovanillic acid, across all strata. The crotonaldehyde metabolite,
HPMMA, was strongly associated with the serotonin metabolite, 5-hydroxyindole acetic acid.
Finally, we report null results of catecholamines mediating the relationship between VOC
exposure and blood pressure.
Acrolein is a reactive unsaturated aldehyde known to be associated with CVD risk.25
Acrolein can be produced both endogenously from lipid peroxidation, and exogenously from
combustion, chemical production, cigarette smoke, and e-cigarette vapors.147, 152 In the city of
Louisville, Jefferson County census tracts were estimated to have some of the highest ambient
acrolein concentrations across the state of Kentucky in 2011 and 2014, with point and mobile
source emissions (airport and heavy duty vehicles) as top contributors.153 In our analysis, we
found that the acrolein metabolite, 3HPMA, was significantly associated with increased SBP in a
dose-dependent manner.
Similar to our results, previous studies have shown that exposure to acrolein increases
BP in both normotensive and hypertensive rats.154, 155 Additionally, several experimental studies
have shown that exposure to acrolein affects endothelial function by suppressing endothelial
nitric oxide synthase activation,156 attenuating endothelial cell migration,157 blocking vascular
endothelial growth factor,158 and reducing circulating levels of angiogenic cells.25 Specifically, an
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intact endothelium mediates dilation of the mesenteric bed in response to acrolein exposure; thus
indicating a blunted response with increased sympathetic tone.159 Endothelial function was
similarly impaired in tobacco smokers160-162 and e-cigarette users163-166 -two sources of acrolein
exposure in the general population. Finally, CVD risk markers, EPI and NE did not increase with
respect to acrolein exposure in male Wistar and GK rats.167
The chemical - 1,3-butadiene is an alkene reported to have a possible epidemiological
association with arteriosclerotic heart disease.168-170 This chemical is primarily used to make
synthetic rubber, but it is also produced from petroleum processing and combustion sources such
as vehicle exhaust and cigarette smoke.171 Although our study did not show associations
between 1,3-butadiene exposure and BP, one study found normotensive pregnant women had
increased odds of high BP when exposed to ambient 1,3-butadiene two hours prior to admission
to labor and delivery.18 Another cross-sectional study used principal component analysis of
nonsmokers’ personal exposures to ambient VOCs; the authors observed decreased endothelial
function and increased DBP in relation to a 1,3-butadiene source in the Detroit Exposure and
Aerosol Research Study (DEARS). No effect on SBP was seen.172 Similar to acrolein, several
studies suggest 1,3-butadiene as a major cardiovascular risk driver in cigarette smoke.169, 173
However, from these data the singular contribution of 1,3-butadiene exposure to endothelial
dysfunction in humans could not be ascertained, as in our study.
Crotonaldehyde is an unsaturated aldehyde and an atherogenic compound.174-176
Crotonaldehyde is produced endogenously from the metabolism of 1,3-butadiene and
exogenously from combustion sources like vehicle exhaust and cigarette smoke.177-179
Crotonaldehyde and acrolein did not seem to share similar adverse health effects in our study
despite a potential shared mode of action.178 However, crotonaldehyde exposure was weakly
associated with EPI, NE, DA, HVA, and 5HT and strongly associated with serotonin metabolite
5HIAA, but had little or no relationship with BP or endothelial function. Consistent with this
observation, a recent study shows that chronic inhalation exposure of mice to crotonaldehyde led
to decreases in SBP and DBP and enhanced endothelial function.180 Crotonaldehyde is a
noncompetitive inhibitor of aldehyde dehydrogenases which have been suggested to be involved
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in DA metabolism, release, and synthesis.181-183 Furthermore, cigarette smoke, a major source of
acrolein, 1,3-butadiene, and crotonaldehyde, has been shown to inhibit monoamine oxidase, a
catalyst for the biotransformation of both DA and 5HT to metabolites HVA and 5HIAA,
respectively.143 Therefore, our study suggests exposure to crotonaldehyde may affect
dopaminergic pathways.
We found that Black participants may be more susceptible to acrolein exposure with
respect to SBP, despite lower levels of exposure when compared with White participants. Black
individuals are at an increased risk for CVD184 which may be explained by increased susceptibility
to acrolein exposure, a major driver of CVD.185 Similar to our study, a previous analysis of
NHANES 2005-2006 data reported Black individuals have lower urinary 3HPMA concentrations
compared with White individuals.186 However, racial disparities in the relationship between
acrolein and blood pressure has not previously been reported. This susceptibility may be
explained by a myriad of factors such as access to healthcare or increased stress from systemic
racism, and thus requires future research. In Louisville, Kentucky, the National Air Toxics
Assessment estimates higher concentrations of acrolein in lower percent Black census tracts, but
the health impact of such exposures has not been evaluated.153
Black individuals also had higher levels of NE and NMN associated with 1,3-butadiene
exposure. Two large, retrospective epidemiological studies have reported increased standardized
mortality ratios for arteriosclerotic heart disease in 1,3-butadiene exposed rubber plant workers,
particularly in the Black male population.168-170 Similarly, another study found that Black
hypertensive subjects had the more sensitive and highest-density β-receptors,187 and increased
α1 and β-adrenergic receptor responsiveness compared with White subjects. 188 Because EPI,
NE, and DA are agonists for β-adrenergic receptors, increased catecholamines could produce a
higher β-adrenergic response in Black individuals leading to an increased risk for CVD. Additional
studies with larger populations are needed to replicate these findings.
In our analyses, catecholamines did not mediate the relationship between VOC exposure
and blood pressure. Mediation is the sum of the direct effect (c’) and the indirect effect (a x b) of X
on Y, the total effect.149 Although we found significant direct effects between the acrolein
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metabolites and catecholamines, the indirect effects were null. Therefore, we cannot conclude
that catecholamines mediate the effects of VOC exposure on blood pressure in our study. These
null effects may be explained by the small magnitude of change in catecholamines. Blood
pressure medications, however, may be effect modifiers or confounders of these analyses
because they reduce changes in catecholamines and may attenuate the mediating relationship
between VOC exposures and blood pressure.
CVD is a complex group of pathological conditions that affect the heart and blood
vessels. Although rare cases of CVD can be linked to specific gene-defects, a majority of CVD
risk can be attributed to environmental factors such as poor nutrition, physical inactivity, smoking
and exposure to air pollution.58, 189, 190 There are three proposed biological pathways through
which exposure to air pollution could contribute to the development of CVD: 1) systemic oxidative
stress and inflammation, 2) autonomic nervous system imbalance, and 3) transmission of
constituents from the lung into the blood.6 We observed that exposure to 1,3-butadiene and
crotonaldehyde were associated with endothelial dysfunction and biogenic monoamines, and that
acrolein exposure was associated with SBP and endothelial dysfunction, suggesting that the risk
of CVD attributable to the environment may be in part derived from exposure to VOCs that are
ubiquitously present in the environment.
A major advantage of this study is that interindividual differences in exposure were
accounted for by using human biomonitoring in the exposure assessment. Another advantage is
the removal of smokers based on urinary cotinine values greater than 40 ng/mg of creatinine.
Most studies of VOC exposure are unable to account for smoking, or they overestimate the
contribution of smoking to VOC exposure. Here, we show how low levels of VOCs may contribute
to CVD effects, and that these effects are independent of smoking. Although we chose to use
urinary cotinine values greater than 40 ng/mg creatinine to remove smoking individuals,
participants could still be exposed to low levels of VOCs from marijuana use, or intermittent
smoking.
Limitations of this study include the small sample of nonsmokers, potential bias from
cross-sectional study design and classification of nonsmokers, and exposure and outcome
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measurement error. Misclassification of exposure and outcome is an important source of bias
in epidemiologic studies and is a likely limitation of our study. To quantify exposure, we measured
urinary metabolites. However, urinary metabolites of VOCs range widely in half-life, and therefore
their variable levels due to differences in times of exposure may account for some of the
variability in the data and exposure misclassification. Finally, even though we tested multiple
associations from individual VOC metabolites, we did not adjust for multiple comparisons which
may have allowed for some spurious associations.150
Further work is required to corroborate the findings of our study. Data from larger cohorts
with VOC metabolite data may be particularly informative about these associations in the general
population. However, cohorts like NHANES do not have extensive data on CVD risk factors or
markers of sub-clinical disease progression. While several cohorts such as the Multi-Ethnic
Study of Atherosclerosis (MESA) or the Framingham Heart Study have rich data on CVD risk,
progression, and outcomes, they do not have VOC exposure estimates. Nonetheless,
characterization of VOC exposure in these cohorts may be useful in further strengthening the
associations identified in our work. Additional work is also required to identify sources of
exposure. Source apportionment based on area of residence could be useful in defining
geographic exposure contributors.
Approximately 70% of noncommunicable diseases like CVD are attributable to air
pollution, the fifth leading human health risk factor.191 Although the effects of PM2.5 exposure on
CVD are well documented in the literature, there is a lack of data regarding VOC exposures,
which are a major component of air pollution, tobacco smoke, consumer products, and Superfund
site generated pollutants. This gap is most likely attributable to the gap in VOC emission
inventories and quantification of VOCs in ambient air,11, 13-15 as well as the lack of measurements
of VOC metabolites in exposed populations. Recently, volatile chemical products such as
pesticides, coatings, printing inks, adhesives, cleaning agents, and personal care projects were
reported to make up half of fossil fuel VOC emissions in industrialized cities.8 Our findings
suggest that low levels of VOCs can contribute to CVD at least in an at-risk population,16, 145 and
highlight the importance of investigating VOC exposure as a risk factor in the development of
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CVD. Finally, our findings highlight the need to further survey, reduce, and regulate
environmental pollutants for the prevention of CVD.
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POLLUTION MIXTURES ARE ASSOCIATED WITH CARDIOVASCULAR
MORTALITY AND BLOOD PRESSURE
INTRODUCTION
More than 70% of diseases caused by environmental factors are non-communicable
diseases, of which CVDs are a major component.2 Specifically, evidence supports the
association between exposure to VOCs,18, 20, 25, 26, 75, 77 exposure to metals,192, 193 and exposure to
ambient PM2.5 6, 194, 195 in the development of CVD. However, it is well known that these
exposures do not occur singularly, in a vacuum. Yet, epidemiological studies have historically
assessed the relationship between one exposure and multiple health effects. As a result, the
impact of multiple environmental exposures on health has not been well characterized. The
National Institute of Environmental Health Science 2018-2023 strategic plan highlights this gap by
listing the assessment of co-exposures as a primary goal for advancing environmental health
sciences.196
Environmental exposure data consisting of multiple exposures present challenges of high
dimensionality, multi-collinearity, and multiple comparisons in biostatistical analysis. Therefore,
there are two major types of statistical methods used to overcome these challenges in the study
of mixtures, unsupervised and supervised methods.197 Unsupervised methods commonly use
dimension reduction techniques independent of the modelled outcome and include clustering,
principal component analysis, and exploratory factor analysis. Supervised methods are informed
by the outcome of interest and include the penalized regression, otherwise known as variable
selection, the weighted quantile sum regression, and the Bayesian Kernel Machine Regression
(BKMR). Due to the myriad methods of assessing mixtures, one must consider the research
question of interest and the data to be analyzed prior to choosing a method to assess mixtures.

75

Until now, this dissertation work has focused on single exposure models to assess the
association with CVD mortality and the CVD risk factors in Chapters 2 and 3. Here, we will use
the previously mentioned TRI and LHHS data to cross-sectionally assess mixture patterns in
relationship to our CVD outcomes of CVD mortality and blood pressure. The TRI dataset is a
longitudinal study of county level toxic releases from industries and age-adjusted all cause and
CVD cause mortality between 2002 and 2012. The LHHS dataset is a cross-sectional study of
Louisville residents with moderate to high CVD risk. Between October 2009 and April 2017,
participants were recruited at baseline at the University of Louisville Hospital and associated
clinics. The entire cohort was comprised of 615 participants. The Institutional Review Board (IRB)
at the University of Louisville approved the study.
As we are interested in how these environmental mixtures are associated with a
cardiovascular outcome of mortality or blood pressure, we will be using two supervised methods,
variable selection and BKMR. The variable selection procedure, elastic net, will be used to
assess the relationship between mixtures of county level toxic releases and age-adjusted CVD
mortality in 2012. The BKMR method will be used to assess the relationship between mixtures of
urinary VOC metabolites and systolic and diastolic blood pressure (SBP and DBP). Each method
will aid in the identification of potentially toxic mixture components.
METHODS
Study Populations, Exposures, and Outcomes
National County Level TRI Study
The National County Level TRI Study (NCLTS) is an ecological, longitudinal study
designed to examine the relationship between county-level toxic releases and county-level, ageadjusted all cause and circulatory disease mortality, otherwise referred to as CVD mortality,
between 2002 and 2012 in the contiguous United States. Exposure and outcome data was
acquired from publicly available data from the EPA Toxic Release Inventory database and CDC
Wonder database. County-level covariates were acquired from the U.S. Census Bureau, the U.S.
Department of Labor, and the Institute for Health Metrics and Evaluation. The dataset includes
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2,599 counties in the contiguous United States with repeated observations for the consecutive
years 2002 to 2012, a total of 17,730 unique observations.
To assess county-level exposures, we acquired annual toxic chemical releases from the
TRI.92 We downloaded national annual basic data files from the U.S. Environmental Protection
Agency website for the consecutive years of 2002 to 2012. Section 313 of the Emergency
Planning and Community Right to Know Act (EPCRA) promulgates the TRI. The TRI is a
reporting system for facilities with a primary sector industry code included in the required
reporting list, facilities employing ten or more people, or facilities manufacturing, processing or
using EPCRA 313 chemicals. Facilities must report estimates of annual releases if they exceed
thresholds of 25,000 pounds per year for manufacturing; 25,000 pounds per year for processing;
or 10,000 pounds per year for otherwise use.
To assess mortality outcomes, we used data on deaths by underlying cause of death and
county of residence from vital registration through the National Center for Health Statistics106 and
on population data from the U.S. Census Bureau107 for intercensal estimates of county-level
percentages of sex, and race. From 2002 to 2012, there were a total of 31.8 million deaths in the
contiguous U.S.; 11 million of these deaths were from circulatory disease (ICD-10 codes
beginning with I) for which there is evidence of an association with toxic chemical pollution.2 All
exposure and outcome variables and covariates were harmonized and merged to create a
dataset of publicly available data. All variables were matched by county-level FIPS codes, the
Federal Information Processing Standard.
Louisville Healthy Heart Study
The Louisville Healthy Heart Study (LHHS) is a cross-sectional study designed to
examine the relationship between exposure to environmental pollutants and CVD risk. The study
recruited 615 participants with moderate to high CVD risk at University of Louisville Hospital and
associated clinics in Louisville, KY between October 2009 and April 2017. Smoking is a known
risk factor for CVD, and a major source and confounder of VOC exposure.138, 145, 147 To assess
environmental VOC exposure in individuals, we restricted the cohort to nonsmokers. We
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excluded individuals who were smokers, classified as individuals with urinary cotinine levels
greater than 40 ng/mg of creatinine (n=222), despite self-reported positive smoking status.
To assess VOC exposure, the levels of 22 urinary metabolites of 17 parent VOCs,
(acrolein, acrylamide, acrylonitrile, benzene, 1-bromopropane, 1,3-butadiene, crotonaldehyde,
N,N-dimethylformamide, ethylbenzene, ethylene oxide, propylene oxide, styrene,
tetrachloroethylene, toluene, trichloroethylene, vinyl chloride, and xylene) were quantified using a
modified version of the UPLC-MS method.86, 145 In brief, urine was diluted with 15mM ammonium
acetate and spiked with isotopically labeled internal standards. The analysis was performed on an
Acquity UPLC core system coupled to a Quattro Premier XE triple quadrupole mass spectrometer
with an electrospray source (Waters Inc, MA).145
The VOC metabolites were analyzed using a method adopted from CDC.86, 139 The
method was validated139 and the results showed that the sensitivity, precision, and accuracy of
our method are comparable to the method reported. Specifically, the limit of detection (LOD) of
each analyte is typically within 1 to 10 ng/ml. Precision, assessed by the coefficient of variation of
quality control samples, was within 17%. Accuracy, assessed by analyzing spiked urine, was
determined at three different levels of VOC metabolites, and was within 80 to 120%. The method
is highly reproducible, with relative standard deviations <8%. The sensitivity, accuracy, and
precision were similar to those associated with the method developed by the CDC.
The primary exposure variables were 22 VOC urinary metabolites: N-Acetyl-S-(2carboxyethyl)-L-cysteine (CEMA), N-Acetyl-S-(3-hydroxypropyl)-L-cysteine (3HPMA), N-Acetyl-S(2-cyanoethyl)-L-cysteine (CYMA), N-Acetyl-S- (2-hydroxyethyl)-L-cysteine (HEMA), t,t-Muconic
Acid (MU), N-Acetyl-S-(n-propyl)-L-cysteine (BPMA), N-Acetyl-S-(3,4-dihydroxybutyl)-L-cysteine
(DHBMA), N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine (MHBMA3), N-Acetyl-S-(3hydroxypropyl-1-methyl)-L-cysteine (HPMMA), N-Acetyl-S-(N-methylcarbamoyl)-L-cysteine
(AMCC), Phenylglyoxylic acid (PGA), N-Acetyl-S-(2-hydroxypropyl)-L-cysteine (2HPMA), NAcetyl-S-(1-phenyl-2-hydroxyethyl)-L-cysteine + N-Acetyl-S-(2-phenyl-2-hydroxyethyl)-L-cysteine
(PHEMA), Mandelic Acid (MA), N-Acetyl-S-(trichlorovinyl)-L-cysteine (TCVMA), N-Acetyl-S(benzyl)-L-cysteine (BMA), N-Acetyl-S-(1,2-dichlorovinyl)-L-cysteine (12DCVMA), N-Acetyl-S-
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(2,2-dichlorovinyl)-L-cysteine (22DCVMA), Urinary N-Acetyl-S-(dimethylphenyl)-L-cysteine
(DPMA), 2-Methylhippuric acid (2MHA), and 3-Methylhippuric acid + 4-Methylhippuric acid
(3,4MHA). Analytes were normalized to individual urinary creatinine levels to adjust for dilution,
and reported as levels (nanograms of metabolite per milligram of creatinine, ng/mg).
Blood pressure was collected and measured at time of enrollment. Systolic and diastolic
BP were measured after ten minutes of rest with an automated cuff and recorded as continuous
variables. Three measurements were taken one minute apart with the last two measurements
averaged.
Statistical Analysis
Variable Selection
In simple linear regression, we draw a line of best fit given data points x and y to
summarize the relationship between x and y. To find the beta estimate and the best fit line, we
minimize the residual sum of squares, otherwise known as ordinary least squares (OLS).
However, traditional OLS offers poor prediction accuracy and interpretation, due to low bias and
large variance, and multiple predictors.
Penalization techniques have been proposed to improve OLS estimates. There are three
types of penalization techniques: ridge regression, least absolute shrinkage and selection
operator (lasso), and elastic net. Ridge regression is a continuous shrinkage method which
minimizes the residual sum of squares subject to a bound on the L2-norm of the coefficients (the
sum of the squared coefficients).198 This method improves prediction through a bias-variance
trade-off, but it does not reduce the number of interpretable predictors. The lasso technique is a
penalized least squares method imposing an L1-penalty on the regression coefficients (the sum of
the absolute coefficients). The lasso does both continuous shrinkage, as in ridge regression, and
automatic variable selection, reducing the number of interpretable predictors.199 Limitations of the
lasso are model saturation when there are more predictors than observations (𝑝 > 𝑛), prediction
performance domination by ridge regression when there are more observations than predictors
(𝑛 > 𝑝), and selection of one variable when predictor correlations are high.200 Elastic net has the

79

advantage of simultaneously doing automatic variable selection, continuous shrinkage, and
selection of groups of correlated variables. Elastic net constrains the model by shrinking
regression coefficients of highly correlated variables towards each other, with a combination of
the penalty terms L1 and L2 norm.200
If the dataset has 𝑛 observations and 𝑝 predictors, let 𝑦 = (𝑦1 … 𝑦𝑛 )𝑇 be the response
and 𝑋 = (𝑥1 | … |𝑥𝑝 ) be the model matrix, where 𝑥𝑗 = (𝑥𝑖𝑗 , … 𝑥𝑛𝑗 )𝑇 , 𝑗 = 1, … 𝑝, are the predictors.
For any fixed non-negative 𝜆1 and 𝜆2 , we define the naïve elastic net criterion:

𝐿(𝜆1 , 𝜆2 , 𝛽) = |𝑦 − 𝑋𝛽|2 + 𝜆2 |𝛽|2 + 𝜆1 |𝛽|1

𝑝

𝑝

where |𝛽|2 = ∑𝑗=1 𝛽𝑗2 , 𝛽1 = ∑𝑗=1 |𝛽𝑗 |.

The naïve elastic net estimator 𝛽̂ is the minimizer of 𝛽̂ = 𝑎𝑟𝑔𝑚𝑖𝑛(𝜆1 , 𝜆2 , 𝛽). This
procedure can be viewed as a penalized least squares method. Let 𝛼 = 𝜆2 /(𝜆1 + 𝜆2 ); then solving
beta hat is equivalent to the optimization problem 𝛽̂ = 𝑎𝑟𝑔𝑚𝑖𝑛|𝑦 − 𝑋𝛽|2 , subject to (1 − 𝛼)|𝛽|1 +
𝛼|𝛽|2 ≤ 𝑡 for some 𝑡. We call the (1 − 𝛼)|𝛽|1 + 𝛼|𝛽|2 the elastic net penalty, which is a convex
combination of the lasso and ridge penalty.
To begin, we subset the data to the year 2012 and summed the chemicals per FIPS
codes based on total releases in pounds. Any chemicals made up of entirely zeroes were
removed. We log transformed the outcome variable and predictor variables and any covariate
county-level percentages were logit transformed. Then we created a training dataset and testing
data set based on 80% of the data to build a predictive model, and 20% to evaluate the model.
The X variables included 467 chemicals (predictors/exposures), and 8 model sociodemographic
and characteristic model adjustments, a possibility of 2467 = 3.81 E +140 models. The GLMNET
package in R fits the generalized linear model via penalized maximum likelihood. The algorithm is
quite fast and can reduce quickly the number of 2p models.201 For each variable selection method,
we used the GLMNET procedure to fit the final model on the training data of the matrix of X
variables (the 467 chemicals and the 8 model adjustments). The 8 covariates were forced into the
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model by setting the penalty to zero so that model adjustments were not penalized. We tested the
ridge regression model (α=0), the lasso model (α=1) and the elastic net model by using a tuning
grid to determine the best α for the data. The α value controls the penalty and bridges the gap
between ridge regression (α=0), elastic net (α= between 0 and 1), and lasso (a=1). We found the
best λ by using the cross-validation technique. We use the minimum lambda to fit the model on
the training data because it is the value of λ at which the cross-validation takes the minimum
mean squared error. Finally, we checked the prediction error for the test data to choose the best
model.
Bayesian Kernel Machine Regression
Simple parametric models typically used in variable selection assume a simple functional
form like a normal distribution. Semi- or nonparametric techniques are preferred in the
identification of potentially synergistic effects of mixture components because they do not assume
the functional form and allow adjustment for potential confounders.202 The Bayesian Kernel
Machine Regression is a semi-parametric technique that models the exposure response
relationship as a non-parametric kernel function of the mixture components, adjusting for
covariates parametrically. The Gaussian kernel flexibly captures underlying functional forms
without specifying the shape of the exposure-response curve. The BKMR method can assess
independent effects, estimate the overall mixture, and assess for interactions among mixture
components.203
Using BKMR, we can assume:

𝑌𝑖 = ℎ(𝑧𝑖 ) + 𝑥𝑖𝑇 𝛽 + 𝜖𝑖

Where 𝑌𝑖 is a health endpoint, 𝑧𝑖 = (𝑧𝑖1 , … , 𝑧𝑖𝑀 )𝑇 is a vector of 𝑀 exposure variables, 𝑥𝑖 contains a
set of potential confounders, and 𝜖𝑖

𝑖. 𝑖. 𝑑
𝑁(0, 𝜎 2 ). In the context of mixtures, ℎ(. ) characterizes a
~

high-dimensional exposure-response function that may incorporate non-linearity and interaction
among the components of the mixture. Therefore, it is difficult to represent ℎ(. ) and is instead

81

presented as a kernel machine representation. The Gaussian kernel is 𝐾(𝑧, 𝑧 ′ ) =
′
2
exp [− ∑𝑀
𝑚=1(𝑧𝑚 − 𝑧 𝑚 ) /𝑝] with 𝑝 tuning parameter. The Gaussian kernel flexibly captures a wide

range of underlying functional forms for ℎ(. ).203
We created models for multiple VOC exposures. Results are reported for the following
five VOC metabolites (CEMA, 3HPMA, DHBMA, MHBMA3, and HPMMA) of three parent
compounds (acrolein, 1,3-butadiene, and crotonaldehyde). To assess multiple VOC models, we
included VOC metabolites that showed statistically significant associations with vascular
outcomes in single-VOC models in chapter 3. We applied a BKMR approach to flexibly model the
relationship between VOC metabolites CEMA, 3HPMA, DHBMA, MHBMA3, and HPMMA and
blood pressure. The method also allowed us to examine statistical interactions between VOC
metabolites within the mixture and joint associations between the whole mixture and blood
pressure. The BKMR creates posterior inclusion probabilities (PIPs) that quantify the relative
importance of each exposure in the model.203 Hierarchical variable selection is used when
components of the mixture are highly correlated (ρ>0.7). Because the VOC metabolites were not
highly correlated (Figure 3), we did not use the hierarchical variable selection procedure of the
BKMR.
All statistical analyses and visualizations were created with R software (version 4.0.2).120
Additionally we used the tidyverse,119 glmnet,204 and kmbayes205 packages to analyze the data.
RESULTS
Variable Selection
County-level population estimates for year 2012 are reported in Table 4-1. There are
currently 767 listed chemicals and 33 chemical categories covered under EPCRA Section 313.
We removed 300 TRI chemicals from analysis due to missing values, leaving a total of 467
predictors to be included in the matrix (Appendix A). The top released chemicals in pounds in
2012 include metal compounds lead, copper, arsenic, and zinc. Lead compounds were the most
released compounds in 2012 at a total of 109 million pounds and qualify as the most released
Clean Air Act chemical.
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For ridge regression, the best λ value obtained from cross-validation is 11.2265 (Table 42). Using this λ generated 446 out of 467 non-zero coefficients. The mean squared error was
0.0252, the largest error of the three models.

Table 4-1. Descriptive statistics [mean (± standard deviation (SD))] for county-level characteristics
in the National County Level Study (n=2,287) in 2012.
Variable
n
CVD Age Adj Rate a
% Male
% White
% Hispanic
% Less than High School
Median HH Income b
Total Mean Smoking
Alcohol
PM2.5 c

Mean (SD)
2287
251.61 (59.20)
0.50 (0.02)
0.85 (0.15)
0.08 (0.12)
22.26 (8.29)
37237.08 (9462.44)
23.68 (3.97)
50.09 (11.34)
8.45 (1.35)

a

County level age-adjusted circulatory disease mortality rate in 2012
County-level median household income in 2012
c
County-level PM2.5 concentrations in 2012
b

Table 4-2. Mean squared errors (MSE) and tuning parameters of the three variable selection
techniques, ridge regression, lasso, and elastic net. The ridge regression uses a tuning
parameter of α=0, lasso uses a tuning parameter of α=1, and the elastic net procedure uses a
tuning parameter of α =0.3.
Ridge
Lambda
11.2265

Ridge
MSE
0.0252

Lasso Lambda
0.0111

Lasso
MSE
0.0245

Elastic Net
Lambda
0.0256

Elastic Net
MSE
0.0244

For lasso, the best λ value obtained from cross-validation is 0.0111. Using this λ in the
lasso model did not generate any non-zero coefficients for any TRI chemicals. County-level
demographics and characteristics were forced into the model and thus were the only variables for
which there were non-zero coefficients.
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With elastic net, we estimated α=0.3 and λ=0.0256 from cross-validation. The elastic net
model using these λ and α values generated non-zero coefficients for five of the 467 TRI
chemicals included (Figure 4-1). The five chemicals included were bromoform,
dichlorobromomethane, dichlorotrifluoroethane, nitrophenol, and thallium. Given that the α=1 for
the lasso procedure, different non-zero coefficients are expected for an elastic net regularization
with α=0.3, an alpha closer to the ridge regression. The mean squared error was smaller for the
elastic net procedure (Table 4-2) and is the preferred variable selection technique for the data.

Figure 4-1. Beta coefficients plotted for each selected variable in the elastic net regularization
technique.
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Bayesian Kernel Machine Regression
Because the VOC metabolites were not highly correlated (Figure 4-2), we did not use the
hierarchical variable selection procedure of the BKMR. In the BKMR model, the metabolites
3HPMA and DHBMA had higher posterior inclusion probabilities (PIPs) for SBP and DBP,
respectively (Table 4-3), indicating that 3HPMA and DBHMA were the most important metabolites
of the group in relation to SBP and DBP. When VOC metabolite predictors were fixed to the 50th
percentile, the 3HPMA exhibited a linear relationship with SBP and several individual VOCs
exhibited a linear relationship with DBP in univariate analysis (Figure 4-3 and 4-4). There was a
positive linear relationship between the whole mixture and SBP, and between the whole mixture
and DBP, when all other predictors were fixed at a range of percentiles (25th to 75th by 0.05),
compared with when they were fixed to the 50th percentile (Figure 4-5 and 4-6). There was no
evidence of interaction between VOC metabolites when all other exposures were fixed to a
percentile or a second VOC was fixed to either the 25th, 50th, or 75th percentile (Figure 4-7 and 48). However, 3HPMA was a critical component of the mixture acting as the primary driver in the
relationship with SBP.

Figure 4-2. Beta coefficients plotted for each selected variable in the elastic net regularization
technique.
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Table 4-3. Posterior inclusion probabilities of individual VOC metabolites in the Bayesian Kernel
Machine Regression model.
VOCa
CEMA
3HPMA
DHBMA
MHBMA3
HPMMA

SBPa
0.0448
0.1212
0.099
0.0462
0.0786

DBPc
0.0412
0.0128
0.0838
0.0082
0.0242

a

Volatile organic compound metabolite short name
Systolic blood pressure
c
Diastolic blood pressure
b

Figure 4-3. Single-VOC metabolite exposure response association when all other metabolites are
fixed to their 50th percentile.

BKMR models adjusted for age, sex, race, BMI, ace inhibitor, ARBs, beta blockers, and daily
PM2.5.
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Figure 4-4. Overall effect of the VOC mixture on systolic and diastolic blood pressure when all
other predictors are at a particular percentile when compared with the value when all predictors
are at their 50th percentile.

BKMR models were adjusted for age, sex, race, BMI, ace inhibitors, ARBs, beta blockers, and
daily PM2.5.

Figure 4-5. Systolic and diastolic blood pressure for an interquartile range increase comparison of
individual VOC metabolite concentrations when all other VOC metabolites have been fixed to the
25th, 50th, and 75th percentiles.
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DISCUSSION
Using two supervised methods to assess mixtures, we were able to understand the
scope of environmental exposures and how they are associated with CVD outcomes. Using the
variable selection technique, elastic net, we identified five TRI chemicals bromoform,
dichlorobromomethane, dichlorotrifluoroethane, nitrophenol, and thallium as the chemicals most
strongly associated with increased county-level age-adjusted CVD mortality rates in 2012. Using
the machine learning technique, BKMR, we identified 3HPMA and DHBMA as the most toxic
VOC metabolites associated with SBP and DBP and found a significantly positive overall mixture
effect, but no interactions.
The variable selection technique, elastic net, identified five chemicals most associated
with CVD mortality, bromoform, dichlorobromomethane, dichlorotrifluoroethane, nitrophenol, and
thallium. Bromoform and dichlorobromomethane are two trihalomethanes otherwise known as
disinfection byproducts with some evidence of congenital anomalies.206-209 Dichlorotrifluoroethane
is a hydrochlorofluorocarbon (HCFC) more commonly known as refrigerants like Freon.
Regulatory agencies have been phasing out HCFCs as part of the Montreal Protocol due to their
ozone depleting nature. However, the extent to which HCFCs affect cardiovascular health is less
studied. Nitrophenol is used in the production of drugs, fungicides, insecticides, and dyes. A
recent longitudinal study of pesticide biomarkers found that type-1 diabetes diagnosed
adolescents with high concentrations of nitrophenol had high HbA1c and low fasting C-peptide
levels, two risk factors in the development of CVD.210 Thallium is a heavy metal produced from
cigarette smoke, mine waste discharge, ore-processing, and coal-burning plants. The primary
symptom of thallium poisoning in humans is hypertension.211
Bayesian Kernel Machine Regression revealed 3HPMA and DHBMA were the most
important contributors of the mixture associated with SBP and DBP, respectively. The parent
compounds, acrolein and 1,3-butadiene are known to be associated with CVD risk.25, 168-170
Acrolein can be produced both endogenously from lipid peroxidation, and exogenously from
combustion, chemical production, cigarette smoke, and e-cigarette vapors.147, 152 1,3-Butadiene is
primarily used to make synthetic rubber, but it is also produced from petroleum processing and
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combustion sources such as vehicle exhaust and cigarette smoke.171 Similar to our results,
previous studies have shown that exposure to acrolein increases BP in both normotensive and
hypertensive rats.154, 155 Another study found normotensive pregnant women had increased odds
of high BP when exposed to ambient 1,3-butadiene two hours prior to admission to labor and
delivery.18 Another cross-sectional study used principal component analysis of nonsmokers’
personal exposures to ambient VOCs. The authors observed decreased endothelial function and
increased DBP in relation to a 1,3-butadiene source in the Detroit Exposure and Aerosol
Research Study (DEARS). No effect on SBP was seen.172
The advantages of this study are the use of methods to assess the association between
mixtures of environmental exposures and CVD. These methods reduce high dimensionality, high
correlation, and multiple comparisons in large datasets. Compared to unsupervised methods,
supervised methods are advantageous due to the consideration of the outcome of interest in the
model. Finally, supervised methods have better prediction accuracy than traditional ordinary least
squares methods. In the National County Level TRI Study, we used three variable selection
procedures, ridge regression, lasso, and elastic net, to determine the best fit model for the most
toxic components associated with county-level age-adjusted mortality rates. Variable selection is
a regularization technique used to penalize lesser contributing predictors in the model toward
zero and select the most important predictors. Variable selection reduced a high dimension
dataset of 467 toxic chemical predictors to five chemical predictors associated with CVD
mortality, which created a more interpretable set of data. In the Louisville Healthy Heart Study, we
used the Bayesian Kernel Machine Regression technique to flexibly model the effect of the VOC
metabolite mixture on blood pressure. This technique allowed us to visualize the univariate and
bivariate relationship of VOC metabolites and blood pressure, assess interactions between VOC
metabolites, and model the effect of the whole mixture on blood pressure. Furthermore, this
method served as a confirmatory analysis to our initial single-pollutant model in Chapter 3.
Finally, to the best of our knowledge, elastic net and BKMR have not yet been used on TRI data
or VOC metabolite data.

89

The major disadvantages of this study are the cross-sectional nature of both datasets,
and the aggregate units in our national county-level study. Both studies are observational studies
and cannot prove causation. Because the national county-level study uses an aggregate
exposure and outcome variable, we cannot extrapolate the results to the individual level.
Furthermore, the ecological design introduces ecological bias: bias due to interaggregate
variation in the disease rate among those not exposed to the risk factor, bias due to groups acting
as effect modifiers in the dose response relationship, and bias due to confounding variables.
Finally, exposure misclassification may be another important source of bias in both datasets.
In our use of variable selection to assess the National County Level TRI data, we are
unable to estimate confidence intervals for nonzero coefficients, a major limitation of prediction.
Additionally, estimated coefficients depend on the scaling of the predictors and may hinder
interpretability. In our use of BKMR to assess the Louisville Healthy Heart data, we had a small
dataset. The BKMR needs a large dataset due to the non-parametric kernel function. The kernel
estimates the mixture-response relationship with a smoothing function and reduces the power.
Finally, because measurement error varies across datasets, a statistical method will choose a
chemical with less error over a more toxic chemical, as long as the two are correlated.212, 213
Human populations are exposed to many anthropogenic pollutants which remain as
complex mixtures in the environment.6, 33 Although there is growing analysis of mixtures and copollutants in epidemiology studies, large gaps in mixture assessment persist. This study used two
supervised methods, elastic net and BKMR, to determine the relevance of mixture components
and the whole mixture in CVD outcomes. In our large matrix of 467 TRI chemicals, the elastic net
procedure identified five potentially toxic chemicals associated with county-level CVD mortality in
2012. In our smaller mixture of five VOC metabolites, the BKMR identified two metabolites as the
most toxic VOC metabolites associated with blood pressure. This study implicates further study of
the toxic compounds identified, acrolein, bromoform, 1,3-butadiene, dichlorobromomethane,
dichlorotrifluoroethane, nitrophenol, and thallium and their role in the development of CVD. This
study also highlights the importance of applying novel, supervised mixture assessment methods
to a range of environmental exposure data. Finally, we want to emphasize the public health
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implications of using these methods to determine and better understand less studied pollutants
and their contribution to adverse health effects.
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SUMMARY AND CONCLUSIONS
SUMMARY OF STUDY
Overall, this work aimed to examine the effect of pollutants with lesser documented
effects on cardiovascular disease using a multi-pronged approach to exposure assessment. The
three aims were to examine the relationship between county-level toxic chemical releases and
CVD mortality in the contiguous United States between 2002 and 2012, to assess the relationship
between individual-level VOC metabolites and vascular function, and to build multipollutant
models from the previous two aims to assess the role of mixtures and mixture components in
CVD mortality and vascular function. Cardiovascular disease is the leading cause of death from
environmental exposures.1 Because criteria pollutants require heavy surveillance under the Clean
Air Act, evidence linking criteria pollutants and CVD preclude investigations of under regulated
pollutants like TRI chemicals and VOCs. The significance of this work is outlined by new,
longitudinal observations using publicly available TRI data, the elucidation of the mechanism of
gaseous pollutants on vascular function, and the identification of potential toxic contributors to
CVD. Furthermore, this work implicates the need for new environmental policies to regulate,
surveil, and reduce pollutants in addition to the six criteria pollutants.
MAJOR FINDINGS
National County Level TRI Study
Exposure to environmental pollution is widespread, threatens all routes of exposure, and
thus is the largest cause of disease and premature death in the world.2 Non-communicable
diseases like CVD have largely been underestimated in relation to pollution. Particularly, the
effects of chemical pollution on human health are poorly defined due to poor knowledge of many
chemicals in common use.90, 91, 130-132 Furthermore, the number of chemicals in commerce
continues to grow exponentially despite unstudied potential adverse health effects.90 Therefore,
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the National County Level TRI Study was designed to examine the effect of pollution from eligible
industries on age-adjusted all cause and circulatory disease mortality rates at the county level
between 2002 and 2012.
County-level age-adjusted all-cause mortality rates, circulatory disease mortality rates,
and the total pollution by quantity and by risk declined between 2002 and 2012. These declines
indicate improvements in pollution reduction programs and public health prevention. Few studies
have examined the effects of county-level toxic releases across the nation, but the declines in
mortality previously seen during industrial shutdowns and post pollution reduction programs214
indicate the rationale for further study. As this decline in mortality is attributed to declines in
pollution, longitudinal examination in the National County Level TRI Study could help clarify the
benefits of further reduction. Additionally, the use of risk reporting in reporting toxic releases to
the TRI could further reduce mortality rates. Our longitudinal analysis of changes in county-level
quantity-based and risk-based pollution showed significant associations with changes in both
age-adjusted all-cause and circulatory disease mortality. Although the association between the
risk-based pollution measure and all-cause mortality was smaller than that for the quantity-based
measure, the association for the risk measure was somewhat larger for circulatory disease
mortality.
Additional nationwide, longitudinal studies of pollution are needed to further strengthen
these findings. Moreover, large studies must be more spatially granular to better understand the
true extent to which pollution exposure affects individuals. However, this study is the first of its
kind to longitudinally assess county-level pollution using mixed effects models. Additionally, the
ecological nature of the study further supports previous reports on the benefits of pollution
reduction in reducing mortality.
Louisville Healthy Heart Study
Volatile organic compounds (VOCs) are another group of pervasive environmental
pollutants classified by their low molecular weight and high vapor pressure. Exposure to VOCs
has been found to be associated with health effects such as CVD, neurological effects, organ
toxicity, and cancer.16, 36 However, most epidemiological studies examine the effects of VOC
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exposure using indirect exposure assessment methods such as ambient air monitoring stations.
The Louisville Healthy Heart Study was designed to examine the effect of environmental
pollutants from human biomonitoring on cardiovascular health. This study focused on the
individual effect of single VOC pollutants on cardiovascular effects such as blood pressure,
endothelial function, and sympathetic response.
Nonsmoking participants with higher VOC metabolite concentrations were older and had
poor cardiovascular health. Specifically, there were significant associations between the acrolein
metabolite, 3HPMA, and systolic blood pressure and endothelial dysfunction, and between the
1,3-butadiene metabolite, DHBMA, and endothelial dysfunction. Black participants had a larger
association between 3HPMA and systolic blood pressure despite lower concentrations of
3HPMA. Several catecholamines were significantly associated with VOC metabolites. The
crotonaldehyde metabolite, HPMMA, was weakly associated with epinephrine, norepinephrine,
dopamine, homovanillic acid, and 5-hydroxytryptamine and strongly associated with serotonin
metabolite 5-hydroxyindole acetic acid. These results seem to indicate that exposure to VOCs,
acrolein, 1,3-butadiene, and crotonaldehyde play a mechanistic role in the development of CVD
by increasing blood pressure, decreasing endothelial function, and increasing the sympathetic
response.
Further work is required to corroborate the findings of our study. Data from larger cohorts
with VOC metabolite concentrations at multiple timepoints may be particularly informative about
these associations in the general population. However, this study lays the groundwork to begin to
understand biological mechanisms that link air pollution constituents with cardiovascular disease,
which can be used to help inform environmental health policy.
Mixture Assessment
Environmental exposures are multifactorial, heterogeneous mixtures. Observed adverse
health effects associated with individual pollutants may be attributable to the combined effects of
multiple pollutants.215 However, because environmental exposures are often highly correlated,
conventional linear regression is complicated by issues of collinearity, high-dimensionality, and
multiple comparisons. Therefore, the mixture assessment methods of the National County Level
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TRI Study and the Louisville Healthy Heart Study were designed to account for these issues in
the data. We used three types of penalized regression, the ridge, lasso, and elastic net, to
determine the potential toxic chemicals associated with circulatory disease mortality rates in the
National County Level TRI Study. Additionally, we used the Bayesian Kernel Machine Regression
to assess the exposure response function of the whole mixture of VOC metabolites and blood
pressure in the Louisville Healthy Heart Study.
In the National County Level TRI Study, the best fit model used the elastic net variable
selection procedure with an estimated α=0.3 and λ=0.0256 from cross-validation. The elastic net
model generated non-zero coefficients for five of the 467 TRI chemicals included in the matrix.
The five chemicals included were bromoform, dichlorobromomethane, dichlorotrifluoroethane,
nitrophenol, and thallium. In the Louisville Healthy Heart Study, 3HPMA and DHBMA had higher
posterior inclusion probabilities (PIPs) for systolic and diastolic blood pressure, respectively,
indicating that 3HPMA and DBHMA were the most important metabolites of the group in relation
to systolic and diastolic blood pressure. When VOC metabolite predictors were fixed to the 50th
percentile, the whole mixture exhibited a linear relationship with systolic and diastolic blood
pressure. The acrolein metabolite, 3HPMA, was a critical component of the mixture acting as the
primary driver in the relationship with SBP.
In general, more work is needed to understand the adverse health effects of pollutant
mixtures and pollutant mixture components. The National County Level TRI Study analysis would
be strengthened from a longitudinal penalized regression. Moreover, the large database of annual
TRI emissions by chemical from 1979 to 2018 would be a great data source for further mixture
assessment, particularly using penalized regression. Additionally, the Bayesian Kernel Machine
Regression would be a useful method to apply to the wealth of urinary VOC metabolite data as
well as other national biomonitoring studies.
STRENGTHS
There are several strengths of our multipronged approach to examine the effects of
multiple pollutants on cardiovascular disease in human populations. Although ecological, the
National County Level TRI Study modelled TRI chemicals and mortality rates at multiple
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timepoints using mixed models. Previous investigations have used averages to assess
associations across multiple years using this data.19, 104, 105 In addition, we created a county-level
risk score to better assess the toxicity of the chemicals released. Previously, studies have
neglected to account for the TRI chemical risk level when modelling adverse health effects.97-99
Finally, to the best of our knowledge, supervised methods to assess mixtures have not yet been
used to assess potential toxicity of TRI chemicals and their effect on cardiovascular health
outcomes. Penalized regression methods reduced a high dimension dataset of 467 toxic
chemical predictors to five chemical predictors associated with CVD mortality, which created a
more interpretable set of data.
The Louisville Healthy Heart Study investigation was strengthened by a strong exposure
assessment method and cotinine cutoff to remove confounding of VOC exposures from smoke
exposure.23, 138, 216 Most studies of VOC exposure are unable to account for smoking, or they
overestimate the contribution of smoking to VOC exposure.64, 65, 172 In addition, about two-thirds of
the cohort reported a diagnosis of some type of CVD. As the prevalence of CVD continues to
increase, it is important to capture susceptible individuals to provide accurate data for the
prevention of CVD. Finally, our supervised methods were advantageous due to the consideration
of the outcome of interest in the model and the better prediction accuracy than traditional ordinary
least squares methods. We used the Bayesian Kernel Machine Regression technique to flexibly
model the effect of the VOC metabolite mixture on blood pressure. This technique allowed us to
visualize the univariate and bivariate relationship of VOC metabolites and blood pressure, assess
interactions between VOC metabolites, and model the effect of the whole mixture on blood
pressure.
LIMITATIONS
Limitations of this study include potential bias from cross-sectional and ecological study
designs, and exposure and outcome measurement error. Misclassification of exposure and
outcome is an important source of bias in epidemiologic studies and present limitations in our
study. Ecological study designs, while beneficial, are aggregated data which cannot be
extrapolated to the individual. Cross-sectional designs only provide one time point, muddying the
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inference for chronic diseases like CVD. Finally, in our method of modelling exposure to mixtures,
we only assume exposure to the chemicals for which we have data. We do not consider the
myriad other exposures present in the environment.
Although our ecological National County Level TRI Study is longitudinal, it is an
observational study and cannot prove causation. Second, because the study uses an aggregate
exposure and outcome variable, we cannot infer results to the individual level. Furthermore, the
ecological design introduces ecological bias: bias due to interaggregate variation in the disease
rate among those not exposed to the risk factor, bias due to groups acting as effect modifiers in
the dose response relationship, and bias due to confounding variables. Finally, even though our
study accounted for chemical toxicity, the values used were already established by the Agency
for Toxic Substances and Disease Registry. While advantageous to our development of a risk
score, reportable quantities are often based on limited or dated toxicology studies and do not
represent more sensitive cardiovascular endpoints.
Limitations of the Louisville Healthy Heart Study include the small sample of nonsmokers,
potential bias from cross-sectional study design and potential misclassification of nonsmokers,
and exposure and outcome measurement error. Misclassification of exposure and outcome is an
important source of bias in epidemiologic studies and is a likely limitation of our study. To quantify
exposure, we measured urinary metabolites. However, urinary metabolites of VOCs range widely
in half-life, and therefore their variable levels due to differences in times of exposure may account
for some of the variability in the data and exposure misclassification. Finally, even though we
tested multiple associations from individual VOC metabolites, we did not adjust for multiple
comparisons which may have allowed for some spurious associations.150
The major limitations of assessing mixtures in the National County Level TRI Study and
the Louisville Healthy Heart Study are the cross-sectional nature of both datasets, and the
aggregate units. Although these methods were better predictive models, we could only predict at
a cross-section of time, further limiting the strength of associations. In our use of variable
selection to assess the National County Level TRI data, we are unable to estimate confidence
intervals for nonzero coefficients, a major limitation of prediction. Additionally, estimated
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coefficients depend on the scaling of the predictors and may hinder interpretability. In our use of
BKMR to assess the Louisville Healthy Heart data, we had a small dataset. The BKMR needs a
large dataset due to the non-parametric kernel function. The kernel estimates the mixtureresponse relationship with a smoothing function and reduces the power. Finally, because
measurement error varies across datasets, a statistical method will choose a chemical with less
error over a more toxic chemical, as long as the two are correlated.212, 213
FUTURE DIRECTIONS
More research is needed to explore less understood pollutants like TRI chemicals and
VOCs. The TRI database is an under-utilized source of toxic chemical data dating back to 1987.
Although the database tracks 737 eligible chemicals, it is an untapped resource of chemicals
polluting our environment, many of which are not regulated. More work needs to be done to
understand the role of specific chemicals and their toxicity in the development of cardiovascular
disease. Additionally, all chemical data have geographic coordinates and have the potential to be
significant spatial data for adverse health outcomes at the individual level. Therefore, future
studies must be designed to better understand chemical specificity and chemical toxicity using
spatial granularity.
There is also a wealth of VOC metabolite data in several national cohorts, as well as the
potential to measure these data in cohorts like the Multi-Ethnic Study of Atherosclerosis or the
Framingham Heart Study. As the measurement of VOCs in human tissue is a sensitive exposure
assessment method, this wealth of data must be used to better understand the mechanistic role
of toxic VOC metabolites in the development of cardiovascular disease. Analyzing these cohorts
will further strengthen the associations identified in our work by providing more statistical power.
More work must be done to understand the role of mixtures in environmental exposure
data. Innovative statistical methods have been developed to investigate the role of multiple
pollutants and must be used in addition to traditional single pollutant models. As environmental
policy is governed by single pollutants, additional work on multiple pollutants will move
environmental policy forward to better regulate multiple pollutants and reduce real-world
exposures. Furthermore, there is a gap in risk reporting of known toxic chemicals, specifically to
98

the TRI, as well as an increasing amount of untested chemicals. We want to emphasize the
public health implications of better understanding less studied pollutants and their contribution to
adverse health effects.
CONCLUSIONS
Overall, the work described here demonstrates the adverse cardiovascular health effects
induced by exposure to pollutants and supports the hypothesis that exposure to pollutants such
as TRI chemicals and VOCs contribute to the development of and mortality from cardiovascular
disease, particularly through increased blood pressure, endothelial dysfunction, and increased
sympathetic response. The aim of this work was to employ three distinct methods of exposure
assessment to evaluate the relationship between exposure to pollutants and CVD. These
methods include the indirect measure of source data from the Toxic Release Inventory, a direct
measure of human biomonitoring, and the assessment of multiple pollutants using the novel
statistical methods elastic net and Bayesian Kernel Machine Regression. Although the results of
these methods were not directly comparable, they contribute novel assessments of environmental
data to the field of environmental cardiology. These results elucidate the potential mechanisms of
environmental pollutants on the development of CVD and identify potential contributors to CVD
mortality. These results further implicate the need for improved environmental policy to prevent
and reduce the prevalence of CVD.
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APPENDICES
APPENDIX A
Variable
_1__3_CHLOROALLYL__3_5_7_TRIAZA_
_1_CHLORO_1_1_DIFLUOROETHANE
_1_CHLORO_1_1_2_2_TETRAFLUOROETH
_1_1_DICHLORO_1_FLUOROETHANE
_1_1_DIMETHYL_HYDRAZINE
_1_1_1_TRICHLOROETHANE
_1_1_1_2_TETRACHLORO_2_FLUOROETH
_1_1_1_2_TETRACHLOROETHANE
_1_1_2_TRICHLOROETHANE
_1_1_2_2_TETRACHLOROETHANE
_1_2_BUTYLENE_OXIDE
_1_2_DIBROMO_3_CHLOROPROPANE
_1_2_DIBROMOETHANE
_1_2_DICHLORO_1_1_DIFLUOROETHANE
_1_2_DICHLORO_1_1_2_TRIFLUOROETH
_1_2_DICHLOROBENZENE
_1_2_DICHLOROETHANE
_1_2_DICHLOROETHYLENE
_1_2_DICHLOROPROPANE
_1_2_DIPHENYLHYDRAZINE
_1_2_PHENYLENEDIAMINE
_1_2_3_TRICHLOROPROPANE
_1_2_4_TRICHLOROBENZENE
_1_2_4_TRIMETHYLBENZENE
_1_3_BUTADIENE
_1_3_DICHLORO_1_1_2_2_3_PENTAFLU
_1_3_DICHLOROBENZENE
_1_3_DICHLOROPROPYLENE
_1_3_PHENYLENEDIAMINE
_1_4_DICHLORO_2_BUTENE
_1_4_DICHLOROBENZENE
_1_4_DIOXANE
_2_ACETYLAMINOFLUORENE
_2_CHLORO_1_1_1_TRIFLUOROETHANE
_2_CHLORO_1_1_1_2_TETRAFLUOROETH
_2_ETHOXYETHANOL
_2_MERCAPTOBENZOTHIAZOLE
_2_METHOXYETHANOL
_2_METHYLLACTONITRILE
_2_METHYLPYRIDINE
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Mean
46.7
66.1
3.6
18.3
0.0
47.5
0.0
2.5
9.9
1.9
2.1
0.0
0.8
12.9
46.1
27.6
230.9
3.7
30.4
0.0
1.6
2.7
3.8
2690.5
547.2
0.0
0.0
3.2
14.4
2.6
18.1
513.4
0.1
19.5
166.5
16.7
16.8
38.3
104.1
25.4

Std Dev
1940.3
2552.5
128.6
516.6
0.4
1008.1
0.2
85.8
219.0
44.6
44.3
0.2
33.9
616.7
2133.8
1120.3
3835.8
120.3
1162.3
0.4
66.6
96.3
118.9
19369.0
10591.1
1.5
0.6
57.4
424.9
121.4
618.2
21612.4
3.3
606.7
3959.2
587.3
427.6
1674.5
4882.1
786.4

Min
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Max
92183
121220
5938
21908
17.32
36502
10
3430
8334
1387.81
1376
10.78
1619
29580
102300
52950
115996.4
5507
55197
15.06
3168
4173
5450
408713
345413.8
73
22.49
1845
17403.8
5824
27128
1035580
158.44
25028
129000
27406
18788
80237.87
234144
27783

_2_NITROPHENOL
_2_NITROPROPANE
_2_PHENYLPHENOL
_2_2_BIS_BROMOMETHYL__1_3_PROPAN
_2_2_DICHLORO_1_1_1_TRIFLUOROETH
_2_3_DICHLOROPROPENE
_2_4_D
_2_4_D_2_ETHYLHEXYL_ESTER
_2_4_D_BUTOXYETHYL_ESTER
_2_4_D_SODIUM_SALT
_2_4_DIAMINOTOLUENE
_2_4_DICHLOROPHENOL
_2_4_DIMETHYLPHENOL
_2_4_DINITROPHENOL
_2_4_DINITROTOLUENE
_2_4_DITHIOBIURET
_2_4_5_TRICHLOROPHENOL
_2_4_6_TRICHLOROPHENOL
_2_6_DINITROTOLUENE
_2_6_XYLIDINE
_3_CHLORO_1_1_1_TRIFLUOROPROPANE
_3_CHLORO_2_METHYL_1_PROPENE
_3_CHLOROPROPIONITRILE
_3_IODO_2_PROPYNYL_BUTYLCARBAMAT
_3_3__DICHLOROBENZIDINE
_3_3__DICHLOROBENZIDINE_DIHYDROC
_3_3__DIMETHOXYBENZIDINE
_3_3__DIMETHOXYBENZIDINE_DIHYDRO
_3_3__DIMETHYLBENZIDINE
_3_3_DICHLORO_1_1_1_2_2_PENTAFLU
_4_AMINOAZOBENZENE
_4_AMINOBIPHENYL
_4_DIMETHYLAMINOAZOBENZENE
_4_NITROPHENOL
_4_4__DIAMINODIPHENYL_ETHER
_4_4__ISOPROPYLIDENEDIPHENOL
_4_4__METHYLENEBIS_2_CHLOROANILI
_4_4__METHYLENEDIANILINE
_4_6_DINITRO_O_CRESOL
_5_NITRO_O_TOLUIDINE
ABAMECTIN
ACEPHATE
ACETALDEHYDE
ACETAMIDE
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1.5
14.4
1.5
0.1
91.3
2.0
173.6
0.5
0.6
0.0
1.1
124.7
21.4
3.4
3.1
0.0
0.0
0.0
0.8
0.0
0.1
0.0
0.0
106.9
0.0
0.0
0.0
0.1
0.0
1.6
0.4
0.0
0.0
0.2
0.4
715.2
0.2
55.4
0.0
0.0
6.1
1.9
4125.8
574.7

69.7
684.1
64.2
3.0
1755.5
88.9
5954.4
15.6
28.8
0.2
38.1
5417.4
845.9
121.8
137.5
0.2
1.0
0.8
39.9
1.7
3.5
1.4
0.2
4939.5
0.3
0.0
0.3
5.3
0.3
77.2
17.0
0.2
0.3
7.7
15.7
12516.3
7.0
2528.7
0.0
0.4
265.9
90.9
18828.5
20107.5

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

3344
32814
3071
145
53928
4255
277319
612
1380
9
1710.7
259321
40470.4
5500
6576
7.49
41.97
29
1915
80
169
52
8
236887
13.52
1.4
13.62
255
13.6
3704
814
11
13.52
371
752.6
405328
250
121267
1
21.06
12684.4
4359
316488
938500

ACETONITRILE
ACETOPHENONE
ACIFLUORFEN__SODIUM_SALT
ACROLEIN
ACRYLAMIDE
ACRYLIC_ACID
ACRYLONITRILE
ALACHLOR
ALDICARB
ALDRIN
ALLYL_ALCOHOL
ALLYL_CHLORIDE
ALLYLAMINE
ALPHA_NAPHTHYLAMINE
ALUMINUM__FUME_OR_DUST_
ALUMINUM_OXIDE__FIBROUS_FORMS_
ALUMINUM_PHOSPHIDE
AMETRYN
AMITROLE
AMMONIA

7619.5
277.4
0.0
358.6
2255.5
1642.4
4736.9
0.0
0.0
0.4
210.8
11.6
3.0
0.0
6908.8
4691.3
0.0
44.9
0.0
73401.7

189245.6
8960.5
0.3
11549.1
57407.3
60080.8
170216.6
0.6
1.5
17.1
5352.4
281.7
88.6
0.3
73851.6
88376.7
2.1
1527.9
0.3
494953.2

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

ANILAZINE
ANILINE
ANTHRACENE
ANTIMONY
ANTIMONY_COMPOUNDS
ARSENIC
ARSENIC_COMPOUNDS

100.0
752.4
20.5
360.3
2459.5
587.2
33190.1

4795.1
31841.2
529.7
12367.6
32822.1
11805.4
1112963.0

0
0
0
0
0
0
0

ASBESTOS__FRIABLE_
ATRAZINE
BARIUM
BARIUM_COMPOUNDS

6119.1
374.7
2514.5
88172.7

181833.6
9920.6
51997.9
454228.4

0
0
0
0

BENFLURALIN
BENZAL_CHLORIDE
BENZENE
BENZIDINE
BENZO_G_H_I_PERYLENE
BENZOIC_TRICHLORIDE
BENZOYL_CHLORIDE
BENZOYL_PEROXIDE
BENZYL_CHLORIDE
BERYLLIUM
BERYLLIUM_COMPOUNDS
BETA_NAPHTHYLAMINE

0.5
0.1
1778.2
0.0
52.8
0.0
1.3
18.4
6.7
0.7
209.3
0.0

21.5
3.9
13834.3
0.4
1020.1
0.3
40.1
423.9
135.1
19.8
2434.4
0.3

0
0
0
0
0
0
0
0
0
0
0
0
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6601129
397371.1
12.3
551074
2111600
2855236
7801250
28
69.9
820
226675.9
12328
3472
13.59
1954989
3032740
99.55
63412
15.15
1177202
3
230015
1524786
23727.3
584866.5
963955
434362.4
5100052
6
8559260
412017
2014596
1253163
3
1000
186
456093.5
13.1
33490.75
13.93
1817
13804
4473
790
61981.75
13.55

BIFENTHRIN
BIPHENYL
BIS_2_CHLORO_1_METHYLETHYL__ETH
BIS_2_CHLOROETHOXY_METHANE
BIS_2_CHLOROETHYL__ETHER
BIS_CHLOROMETHYL__ETHER
BORON_TRICHLORIDE
BORON_TRIFLUORIDE
BROMINE
BROMOCHLORODIFLUOROMETHANE
BROMOFORM
BROMOMETHANE
BROMOTRIFLUOROMETHANE
BROMOXYNIL
BROMOXYNIL_OCTANOATE
BRUCINE
BUTYL_ACRYLATE
BUTYRALDEHYDE
C_I__DIRECT_BLACK_38
C_I__DIRECT_BLUE_218
C_I__SOLVENT_YELLOW_34
CADMIUM
CADMIUM_COMPOUNDS
CALCIUM_CYANAMIDE
CAPTAN
CARBARYL
CARBOFURAN
CARBON_DISULFIDE
CARBON_TETRACHLORIDE
CARBONYL_SULFIDE
CARBOXIN
CATECHOL
CERTAIN_GLYCOL_ETHERS
CHLORDANE
CHLORIMURON_ETHYL
CHLORINE
CHLORINE_DIOXIDE
CHLOROACETIC_ACID
CHLOROBENZENE
CHLOROBENZILATE
CHLORODIFLUOROMETHANE
CHLOROETHANE
CHLOROFORM
CHLOROMETHANE

1.3
197.9
0.0
0.0
0.1
0.0
0.4
5.1
193.2
1.4
4.1
120.8
3.0
0.0
0.0
0.0
182.6
170.5
0.0
0.1
0.0
181.3
3984.0
0.0
0.0
0.5
0.1
4041.6
100.1
5880.2
0.0
6.9
7029.2
0.6
0.0
2567.6
214.9
473.0
217.7
0.0
1014.3
69.4
197.2
558.6
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63.3
3980.5
1.8
0.5
3.8
0.2
14.3
159.4
6633.8
47.9
195.8
2656.4
88.5
0.4
1.1
0.2
4650.6
3586.2
0.3
5.4
0.3
3963.8
139831.5
0.4
0.9
16.8
1.9
94352.4
2173.2
104835.2
0.3
101.5
37529.1
20.5
0.2
86506.5
2586.2
22576.6
7281.2
0.3
21768.6
1629.3
2508.0
6669.6

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

3037
131408
86
21.59
168.0524
7.49
657.2
5656
312000
2081
9392
94400
3238
17.5
54
7.49
156967.7
141549
11
255
13.82
156611
6640948
17.63
27
743.92
89
3752500
72999.47
4100000
12.66
3782.4
915213.1
949.02
9.27
4138718
73690
1082972
337786
13.73
850088.9
67186
57486.68
216252

CHLOROMETHYL_METHYL_ETHER
CHLOROPHENOLS
CHLOROPICRIN
CHLOROPRENE
CHLOROTHALONIL
CHLOROTRIFLUOROMETHANE
CHLORSULFURON
CHROMIUM
CHROMIUM_COMPOUNDS_EXCEPT_CHRO
M
COBALT
COBALT_COMPOUNDS
COPPER
COPPER_COMPOUNDS

0.5
30.2
2.0
114.5
170.4
6.0
0.0
3912.4
20548.6

25.0
1406.1
49.7
5455.2
5216.0
286.7
0.2
38631.4
193615.2

0
0
0
0
0
0
0
0
0

1200
67439.92
2070.91
261675
208162.8
13753
9.39
890005
7152107

204.0
1711.5
6217.4
58918.7

4950.0
11994.2
60476.5
1262744.0

0
0
0
0

CREOSOTE
CRESOL__MIXED_ISOMERS_
CROTONALDEHYDE
CUMENE
CUMENE_HYDROPEROXIDE
CYANAZINE
CYANIDE_COMPOUNDS
CYCLOHEXANE
CYCLOHEXANOL
CYFLUTHRIN
DAZOMET
DECABROMODIPHENYL_OXIDE
DI_2_ETHYLHEXYL__PHTHALATE
DIALLATE
DIAMINOTOLUENE__MIXED_ISOMERS_
DIAZINON
DIBENZOFURAN
DIBROMOTETRAFLUOROETHANE
DIBUTYL_PHTHALATE
DICAMBA
DICHLOROBENZENE__MIXED_ISOMERS_
DICHLOROBROMOMETHANE
DICHLORODIFLUOROMETHANE
DICHLOROFLUOROMETHANE
DICHLOROMETHANE
DICHLOROTETRAFLUOROETHANE__CFC_
DICHLOROTRIFLUOROETHANE
DICHLORVOS
DICOFOL
DICYCLOPENTADIENE

259.0
937.2
23.7
380.0
38.3
6.5
1815.3
1713.0
909.5
1.1
0.6
115.5
367.5
0.0
2.0
9.7
5.5
0.0
71.9
59.4
0.7
1.8
32.2
0.1
1431.9
117.1
0.0
0.0
15.8
156.3

3386.8
9490.3
979.2
6387.3
1169.5
312.7
31339.7
20121.8
34606.7
52.5
15.2
1375.1
4970.7
0.4
87.1
463.6
130.0
2.0
2249.8
2239.0
28.4
85.0
735.5
5.4
14343.1
4038.7
0.2
0.3
758.0
4138.5

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

218387
284233.2
1738355
5164740
2
104730
232200
46305
197016
54463.1
15001
882800
680158
1610800
2518.95
543.3
40002
163525
14.82
4165
22236.25
5627.9
95
101451
101661.8
1356.8
4075
25935
260
369092
184195
9
10
36362.24
183911.8
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DIEPOXYBUTANE
DIETHANOLAMINE
DIETHYL_SULFATE
DIGLYCIDYL_RESORCINOL_ETHER
DIHYDROSAFROLE
DIISOCYANATES
DIMETHIPIN
DIMETHOATE
DIMETHYL_PHTHALATE
DIMETHYL_SULFATE
DIMETHYLAMINE
DIMETHYLAMINE_DICAMBA
DIMETHYLCARBAMYL_CHLORIDE
DINITROBUTYL_PHENOL
DINITROTOLUENE__MIXED_ISOMERS_
DIOXIN_AND_DIOXIN_LIKE_COMPOUND
DIPHENYLAMINE
DIPOTASSIUM_ENDOTHALL
DIPROPYL_ISOCINCHOMERONATE
DIURON
EPICHLOROHYDRIN
ETHOPROP
ETHYL_ACRYLATE
ETHYL_CHLOROFORMATE
ETHYL_DIPROPYLTHIOCARBAMATE
ETHYLBENZENE
ETHYLENE
ETHYLENE_GLYCOL
ETHYLENE_OXIDE
ETHYLENE_THIOUREA
ETHYLENEBISDITHIOCARBAMIC_ACID_
ETHYLENEIMINE
ETHYLIDENE_DICHLORIDE
FENPROPATHRIN
FERBAM
FLUOMETURON
FLUORINE
FOLPET
FOMESAFEN
FORMALDEHYDE

0.0
495.3
2.6
0.0
0.0
1021.7
0.1
0.1
40.5
0.3
114.5
0.2
0.0
19.9
49.5
0.1
15.0
1.5
0.0
22.5
52.3
0.0
90.8
0.2
0.0
1629.0
7775.0
4615.8
135.7
0.5
0.0
0.0
12.8
0.0
0.0
0.4
20.8
0.1
95.4
8794.5

0.3
7585.4
96.3
0.1
0.3
15537.1
5.2
2.3
534.9
5.4
2286.1
6.6
0.3
868.3
1966.5
1.4
442.4
64.0
0.2
938.7
856.1
1.9
3156.4
5.8
0.3
16234.4
116900.8
69610.1
1714.3
14.2
1.4
0.2
407.6
0.7
0.2
20.0
409.4
4.2
4558.2
240336.8

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

FORMIC_ACID
FREON_113
FURAN
GLYCIDOL

6721.0
199.6
1.4
39.7

187411.7
6578.4
65.6
1150.7

0
0
0
0

116

13.58
228941
4515
3
13.55
562488.1
250
109
14698
167.7
83868
305
13.57
41429.7
93632
56.89069
19540
3028
10
44744
29803.1
90
150509.4
255
12
675617.4
3952796
2960751
42929
559
66
7.49
14214
33
9.59
961
14208
201
218648.4
1124903
2
7604518
274832
3146
42201

HEPTACHLOR
HEXACHLORO_1_3_BUTADIENE
HEXACHLOROBENZENE
HEXACHLOROCYCLOPENTADIENE
HEXACHLOROETHANE
HEXACHLOROPHENE
HEXAZINONE
HYDRAZINE
HYDRAZINE_SULFATE
HYDROCHLORIC_ACID__1995_AND_AFT
HYDROGEN_CYANIDE
HYDROGEN_FLUORIDE
HYDROGEN_SULFIDE
HYDROQUINONE
IRON_PENTACARBONYL
ISOBUTYRALDEHYDE
ISODRIN
ISOPRENE
ISOPROPYL_ALCOHOL__MANUFACTURIN
ISOSAFROLE
LACTOFEN
LEAD
LEAD_COMPOUNDS

0.5
1.5
11.3
0.1
1.3
0.0
0.8
218.2
51.2
52993.8
2946.1
14556.4
11493.0
610.9
18.5
63.4
0.0
70.1
0.2
0.0
0.0
4906.8
97319.3

21.3
57.1
414.6
6.6
33.1
0.6
34.6
10439.1
2456.5
266312.6
50569.3
84458.9
110970.6
22793.6
885.4
1933.7
0.0
1670.1
11.8
0.4
0.2
57863.3
2329421.0

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

LINDANE
LINURON
LITHIUM_CARBONATE
M_CRESOL
M_DINITROBENZENE
M_XYLENE
MALATHION
MALEIC_ANHYDRIDE
MALONONITRILE
MANGANESE
MANGANESE_COMPOUNDS
MECOPROP
MERCURY
MERCURY_COMPOUNDS
METHACRYLONITRILE
METHAM_SODIUM
METHANOL
METHOXONE
METHOXONE_SODIUM_SALT
METHOXYCHLOR
METHYL_ACRYLATE

0.0
0.2
96.8
73.9
2.4
114.5
3.5
384.8
0.0
6682.6
69236.6
0.1
31.2
1845.4
289.8
0.7
59486.3
15.2
0.0
0.0
41.6

0.6
10.6
2453.7
3382.6
113.5
2183.5
158.7
9892.5
0.3
99069.2
456307.2
5.5
426.8
50968.1
13900.2
31.7
304890.8
723.0
0.1
0.6
693.7

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
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1019.17
2617.33
19709
313.6
1151.8
29.53
1658
500750.8
117834
5986600
1878928
2036184
4647397
1083808
42472
83540
0.3
61593.4
567
21.08
8
2006487
1.09E+0
8
27.86
509
85811
162201.2
5443
71000
7606.19
446870.9
13.67
4362300
9559607
265
16873.91
1954509
666777
1520
5437770
34683
4
30.36
20167

METHYL_CHLOROCARBONATE
METHYL_HYDRAZINE
METHYL_IODIDE
METHYL_ISOBUTYL_KETONE
METHYL_ISOCYANATE
METHYL_METHACRYLATE
METHYL_TERT_BUTYL_ETHER
METHYLENE_BROMIDE
METRIBUZIN
MIXTURE
MOLYBDENUM_TRIOXIDE
MONOCHLOROPENTAFLUOROETHANE
MYCLOBUTANIL
N_BUTYL_ALCOHOL
N_HEXANE
N_METHYL_2_PYRROLIDONE
N_METHYLOLACRYLAMIDE
N_NITROSO_N_ETHYLUREA
N_NITROSO_N_METHYLUREA
N_NITROSODI_N_PROPYLAMINE
N_NITROSODIPHENYLAMINE
N_NITROSOMETHYLVINYLAMINE
N_NITROSOPIPERIDINE
N_N_DIMETHYLANILINE
N_N_DIMETHYLFORMAMIDE
NABAM
NALED
NAPHTHALENE
NICKEL
NICKEL_COMPOUNDS
NICOTINE_AND_SALTS
NITRAPYRIN
NITRATE_COMPOUNDS

0.1
0.0
9.5
1614.7
0.0
1314.1
824.4
3.3
1.1
302.7
636.3
12.7
0.0
4724.0
14654.8
2939.6
11.2
0.0
0.0
0.0
0.0
0.0
0.0
0.9
437.2
3.3
0.0
922.6
2510.0
12382.3
316.9
0.0
114715.
1
7944.2
18.4
104.4
107.9
28.7
0.1
18.6
2.3
3.0
0.0
99.0

NITRIC_ACID
NITRILOTRIACETIC_ACID
NITROBENZENE
NITROGLYCERIN
NITROMETHANE
O_ANISIDINE
O_CRESOL
O_DINITROBENZENE
O_TOLUIDINE
O_TOLUIDINE_HYDROCHLORIDE
O_XYLENE
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5.5
0.2
312.2
16465.8
0.2
21684.5
32565.4
84.7
52.7
11179.4
7827.5
511.5
0.1
26977.3
88169.6
52931.5
420.9
0.2
0.2
0.0
0.2
0.2
0.4
29.6
12857.3
157.2
0.2
7168.1
36824.5
172867.0
4351.0
0.5
722307.2

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

162499.5
597.6
3340.6
3060.8
1167.8
5.0
689.5
108.7
88.0
0.5
1818.5

0
0
0
0
0
0
0
0
0
0
0

260
8.05
14295
471920
8.63
886657
1550810
2899
2528.77
532750
248254.4
24285
5
451529.6
1950400
1572984
19958.26
8.59
8.56
1
10
7.49
21.07
1258
600490
7540
10
147697
1654067
6909875
120836
21.603
2137602
5
6303631
22363
146196
118369
55523
242
32015
5212
3461
21.68
73000

OCTACHLOROSTYRENE
OSMIUM_TETROXIDE
OXYDIAZON
OXYFLUORFEN
OZONE
P_CHLOROANILINE
P_CRESIDINE
P_CRESOL
P_DINITROBENZENE
P_NITROANILINE
P_PHENYLENEDIAMINE
P_XYLENE
PARALDEHYDE
PARAQUAT_DICHLORIDE
PENDIMETHALIN
PENTACHLOROBENZENE
PENTACHLOROETHANE
PENTACHLOROPHENOL
PENTOBARBITAL_SODIUM
PERACETIC_ACID
PERMETHRIN
PHENANTHRENE
PHENOL
PHENOTHRIN
PHENYTOIN
PHOSGENE
PHOSPHINE
PHOSPHORUS__YELLOW_OR_WHITE_
PHTHALIC_ANHYDRIDE
PICLORAM
PICRIC_ACID
PIPERONYL_BUTOXIDE
POLYCHLORINATED_ALKANES
POLYCHLORINATED_BIPHENYLS
POLYCYCLIC_AROMATIC_COMPOUNDS
POTASSIUM_BROMATE
POTASSIUM_DIMETHYLDITHIOCARBAMA
POTASSIUM_N_METHYLDITHIOCARBAMA
PROMETRYN
PRONAMIDE
PROPACHLOR
PROPANE_SULTONE
PROPANIL
PROPARGITE

0.2
0.0
0.1
0.0
301.5
0.6
0.2
38.1
0.6
0.0
8.9
294.2
0.1
14.2
27.3
0.3
0.7
2.6
0.0
19.6
2.4
76.0
3253.0
0.0
0.5
6.2
2.4
23.1
102.6
0.1
29.9
0.0
0.2
1988.0
938.2
0.1
2.2
17.4
1.1
0.0
0.0
0.1
14.9
0.0
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6.6
0.2
5.3
1.4
4976.7
30.2
6.9
1730.4
27.1
0.4
311.7
6244.9
1.3
488.0
1252.8
10.0
29.5
70.9
0.1
464.3
115.3
1963.9
22994.2
0.4
25.0
175.1
102.2
536.9
1889.0
4.4
1427.7
0.3
6.8
37594.1
14545.6
5.2
107.8
831.0
38.7
0.4
0.1
6.9
498.7
2.3

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

315.92
7.36
250
64.77
141280.2
1450
260
82960.48
1298
20.7
14250
237000
45.2
22573
60080
459.41
1411
2858.5
3
20691
5532
89048.2
569862
20
1200
7600
4845.3
18399.55
68264
204
68483
15
319
1104719
541907.9
250
5173
39862
1455
16.03
4.01
333.03
20500
110

PROPARGYL_ALCOHOL
PROPICONAZOLE
PROPIONALDEHYDE
PROPYLENE
PROPYLENE_OXIDE
PROPYLENEIMINE
PYRIDINE
QUINOLINE
QUINONE
QUINTOZENE
S_S_S_TRIBUTYLTRITHIOPHOSPHATE
SACCHARIN__MANUFACTURING__NO_SU
SAFROLE
SEC_BUTYL_ALCOHOL
SELENIUM
SELENIUM_COMPOUNDS
SILVER
SILVER_COMPOUNDS
SIMAZINE
SODIUM_AZIDE
SODIUM_DICAMBA
SODIUM_DIMETHYLDITHIOCARBAMATE
SODIUM_FLUOROACETATE
SODIUM_NITRITE
STRYCHNINE_AND_SALTS
STYRENE
STYRENE_OXIDE
SULFURIC_ACID__1994_AND_AFTER_A
SULFURYL_FLUORIDE
TERT_BUTYL_ALCOHOL
TETRABROMOBISPHENOL_A
TETRACHLOROETHYLENE
TETRACHLORVINPHOS
TETRACYCLINE_HYDROCHLORIDE
TETRAFLUOROETHYLENE
THALLIUM
THALLIUM_COMPOUNDS
THIABENDAZOLE
THIOACETAMIDE
THIOBENCARB
THIODICARB
THIOPHANATE_METHYL
THIOSEMICARBAZIDE
THIOUREA
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0.6
96.4
94.9
3644.0
167.7
0.1
327.0
7.0
0.2
0.2
0.1
0.0
0.0
213.1
122.4
794.7
125.7
105.0
34.6
1.1
4.5
87.1
0.0
4104.2
0.0
11876.8
0.0
43005.9
194.8
708.8
55.4
438.7
0.1
0.8
142.5
47.0
535.9
45.7
0.0
0.0
0.5
0.6
0.0
1.9

18.5
4347.3
1714.9
44834.8
2730.8
5.1
5927.0
311.3
7.5
5.6
3.8
0.0
0.5
2929.1
2722.7
6650.8
2895.3
1652.3
1167.4
52.5
157.4
2434.9
0.3
107186.1
0.1
49754.2
0.7
252987.4
2407.8
24657.4
1783.1
5053.5
5.3
39.8
4504.3
2252.3
5886.1
2179.0
0.6
0.2
24.3
28.4
0.2
86.7

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

844
208160.9
54668
1519031
80153
228.4
160005
14924
357
247
180
0.97
21.06
100890.6
109136
155841
118216
45311
40202
2520.44
6350
100677.5
12.62
4800500
5
1090671
33.97
4477500
51275
1170380
68882
184062
255
1908
199390.4
108038
128103
104520.8
29.44
10
1165
1361
7.49
4158

THIRAM
TITANIUM_TETRACHLORIDE
TOLUENE
TOLUENE_2_4_DIISOCYANATE
TOLUENE_2_6_DIISOCYANATE
TOLUENE_DIISOCYANATE__MIXED_ISO
TOXAPHENE
TRADE_SECRET_CHEMICAL
TRANS_1_3_DICHLOROPROPENE
TRANS_1_4_DICHLORO_2_BUTENE
TRIADIMEFON
TRIALLATE
TRIBENURON_METHYL
TRICHLORFON
TRICHLOROACETYL_CHLORIDE
TRICHLOROETHYLENE
TRICHLOROFLUOROMETHANE
TRICLOPYR_TRIETHYLAMMONIUM_SALT
TRIETHYLAMINE
TRIFLURALIN
TRIPHENYLTIN_HYDROXIDE
TRYPAN_BLUE
URETHANE
VANADIUM__EXCEPT_WHEN_CONTAINED
VANADIUM_COMPOUNDS
VINYL_ACETATE
VINYL_CHLORIDE
VINYL_FLUORIDE
VINYLIDENE_CHLORIDE
WARFARIN_AND_SALTS
XYLENE__MIXED_ISOMERS_
ZINC__FUME_OR_DUST_
ZINC_COMPOUNDS

121

22.9
14.1
11914.7
1.1
0.2
21.5
0.1
0.7
0.2
0.0
0.0
0.0
0.0
0.0
0.0
1055.1
68.7
0.0
165.6
2.8
0.9
0.0
9.7
263.6
13417.0
788.0
227.7
31.1
16.0
0.0
7189.9
3603.6
111384.
3

433.4
365.9
67310.6
24.6
7.2
272.8
2.8
35.3
9.1
0.3
0.2
0.5
0.2
0.1
0.2
10365.2
2063.7
0.0
2298.0
83.8
29.4
0.6
427.0
4998.9
74032.2
14326.5
3320.1
923.8
400.4
0.2
34767.4
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PERSONAL STATEMENT
‘A dedicated Environmental Health Science PhD candidate with a thorough background in
analytical chemistry, human subjects research, air monitoring, and environmental epidemiology.’
As an environmental health scientist, I am interested in conducting actionable research to
address current environmental issues, influence state and local policy, and engage communities
in participatory research to enact necessary change. My personal goals are to gain further
expertise in actionable research to increase pollution regulation. In addition, I would like to
improve upon existing exposure assessment and statistical methods, and to engage more with
affected communities and stakeholders. My future career goal is to gain a leadership research
position in environmental health to reduce pollution. Currently, I hold two leadership positions,
one as a Superfund Research Program Trainee Leader, and another as American Public Health
Association Environment Section Councilor. I have eight publications, one manuscript recently
published in Environmental Research, and two manuscripts in progress.
EDUCATION

University of Louisville, Louisville, KY, PhD 2021. Environmental Health Science
University of Louisville, Louisville, KY, MPH 2016. Environmental Health Science
University of Louisville, Louisville, KY, BA 2011. Major: Chemistry, Minor: Spanish
RELEVANT EXPERIENCE
2016-2021

PhD Candidate
University of Louisville, Louisville, KY
Mentor: Aruni Bhatnagar
The major focus of my dissertation is to understand how gaseous pollutants such
as volatile organic compounds contribute to cardiovascular disease. The first aim
examines associations between cardiovascular risk factors and urinary
biomarkers of exposure. The second aim examines ecological associations
between toxic releases and cardiovascular mortality. The third aim analyzes
multiple urinary biomarkers of exposure as components of mixtures and how
these mixtures contribute to cardiovascular disease.

2016-2021

Graduate Research Assistant
University of Louisville, Louisville, KY
Mentor: Aruni Bhatnagar
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Reviewed contributors to cardiovascular disease: greenness, built environment,
and exposure to volatile organic compounds; conducted passive and active air
sampling of nitrogen oxides, ultra-fine particulates, and particulate matter;
planned and recruited participants in the HEAL study; and analyzed cohort data
for epidemiological associations of biomarkers of exposure and cardiovascular
disease.
2018-2021

Independent Contractor
Environmental Defense Fund, Houston, TX
Mentor: Elena Craft
Quantified industrial emissions after Hurricane Harvey; created an action plan for
elevated concentrations of benzene in air; supervised Houston city air monitoring
pilot program; assisted community engagement; reviewed literature for low
benzene exposure and immunological and hematological disorders; visualized
data for industrial disaster response.

2015-2017

Clinical Research Consultant
ThreeWire, Louisville, KY
Mentor: Brett Weaver
Data collection for phase II randomized clinical trial with Pfizer; mined data from
electronic medical records; recruited participants; conducted participant
interviews.

2014-2016

Clinical Research Associate
Norton Leatherman Spine Center, Louisville KY
Mentor: Leah Carreon
Collected data and recruited participants for multiple clinical trials and outcomes
research following spine surgeries; managed National Neurosurgery Quality
Outcomes Database; examined patients for scoliosis; used common instruments
Short Form 36 (SF36) and the Euroqol EQ5D to measure patients’ quality of life
and disability index.

2013-2014

Production Technician III
Siemens PETNET Solutions, Louisville, KY
Mentor: Virginia Coakley
Performed quality assurance and control of diagnostic radiopharmaceuticals,
maintained and operated particle accelerator, chemistry box, and gas
chromatography instruments; dispensed and delivered radiopharmaceuticals;
formulated new research radiopharmaceuticals.

2011-2012

Fuels Technician
Safety Kleen, Smithfield, KY
Mentor: Keith Smiley
Characterized waste streams for fuel recycling; maintained and operated multiple
gas chromatography instruments, inductively coupled plasma instrument, and
digestion ovens; analyzed chromatograms for polychlorinated biphenyls and
metal concentrations; performed basic wet laboratory techniques such as pH,
flammability, viscosity.

2011

Summer Research Assistant
Universidad de La Plata CONICET, La Plata, Argentina
Mentor: Francisco Ibanez
Synthesized and characterized gold nanoparticles; analyzed gold nanoparticles
for plasmon resonance in the use of solar cells; performed organic chemistry
technique such as distillation.
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2008-2011

Senior Certified Pharmacy Technician
Walgreens, Louisville, KY
Mentor: Rika Schuchard
Supervised and managed retail pharmacy duties; compounded pharmaceuticals;
translated instructions for Spanish speakers; customer service; extensive
pharmaceutical knowledge.

SKILLS
SAS · R · Data Analysis · Mapping · Fluent Spanish Speaker · Bench Laboratory · Laboratory
Instrumentation · Exposure Assessment · Air Monitoring
PUBLICATIONS
McGraw, K.E, Rai SN, Riggs DW, and Bhatnagar A. Changes in County Level Toxic Releases
are Associated with Increased Circulatory Disease Mortality between 2002-2012. In Preparation.
McGraw, K.E, Konkle SL, Riggs DW, Rai SN, Keith RJ, Amraotkar A, Oshunbade A, Hall M,
Bhatnagar A. Volatile Organic Compound Metabolites are Sensitive Markers of Smoking Patterns
and Status in African Americans: the Jackson Heart Study. In Preparation.
McGraw, K. E., et al. (2021). "Exposure to Volatile Organic Compounds – Acrolein, 1,3Butadiene, and Crotonaldehyde – is Associated with Vascular Dysfunction." Environmental
Research: 110903.
Phillips A, Clark-Leach G, McGraw, K.E, Quist A, Bernhardt C, Keldermen K. Preparing for the
Next Storm, Learning from the Man-Made Environmental Disasters that Followed Hurricane
Harvey. Environmental Integrity Project. 16 August 2018.
Jazini, E., Gum, J., Glassman, S., Crawford III, C.H., Djurasovic, M., Owens II, R.K., Dimar II,
J.R., McGraw, K.E., Carreon, L.Y. Cost-Effectiveness of Circumferential Fusion for Lumbar
Spondylolisthesis: Propensity-Matched Comparison of Transforaminal Lumbar Interbody Fusion
with Anterior-Posterior Fusion. Spine Journal, 2018.
Mladen Djurasovic, MD, McGraw, K.E, Kelly Bratcher, RN, CCRP, Charles H. Crawford III, MD,
John R. Dimar II, MD, Rolando M. Puno, MD, Steven D. Glassman, MD, R. Kirk Owens II,
MD, Leah Y. Carreon, MD, MSc. Randomized Trial of Cell Saver in Two- to Three- Level Lumbar
Instrumented Posterior Fusions. J Neurosurg Spine, 2018.
Laratta JL, Bratcher KR, McGraw K.E., Carreon LY, Owens RK 2nd, Outcomes and revision rates
Following multilevel anterior cervical discectomy and fusion. Journal of Spine Surgery,2018.
Gvozdyev, B.V., Carreon, L.Y., Graves, C.M., Riley, S.A., McGraw, K.E., Head, R.J., Dimar II,
J.R., Glassman, S.D. Patient-reported outcome scores underestimate the impact of major
complications in patients undergoing spine surgery for degenerative conditions. J Neurosurg
Spine, 2017. 27(4): p. 397-402.
Owens II, R.K., Djurasovic, M., Onyekwelu, I., Bratcher, K.R., McGraw, K.E., Carreon, L.Y.
Outcomes and revision rates in normal, overweight, and obese patients 5 years after lumbar
fusion. Spine J, 2016. 16(10): p. 1178-1183.
Carreon, Djurasovic, M., Dimar II, J.R., Owens II, R.K., Crawford III, C.H., Puno, R.M., Bratcher,
K.R., McGraw, K.E., Glassman, S.D. Can the anxiety domain of EQ-5D and mental health items
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from SF-36 help predict outcomes after surgery for lumbar degenerative disorders? J Neurosurg
Spine, 2016. 25(3): p. 352-6.
Carreon, L.Y., Owens II, R.K., Bratcher, K.R., McGraw, K.E. Outcomes and Revision Rates
following Multilevel Anterior Cervical Discectomy and Fusion. The Spine Journal, 2015. 15(10): p.
S226-S227.
ABSTRACTS
Changes in County Level Toxic Releases are Associated with Increased Circulatory Disease
Mortality between 2002-2012. Katlyn E. McGraw, Shesh N. Rai, Daniel W. Riggs, and Aruni
Bhatnagar. Superfund Research Program Annual Conference. College Station, TX. December
2020.
Exposure to Volatile Organic Compounds – Acrolein, 1,3-Butadiene, and Crotonaldehyde – is
Associated with Vascular Dysfunction in the Louisville Healthy Heart Study. McGraw KE; Riggs
DW; Rai SN; Navas-Acien A; Xie Z; Lorkiewicz P; Lynch JF; Zafar N; Krishnasamy S; Taylor KC;
Conklin DJ; DeFilippis AP; Srivastava S; Aruni Bhatnagar. International Society of
Environmental Epidemiology, Washington D.C., August 2020.
‘Toxic Release Sites Cluster in Space in Jefferson County, Kentucky.’ McGraw KE, Srivastava S,
Bhatnagar A. Superfund Research Program Annual Conference, Seattle, WA, November
2019.
‘Toxic Release Sites Cluster in Space in Jefferson County, Kentucky.’ McGraw KE, Srivastava S,
Bhatnagar A. Research!Louisville, Louisville, KY, September 2019.
‘Association of Volatile Organic Compound Exposure and Catecholamines.’ McGraw KE, Riggs
DW, Xie Z, Lorkiewicz P, Krivokhizhina T, Yeager R, Conklin DJ, DeFillipis A, Srivastava S,
Bhatnagar A. Society of Toxicology, Baltimore, MD, March 2019.
‘Association of Volatile Organic Compound Exposure and Catecholamines.’ McGraw KE, Riggs
DW, Xie Z, Lorkiewicz P, Krivokhizhina T, Yeager R, Conklin DJ, DeFillipis A, Srivastava S,
Bhatnagar A. Superfund Research Conference, Sacramento, CA, November 2018.
‘Association of Volatile Organic Compound Exposure and Catecholamines.’ McGraw KE, Riggs
DW, Xie Z, Lorkiewicz P, Krivokhizhina T, Yeager R, Conklin DJ, DeFillipis A, Srivastava S,
Bhatnagar A. Research!Louisville, Louisville, KY, October 2018.
‘Exposure to Environmental Volatile Organic Chemicals is Associated with Cardiovascular Risk.’
McGraw KE, Riggs DW, Xie Z, Lorkiwicz P, Krivokhizhina T, Yeager R, Conklin DJ, Defillipis A,
Srivastava S, Bhatnagar A. Annual Kentucky Public Health Association Conference,
Cincinnati, OH, April 2018.
'Exposure to Environmental Volatile Organic Chemicals is Associated with Cardiovascular Risk.'
McGraw KE, Riggs DW, Xie Z, Lorkiewicz P, Krivokhizhina T, Yeager R, Conklin DJ, DeFillipis A,
Srivastava S, Bhatnagar A. Superfund Research Conference, Philadelphia, PA, December
2017.
'Association between Exposure to Volatile Organic Chemicals and Cardiovascular Injury.'
McGraw KE, Srivastava S, Zafar N, Bhatnagar A. Research!Louisville, Louisville, KY,
September 2017.
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'Global Health Initiatives: Addressing the Knowledge Gap Regarding Over the Counter
Medication Among Newly Arriving Refugees Resettling in the Louisville Area.' McGraw KE,
Wilson R, Ford R, Bosson R, Peyrani P, Carrico R. Research! Louisville, Louisville KY,
September 2015.
'Global Health Initiatives: Addressing the Knowledge Gap Regarding Over the Counter
Medication Among Newly Arriving Refugees Resettling in the Louisville Area.' McGraw KE,
Wilson R, Ford R, Bosson R, Peyrani P, Carrico R. Annual Kentucky Public Health
Association, Owensboro, KY, April 2014.
PRESENTATIONS
‘Applications of Environmental Health.’ University of Louisville, Invited Guest Speaker, PHEH
301 Public Health and Our Environment, Louisville, KY, September 2019.
‘Exposure to Environmental Chemicals is Associated with Cardiovascular Disease Risk.’
University of North Carolina Chapel Hill, Invited Guest Speaker, Environmental Epidemiology
Seminar, Chapel Hill, NC, January 2019.
REVIEW ACTIVITIES
Abstract reviewer for APHA Annual Conference November 2021. Reviewed six abstracts for the
Environmental Section.
Abstract reviewer for APHA Annual Conference November 2020. Reviewed six abstracts for the
Environmental Section.
Abstract reviewer for APHA Annual Conference November 2019. Reviewed six abstracts for the
Environmental Section.
Abstract reviewer for APHA Annual Conference November 2018. Reviewed twelve abstracts for
the Environmental Section.
CERTIFICATES
2020 Mediation, Moderation, and Conditional Process Analysis, Statistical Horizons
2020 Transdisciplinary Environmental Science for Society (TESS), University of Arizona
2019

GIS Workshop, Columbia University, New York, NY

2019

Publishing Academy, University of Louisville, Louisville, KY

2018 Disaster Research Training Workshop, Texas A&M TEEX, College Station, TX
PROFESSIONAL MEMBERSHIP
ISEE International Society of Environmental Epidemiology
SOT Society of Toxicology
SETAC Society of Environmental Toxicology
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APHA American Public Health Association
KPHA Kentucky Public Health Association
LEADERSHIP
2020-2023
2019-2020
2019-2020
2016-2017

APHA Environment Section Councilor
SRP Trainee Leader
Graduate Student Council EOHS Department Representative
Student Government Association SPHIS Secretary

SERVICE
2019-2020
2018-2019
2017-2020
2010-2011

Earth Walk Organizer
APHA Chemicals and Health Committee
West Jefferson Cunty Community Task Force Board Member
Adelante Hispanic Achievers Tutor

AWARDS
2021
2020

Dean’s Citation Award
KC Donnelly Award

REFERENCES
Aruni Bhatnagar
PhD
University of Louisville

aruni.bhatnagar@louisville.edu

Leah Carreon
MD, MSc
Norton Healthcare

leah.carreon@nortonhealthcare.org

Elena Craft
Head Scientist
Environmental Defense Fund
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